LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY), a global consulting firm, today announced its Board of Directors has declared a cash dividend of $0.55 per share that will be payable on July 31, 2026 to shareholders of record on July 6, 2026.
“We are pleased to announce another quarterly cash dividend,” said Gary D. Burnison, CEO, Korn Ferry. “This decision underscores the strength and resilience of our business. Also reflecting our continued commitment to a balanced approach to capital allocation and delivering long-term value for shareholders is our purchase of 1.2 million shares during the quarter, bringing total FY’26 buybacks to 1.8 million shares.”
About Korn Ferry
Korn Ferry is a global consulting firm that powers performance. We unlock the potential in your people and unleash transformation across your business—synchronizing strategy, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. That’s why the world’s most forward-thinking companies across every major industry turn to us—for a shared commitment to lasting impact and the bold ambition to Be More Than.
Forward-Looking Statements
Statements in this Press Release that relate to Korn Ferry’s goals, strategies, future plans and expectations, and other statements of future events or conditions are forward-looking statements that involve a number of risks and uncertainties. Words such as “believes”, “expects”, “anticipates”, “may”, “should”, “will”, “likely”, and “confidence”, and variations of such words and similar expressions are intended to identify such forward-looking statements. Readers are cautioned not to place undue reliance on such statements. Such statements are based on current expectations; actual results in future periods may differ materially from those currently expected or desired because of a number of risks and uncertainties that are beyond the control of Korn Ferry, including global and local political and economic developments, demand fluctuations, and those risks and uncertainties included in Korn Ferry’s periodic filings with the Securities and Exchange Commission, including the factors described in the sections entitled “Risk Factors” and “Forward-Looking Statements” of the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2025 and as will be included in the Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2026. Korn Ferry disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by applicable law.
Korn Ferry ve 4. čtvrtletí zvýšila poplatkové tržby na 759,8 mil. USD a zisk na akcii na 1,39 USD. Za celý rok dosáhla poplatkových tržeb 2,9 mld. USD a upraveného zisku na akcii 5,28 USD.
LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY), a global consulting firm, today announced fourth quarter and annual fee revenue of $759.8 million and $2.9 billion, respectively. In addition, fourth quarter diluted earnings per share was $1.39 and adjusted diluted earnings per share was $1.40, while full year diluted earnings per share was $5.22 and adjusted diluted earnings per share was $5.28.
“I am very pleased with our quarterly performance. This marks our fifth consecutive quarter of top-line growth, underscoring the strength of our strategy and the increasing relevance of our solutions – all amid an uneven economic environment,” said Gary D. Burnison, CEO, Korn Ferry. “In addition to increased momentum across our broader offerings, I am particularly encouraged by double-digit growth in Professional Search & Interim, reflecting the depth and breadth of our solutions.
“As we conclude another fiscal year, I have never been more excited about the potential for Korn Ferry, the impact we have on clients and our We Are Korn Ferry mindset that is furthering collaboration across our firm. I am incredibly proud of our colleagues around the world. Their expertise and passion are the catalyst as we unlock potential in people and unleash transformation across organizations.”
Selected Financial Results
(dollars in millions, except per share amounts) (a)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
759.8
$
712.0
$
2,907.5
$
2,730.1
Total revenue
$
768.3
$
719.8
$
2,938.6
$
2,761.1
Estimated remaining fees under existing contracts (b)
$
1,883.0
$
1,709.6
$
1,883.0
$
1,709.6
Net income attributable to Korn Ferry
$
73.1
$
64.2
$
277.4
$
246.1
Net income attributable to Korn Ferry margin
9.6
%
9.0
%
9.5
%
9.0
%
Basic earnings per share
$
1.42
$
1.23
$
5.33
$
4.69
Diluted earnings per share
$
1.39
$
1.21
$
5.22
$
4.60
Adjusted Results (c):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
129.5
$
121.1
$
497.8
$
463.9
Adjusted EBITDA margin
17.0
%
17.0
%
17.1
%
17.0
%
Adjusted net income attributable to Korn Ferry (d)
$
73.5
$
70.1
$
280.9
$
261.2
Adjusted basic earnings per share (d)
$
1.43
$
1.34
$
5.40
$
4.98
Adjusted diluted earnings per share (d)
$
1.40
$
1.32
$
5.28
$
4.88
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Management separation charges are contractual
obligations due upon executive's death
$
—
$
4.6
$
—
$
4.6
Integration/acquisition costs
$
—
$
1.7
$
4.4
$
8.8
Restructuring charges, net
$
—
$
—
$
—
$
1.9
Impairment of fixed assets
$
—
$
—
$
—
$
0.5
Impairment of right-of-use assets
$
—
$
—
$
—
$
2.5
Gain on modification of office lease
$
—
$
—
$
(13.9
)
$
—
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Accelerated depreciation on Digital platform
$
—
$
—
$
13.8
$
—
Tax effect on the adjusted items
$
0.4
$
(0.5
)
$
(0.9
)
$
(3.2
)
Fiscal 2026 Fourth Quarter Results
The Company reported fee revenue in Q4 FY'26 of $759.8 million, an increase of 7% year-over-year (up 5.0% at constant currency), led by Professional Search & Interim up 14%, followed by Executive Search and Consulting, both up 7% and RPO up 5%.
Net income attributable to Korn Ferry was $73.1 million with a margin of 9.6% in Q4 FY'26, compared to Q4 FY'25 net income attributable to Korn Ferry of $64.2 million with a margin of 9.0%, an increase of 60bps. Adjusted EBITDA was $129.5 million in Q4 FY'26 compared to $121.1 million in Q4 FY'25. Adjusted EBITDA margin was 17.0% in both Q4 FY'26 and Q4 FY'25. Increases in net income attributable to Korn Ferry and margin, as well as Adjusted EBITDA, were primarily due to an increase in fee revenue, partially offset by increases in compensation and benefits expenses and costs of services.
Fiscal 2026 Full Year Results
The Company reported fee revenue in FY'26 of $2,907.5 million, an increase of 7% year-over-year (up 5% at constant currency), led by Professional Search & Interim up 11%, Executive Search up 9%, and Consulting and RPO, both up approximately 4%.
Net income attributable to Korn Ferry was $277.4 million with a margin of 9.5% in FY'26, compared to net income attributable to Korn Ferry of $246.1 million with a margin of 9.0% in FY'25, an increase of 50bps. Adjusted EBITDA was $497.8 million in FY'26 compared to $463.9 million in FY'25. Adjusted EBITDA margin was 17.1% in FY'26, essentially flat compared to the year-ago period. Increases in net income attributable to Korn Ferry and margin, as well as Adjusted EBITDA, were primarily due to an increase in fee revenue, partially offset by increases in compensation and benefits expenses and cost of services.
Results by Solution
Selected Consulting Data
(dollars in millions) (a)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
181.9
$
169.4
$
691.7
$
662.7
Total revenue
$
185.3
$
172.5
$
704.1
$
674.1
Estimated remaining fees under existing contracts (b)
$
390.1
$
367.7
$
390.1
$
367.7
Ending number of consultants and execution staff (c)
1,522
1,599
1,522
1,599
Hours worked in thousands (d)
366
373
1,426
1,510
Average bill rate (e)
$
442
$
413
$
458
$
439
Adjusted Results (f):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
30.9
$
29.1
$
118.4
$
115.5
Adjusted EBITDA margin
17.0
%
17.2
%
17.1
%
17.4
%
____________________ (a)
Numbers may not total due to rounding.
(b)
Estimated fee revenue associated with signed contracts for which revenue has not yet been recognized.
(c)
Represents number of employees originating, delivering and executing consulting services.
(d)
The number of hours worked by consultant and execution staff during the period.
(e)
The amount of fee revenue divided by the number of hours worked by consultants and execution staff.
(f)
Adjusted results exclude the following:
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Management separation charges (g)
$
—
$
4.6
$
—
$
4.6
Restructuring charges, net
$
—
$
—
$
—
$
1.7
Gain on modification of office lease
$
—
$
—
$
(4.1
)
$
—
Fee revenue was $181.9 million in Q4 FY'26 compared to $169.4 million in Q4 FY'25, an increase of $12.5 million or 7% (up 5% on a constant currency basis). The year-over-year increase in Consulting fee revenue was primarily driven by higher fee revenue in leadership development, assessment & succession and organizational strategy offerings.
Adjusted EBITDA was $30.9 million in Q4 FY'26 compared to $29.1 million in the year-ago quarter. Adjusted EBITDA margin was 17.0% in Q4 FY'26, essentially flat compared to the year-ago quarter. The increase in Adjusted EBITDA was primarily from higher fee revenue, partially offset by an increase in compensation and benefits expenses.
Selected Digital Data
(dollars in millions) (a)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
89.3
$
91.6
$
363.5
$
363.5
Total revenue
$
89.7
$
91.6
$
364.4
$
363.7
Estimated remaining fees under existing contracts (b)
$
416.9
$
392.6
$
416.9
$
392.6
Ending number of consultants
233
244
233
244
Subscription & License fee revenue
$
38.0
$
34.5
$
148.6
$
137.7
Adjusted Results (c):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
27.7
$
28.5
$
113.1
$
112.7
Adjusted EBITDA margin
31.0
%
31.1
%
31.1
%
31.0
%
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Impairment of fixed assets
$
—
$
—
$
—
$
0.4
Gain on modification of office lease
$
—
$
—
$
(2.0
)
$
—
Fee revenue was $89.3 million in Q4 FY'26 compared to $91.6 million in Q4 FY'25, a decrease of $2.3 million or 3% (down 6% on a constant currency basis).
Adjusted EBITDA was $27.7 million in Q4 FY'26, compared to $28.5 million in the year-ago quarter. Adjusted EBITDA margin was 31.0%, relatively unchanged from the year-ago quarter.
Selected Executive Search Data(a)
(dollars in millions) (b)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
242.0
$
227.0
$
924.1
$
846.2
Total revenue
$
244.1
$
229.1
$
932.1
$
854.1
Estimated remaining fees under existing contracts (c)
$
73.2
$
69.6
$
73.2
$
69.6
Ending number of consultants
566
560
566
560
Average number of consultants
565
560
563
551
Engagements billed
3,794
3,827
9,511
9,151
New engagements (d)
1,712
1,738
6,514
6,325
Adjusted Results (e):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
64.0
$
54.2
$
237.4
$
206.2
Adjusted EBITDA margin
26.4
%
23.9
%
25.7
%
24.4
%
____________________ (a)
Executive Search is the sum of the individual Executive Search Reporting Segments described in our annual and quarterly reporting on Forms 10-K and 10-Q and is presented on a consolidated basis as it is consistent with the Company’s discussion of its Solutions, and financial metrics used by the Company’s investor base.
(b)
Numbers may not total due to rounding.
(c)
Estimated fee revenue associated with signed contracts for which revenue has not yet been recognized.
(d)
Represents new engagements opened in the respective period.
(e)
Executive Search Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures that adjust for the following:
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Impairment of right-of-use assets
$
—
$
—
$
—
$
2.5
Impairment of fixed assets
$
—
$
—
$
—
$
0.2
Gain on modification of office lease
$
—
$
—
$
(3.7
)
$
—
Restructuring charges, net
$
—
$
—
$
—
$
0.2
Fee revenue was $242.0 million in Q4 FY'26 compared to $227.0 million in Q4 FY'25, an increase of $15.0 million or 7% (up 5% at constant currency). The year-over-year increase in fee revenue was driven by an increase in the weighted-average fees billed per engagement, resulting from more search work at higher levels. The Company experienced fee revenue growth in all regions.
Adjusted EBITDA was $64.0 million in Q4 FY'26 compared to $54.2 million in the year-ago quarter, an increase of $9.8 million or 18% year-over-year. Adjusted EBITDA margin was 26.4%, compared to 23.9% in the year-ago quarter. The increase in Adjusted EBITDA and Adjusted EBITDA margin was primarily due to an increase in fee revenue combined with lower general and administrative expenses, partially offset by an increase in compensation and benefits expenses.
Selected Professional Search & Interim Data
(dollars in millions) (a)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
149.1
$
130.7
$
561.1
$
503.5
Total revenue
$
150.4
$
131.7
$
566.3
$
507.2
Permanent Placement:
Fee revenue
$
59.8
$
50.9
$
222.4
$
203.8
Estimated remaining fees under existing contracts (b)
$
16.5
$
14.1
$
16.5
$
14.1
Engagements billed
1,784
1,829
4,835
4,830
New engagements (c)
1,034
1,009
3,902
3,811
Ending number of consultants
290
309
290
309
Interim:
Fee revenue
$
89.3
$
79.8
$
338.7
$
299.7
Estimated remaining fees under existing contracts (b)
$
144.1
$
107.6
$
144.1
$
107.6
Average bill rate (d)
$
151
$
131
$
145
$
133
Average weekly billable consultants (e)
1,234
1,301
1,237
1,168
Adjusted Results (f):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
33.9
$
27.4
$
121.2
$
107.6
Adjusted EBITDA margin
22.7
%
21.0
%
21.6
%
21.4
%
____________________ (a)
Numbers may not total due to rounding.
(b)
Estimated fee revenue associated with signed contracts for which revenue has not yet been recognized.
(c)
Represents new engagements opened in the respective period.
(d)
Fee revenue from interim divided by the number of hours worked by consultants.
(e)
The number of billable consultants based on a weekly average in the respective period.
(f)
Adjusted results exclude the following:
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Integration/acquisition costs
$
—
$
1.6
$
4.4
$
6.0
Gain on modification of office lease
$
—
$
—
$
(2.6
)
$
—
Fee revenue was $149.1 million in Q4 FY'26 compared to $130.7 million in Q4 FY'25, an increase of $18.4 million or 14% (up 12% at constant currency). Fee revenue increased due to higher fee revenues in both Permanent Placement and Interim. The year-over-year increase in Interim fee revenue was primarily due to a 15% increase in average bill rate. The year-over-year increase in Permanent Placement fee revenue was driven by an increase in the weighted-average fee billed per engagement.
Adjusted EBITDA was $33.9 million in Q4 FY'26 compared to $27.4 million in the year-ago quarter. Adjusted EBITDA margin was 22.7% in Q4 FY'26 compared to 21.0% in the year-ago quarter. The increase in Adjusted EBITDA and Adjusted EBITDA margin was due to an increase in fee revenue, partially offset by increases in compensation and benefits expenses and cost of services.
Selected Recruitment Process Outsourcing ("RPO") Data
(dollars in millions) (a)
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Fee revenue
$
97.6
$
93.3
$
367.1
$
354.1
Total revenue
$
98.7
$
94.8
$
371.8
$
362.0
Estimated remaining fees under existing contracts (b)
$
842.2
$
758.0
$
842.2
$
758.0
RPO new business (c)
$
137.2
$
118.8
$
543.9
$
533.4
Adjusted Results (d):
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Adjusted EBITDA
$
15.5
$
14.5
$
57.7
$
52.6
Adjusted EBITDA margin
15.8
%
15.5
%
15.7
%
14.9
%
Fourth Quarter
Year to Date
FY’26
FY’25
FY’26
FY’25
Gain on modification of office lease
$
—
$
—
$
(1.5
)
$
—
Fee revenue was $97.6 million in Q4 FY'26 compared to $93.3 million in Q4 FY'25, an increase of $4.3 million or 5% (up 3% at constant currency). RPO fee revenue increased primarily due to new logo client wins in North America.
Adjusted EBITDA was $15.5 million in Q4 FY'26 compared to $14.5 million in the year-ago quarter. Adjusted EBITDA margin was 15.8% in Q4 FY'26, compared to 15.5% in Q4 FY'25.
Outlook
Assuming no material negative impact from the recent Middle East conflict and that other worldwide geopolitical conditions, economic conditions, financial markets and foreign exchange rates remain steady, on a consolidated basis:
Q1 FY’27 fee revenue is expected to be in the range of $725 million and $745 million; and Q1 FY’27 diluted earnings per share is expected to range between $1.32 to $1.38. Earnings Conference Call Webcast
The earnings conference call will be held today at 12:00 PM (EDT) and hosted by CEO Gary Burnison, CFO Robert Rozek, SVP Business Development & Analytics Gregg Kvochak and VP Investor Relations Tiffany Louder. The conference call will be webcast and available online at ir.kornferry.com. We will also post to the investor relations section of our website earnings slides, which will accompany our webcast, and other important information, and encourage you to review the information that we make available on our website.
About Korn Ferry
Korn Ferry is a global consulting firm that powers performance. We unlock the potential in your people and unleash transformation across your business—synchronizing strategy, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. That’s why the world’s most forward-thinking companies across every major industry turn to us—for a shared commitment to lasting impact and the bold ambition to Be More Than.
Forward-Looking Statements
Statements in this press release and our conference call that relate to our outlook, projections, goals, strategies, future plans and expectations, including statements relating to expected labor market conditions, expected demand for and relevance of our products and services, expected results of our business diversification strategy, impact of global events on our business, and other statements of future events or conditions are forward-looking statements that involve a number of risks and uncertainties. Words such as “believes”, “expects”, “anticipates”, “goals”, “estimates”, “guidance”, “may”, “should”, “could”, “will” or “likely”, and variations of such words and similar expressions are intended to identify such forward-looking statements. Readers are cautioned not to place undue reliance on such statements. Such statements are based on current expectations; actual results in future periods may differ materially from those currently expected or desired because of a number of risks and uncertainties that are beyond the control of Korn Ferry. The potential risks and uncertainties include those relating to global and local political and or economic developments in or affecting countries where we have operations, such as inflation, trade wars, interest rates, labor market conditions, global slowdowns, or recessions, competition, geopolitical tensions, including the recent Middle East conflict, shifts in global trade patterns, changes in demand for our services as a result of automation, dependence on and costs of attracting and retaining qualified and experienced consultants, impact of inflationary pressures on our profitability, our ability to maintain relationships with customers and suppliers and retaining key employees, maintaining our brand name and professional reputation, potential legal liability and regulatory developments, portability of client relationships, consolidation of or within the industries we serve, changes and developments in government laws and regulations, evolving investor and customer expectations with regard to corporate responsibility matters, currency fluctuations in our international operations, risks related to growth, alignment of our cost structure, including as a result of recent workforce, real estate, and other restructuring initiatives, restrictions imposed by off-limits agreements, reliance on information processing systems, cyber security vulnerabilities or events, changes to data security, data privacy, and data protection laws, dependence on third parties for the execution of critical functions, limited protection of our intellectual property, our ability to enhance, develop and respond to new technology, including artificial intelligence, our ability to successfully recover from a disaster or other business continuity problems, employment liability risk, an impairment in the carrying value of goodwill and other intangible assets, treaties, or regulations on our business and our Company, deferred tax assets that we may not be able to use, our ability to develop new products and services, changes in our accounting estimates and assumptions, the utilization and billing rates of our consultants, seasonality, the use of social media platforms, the ability to effect acquisitions and integrate acquired businesses, resulting organizational changes, our indebtedness, and those relating to the ultimate magnitude and duration of any pandemic or outbreaks. For a detailed description of risks and uncertainties that could cause differences from our expectations, please refer to Korn Ferry’s periodic filings with the Securities and Exchange Commission. Korn Ferry disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Use of Non-GAAP Financial Measures
This press release contains financial information calculated other than in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). In particular, it includes:
Adjusted net income attributable to Korn Ferry, adjusted to exclude accelerated depreciation on our Digital platform, management separation charges, integration/acquisition costs, restructuring charges, impairment of fixed assets, impairment of right-of-use assets and gain on modification of an office lease, net of income tax effect; Adjusted basic and diluted earnings per share, adjusted to exclude cost associated with accelerated depreciation on our Digital platform, management separation charges, integration/acquisition costs, restructuring charges, impairment of fixed assets, impairment of right-of-use assets and gain on modification of an office lease, net of income tax effect; Constant currency (calculated using a quarterly average) percentages that represent the percentage change that would have resulted had exchange rates in the prior period been the same as those in effect in the current period; and Consolidated and Executive Search Adjusted EBITDA, which is earnings before interest, taxes, depreciation and amortization, further adjusted to exclude management separation charges, integration/acquisition costs, restructuring charges, impairment of fixed assets, impairment of right-of-use assets and gain on modification of an office lease, net when applicable, and Consolidated and Executive Search Adjusted EBITDA margin. This non-GAAP disclosure has limitations as an analytical tool, should not be viewed as a substitute for financial information determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies.
Management believes the presentation of non-GAAP financial measures in this press release provides meaningful supplemental information regarding Korn Ferry’s performance by excluding certain items that may not be indicative of Korn Ferry’s ongoing operating results. These non-GAAP financial measures are performance measures and are not indicative of the liquidity of Korn Ferry. These items, which are described in the footnotes in the attached reconciliations, represent 1) costs associated with previous acquisitions, such as legal and professional fees, retention awards and on-going integration expenses, 2) gain on modification of an office lease where the Company received lease incentives to shorten the lease term, 3) restructuring charges, net to align workforce to eliminate excess capacity resulting from challenging macroeconomic business environment, 4) accelerated depreciation associated with the decision to sunset our Digital platform, 5) impairment of fixed assets primarily due to software impairment charge in our Digital segment, 6) impairment of right-of-use assets due to the decision to terminate and sublease some of our offices and 7) management separation charges due to contractual obligations due upon executive's death. The use of non-GAAP financial measures facilitates comparisons to Korn Ferry’s historical performance. Korn Ferry includes non-GAAP financial measures because management believes they are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its evaluation of Korn Ferry’s ongoing operations and financial and operational decision-making. Adjusted net income attributable to Korn Ferry, adjusted basic and diluted earnings per share and Consolidated and Executive Search Adjusted EBITDA, exclude certain charges that management does not consider on-going in nature and allows management and investors to make more meaningful period-to-period comparisons of the Company’s operating results. Management further believes that Consolidated and Executive Search Adjusted EBITDA is useful to investors because it is frequently used by investors and other interested parties to measure operating performance among companies with different capital structures, effective tax rates and tax attributes and capitalized asset values, all of which can vary substantially from company to company. In the case of constant currency percentages, management believes the presentation of such information provides useful supplemental information regarding Korn Ferry's performance as excluding the impact of exchange rate changes on Korn Ferry's financial performance allows investors to make more meaningful period-to-period comparisons of the Company’s operating results, to better identify operating trends that may otherwise be masked or distorted by exchange rate changes and to perform related trend analysis, and provides a higher degree of transparency of information used by management in its evaluation of Korn Ferry's ongoing operations and financial and operational decision-making.
KORN FERRY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
Three Months Ended
April 30,
Year Ended
April 30,
2026
2025
2026
2025
(unaudited)
Fee revenue
$
759,772
$
712,048
$
2,907,469
$
2,730,088
Reimbursed out-of-pocket engagement expenses
8,484
7,779
31,172
30,998
Total revenue
768,256
719,827
2,938,641
2,761,086
Compensation and benefits
486,737
443,503
1,867,005
1,758,024
General and administrative expenses
67,659
68,623
247,727
258,488
Reimbursed expenses
8,484
7,779
31,172
30,998
Cost of services
82,262
74,827
319,150
285,075
Depreciation and amortization
21,591
20,531
98,844
80,287
Restructuring charges, net
—
—
—
1,892
Total operating expenses
666,733
615,263
2,563,898
2,414,764
Operating income
101,523
104,564
374,743
346,322
Other income (loss), net
6,410
(10,306
)
33,705
18,953
Interest expense, net
(5,056
)
(5,331
)
(19,998
)
(20,363
)
Income before provision for income taxes
102,877
88,927
388,450
344,912
Income tax provision
29,052
23,789
107,630
93,836
Net income
73,825
65,138
280,820
251,076
Net income attributable to noncontrolling interest
(691
)
(894
)
(3,386
)
(5,014
)
Net income attributable to Korn Ferry
$
73,134
$
64,244
$
277,434
$
246,062
Earnings per common share attributable to Korn Ferry:
Basic
$
1.42
$
1.23
$
5.33
$
4.69
Diluted
$
1.39
$
1.21
$
5.22
$
4.60
Weighted-average common shares outstanding:
Basic
50,932
51,599
51,428
51,778
Diluted
51,922
52,504
52,519
52,806
KORN FERRY AND SUBSIDIARIES
FINANCIAL SUMMARY BY REPORTING SEGMENT
(dollars in thousands)
(unaudited)
Three Months Ended April 30,
Year Ended April 30,
2026
2025
% Change
2026
2025
% Change
Fee revenue:
Consulting
$
181,920
$
169,363
7.4
%
$
691,654
$
662,708
4.4
%
Digital
89,282
91,634
(2.6
%)
363,523
363,530
—
%
Executive Search:
North America
156,095
143,014
9.1
%
583,394
535,921
8.9
%
EMEA
54,135
53,479
1.2
%
215,134
194,088
10.8
%
Asia Pacific
24,622
23,630
4.2
%
97,527
87,337
11.7
%
Latin America
7,099
6,880
3.2
%
28,049
28,862
(2.8
%)
Total Executive Search (a)
241,951
227,003
6.6
%
924,104
846,208
9.2
%
Professional Search & Interim
149,060
130,710
14.0
%
561,077
503,515
11.4
%
RPO
97,559
93,338
4.5
%
367,111
354,127
3.7
%
Total fee revenue
759,772
712,048
6.7
%
2,907,469
2,730,088
6.5
%
Reimbursed out-of-pocket engagement expenses
8,484
7,779
9.1
%
31,172
30,998
0.6
%
Total revenue
$
768,256
$
719,827
6.7
%
$
2,938,641
$
2,761,086
6.4
%
KORN FERRY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
April 30,
2026
April 30,
2025
ASSETS
Cash and cash equivalents
$
1,095,445
$
1,006,964
Marketable securities
38,914
36,388
Receivables due from clients, net of allowance for doubtful accounts of $42,527 and $40,461 at April 30, 2026 and 2025, respectively
573,350
565,255
Income taxes and other receivables
75,410
38,394
Unearned compensation
64,421
61,649
Prepaid expenses and other assets
58,437
41,488
Total current assets
1,905,977
1,750,138
Marketable securities, non-current
247,132
233,626
Property and equipment, net
191,531
173,610
Operating lease right-of-use assets, net
170,986
152,712
Cash surrender value of company-owned life insurance policies, net of loans
289,058
252,621
Deferred income taxes
113,207
144,560
Goodwill
950,636
948,832
Intangible assets, net
45,858
70,193
Unearned compensation, non-current
118,592
106,965
Investments and other assets
31,799
27,967
Total assets
$
4,064,776
$
3,861,224
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable
$
49,682
$
58,884
Income taxes payable
19,573
23,079
Compensation and benefits payable
570,242
530,473
Operating lease liability, current
28,111
38,573
Other accrued liabilities
314,402
304,589
Total current liabilities
982,010
955,598
Deferred compensation and other retirement plans
510,774
477,770
Operating lease liability, non-current
164,899
131,762
Long-term debt
398,565
397,736
Deferred tax liabilities
5,723
5,981
Other liabilities
23,902
20,238
Total liabilities
2,085,873
1,989,085
Stockholders' equity
Common stock: $0.01 par value, 150,000 shares authorized, 79,203 and 78,264 shares issued and 50,225 and 51,458 shares outstanding at April 30, 2026 and 2025, respectively
284,370
364,425
Retained earnings
1,761,063
1,588,274
Accumulated other comprehensive loss, net
(72,827
)
(86,243
)
Total Korn Ferry stockholders' equity
1,972,606
1,866,456
Noncontrolling interest
6,297
5,683
Total stockholders' equity
1,978,903
1,872,139
Total liabilities and stockholders' equity
$
4,064,776
$
3,861,224
KORN FERRY AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(dollars in thousands)
(unaudited)
Three Months Ended
April 30,
Year Ended
April 30,
2026
2025
2026
2025
Net income attributable to Korn Ferry
$
73,134
$
64,244
$
277,434
$
246,062
Net income attributable to non-controlling interest
691
894
3,386
5,014
Net income
73,825
65,138
280,820
251,076
Income tax provision
29,052
23,789
107,630
93,836
Income before provision for income taxes
102,877
88,927
388,450
344,912
Interest expense, net
5,056
5,331
19,998
20,363
Depreciation and amortization (1)
21,591
20,531
98,844
80,287
Management separation charges (2)
—
4,614
—
4,614
Integration/acquisition costs (3)
—
1,738
4,420
8,837
Gain on modification of office lease (4)
—
—
(13,907
)
—
Impairment of right-of-use assets (5)
—
—
—
2,452
Impairment of fixed assets (6)
—
—
—
509
Restructuring charges, net (7)
—
—
—
1,892
Adjusted EBITDA
$
129,524
$
121,141
$
497,805
$
463,866
Net income attributable to Korn Ferry margin
9.6
%
9.0
%
9.5
%
9.0
%
Net income attributable to non-controlling interest
0.1
%
0.1
%
0.1
%
0.2
%
Income tax provision
3.8
%
3.3
%
3.7
%
3.4
%
Interest expense, net
0.7
%
0.8
%
0.7
%
0.8
%
Depreciation and amortization (1)
2.8
%
2.9
%
3.4
%
2.9
%
Management separation charges (2)
—
%
0.7
%
—
%
0.2
%
Integration/acquisition costs (3)
—
%
0.2
%
0.2
%
0.3
%
Gain on modification of office lease (4)
—
%
—
%
(0.5
%)
—
%
Impairment of right-of-use assets (5)
—
%
—
%
—
%
0.1
%
Impairment of fixed assets (6)
—
%
—
%
—
%
0.0
%
Restructuring charges, net (7)
—
%
—
%
—
%
0.1
%
Adjusted EBITDA margin
17.0
%
17.0
%
17.1
%
17.0
%
Net income attributable to Korn Ferry
$
73,134
$
64,244
$
277,434
$
246,062
Accelerated depreciation on Digital platform (1)
—
—
13,846
—
Management separation charges (2)
—
4,614
—
4,614
Integration/acquisition costs (3)
—
1,738
4,420
8,837
Gain on modification of office lease (4)
—
—
(13,907
)
—
Impairment of right-of-use assets (5)
—
—
—
2,452
Impairment of fixed assets (6)
—
—
—
509
Restructuring charges, net (7)
—
—
—
1,892
Tax effect on the adjusted items (8)
380
(487
)
(863
)
(3,187
)
Adjusted net income attributable to Korn Ferry
$
73,514
$
70,109
$
280,930
$
261,179
Explanation of Non-GAAP Adjustments
(1)
Depreciation and amortization includes $13.8 million of accelerated depreciation associated with the decision to sunset our Digital platform in the year ended April 30, 2026.
(2)
Contractual obligations due upon executive's death.
(3)
Costs associated with previous acquisitions, such as legal and professional fees, retention awards and the on-going integration expenses.
(4)
Gain on the modification of an office lease where the Company received lease incentives to shorten the lease term.
(5)
Costs associated with impairment of right-of-use assets due to terminating and deciding to sublease some of our offices.
(6)
Costs associated with impairment of fixed assets primarily due to software impairment charge in our Digital segment.
(7)
Restructuring charges incurred to align our workforce to eliminate excess capacity resulting from challenging macroeconomic business environment.
(8)
Tax effect on accelerated depreciation on Digital platform, management separation charges, integration/acquisition costs, gain on modification of office lease, impairment of right-of-use assets and fixed assets, and restructuring charges, net.
KORN FERRY AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - CONTINUED
(unaudited)
Three Months Ended
April 30,
Year Ended
April 30,
2026
2025
2026
2025
Basic earnings per common share
$
1.42
$
1.23
$
5.33
$
4.69
Accelerated depreciation on Digital platform (1)
—
—
0.27
—
Management separation charges (2)
—
0.09
—
0.09
Integration/acquisition costs (3)
—
0.03
0.09
0.17
Gain on modification of office lease (4)
—
—
(0.27
)
—
Impairment of right-of-use assets (5)
—
—
—
0.05
Impairment of fixed assets (6)
—
—
—
0.01
Restructuring charges, net (7)
—
—
—
0.03
Tax effect on the adjusted items (8)
0.01
(0.01
)
(0.02
)
(0.06
)
Adjusted basic earnings per share
$
1.43
$
1.34
$
5.40
$
4.98
Diluted earnings per common share
$
1.39
$
1.21
$
5.22
$
4.60
Accelerated depreciation on Digital platform (1)
—
—
0.26
—
Management separation charges (2)
—
0.09
—
0.09
Integration/acquisition costs (3)
—
0.03
0.08
0.16
Gain on modification of office lease (4)
—
—
(0.26
)
—
Impairment of right-of-use assets (5)
—
—
—
0.05
Impairment of fixed assets (6)
—
—
—
0.01
Restructuring charges, net (7)
—
—
—
0.03
Tax effect on the adjusted items (8)
0.01
(0.01
)
(0.02
)
(0.06
)
Adjusted diluted earnings per share
$
1.40
$
1.32
$
5.28
$
4.88
Explanation of Non-GAAP Adjustments
(1)
Depreciation and amortization includes $13.8 million of accelerated depreciation associated with the decision to sunset our Digital platform in the year ended April 30, 2026.
(2)
Contractual obligations due upon executive's death.
(3)
Costs associated with previous acquisitions, such as legal and professional fees, retention awards and the on-going integration expenses.
(4)
Gain on the modification of an office lease where the Company received lease incentives to shorten the lease term.
(5)
Costs associated with impairment of right-of-use assets due to terminating and deciding to sublease some of our offices.
(6)
Costs associated with impairment of fixed assets primarily due to software impairment charge in our Digital segment.
(7)
Restructuring charges incurred to align our workforce to eliminate excess capacity resulting from challenging macroeconomic business environment.
(8)
Tax effect on accelerated depreciation on Digital platform, management separation charges, integration/acquisition costs, gain on modification of office lease, impairment of right-of-use assets and fixed assets, and restructuring charges, net.
KORN FERRY AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - CONTINUED
Korn/Ferry (KFY - Free Report) came out with quarterly earnings of $1.4 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +2.19%. A quarter ago, it was expected that this staffing company would post earnings of $1.22 per share when it actually produced earnings of $1.28, delivering a surprise of +4.92%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Korn/Ferry, which belongs to the Zacks Staffing Firms industry, posted revenues of $759.77 million for the quarter ended April 2026, surpassing the Zacks Consensus Estimate by 2.74%. This compares to year-ago revenues of $712.05 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Korn/Ferry shares have added about 2.7% since the beginning of the year versus the S&P 500's gain of 9.2%.
What's Next for Korn/Ferry?While Korn/Ferry has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Korn/Ferry was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.36 on $732.4 million in revenues for the coming quarter and $5.70 on $3 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Staffing Firms is currently in the bottom 16% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Robert Half (RHI - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.
This staffing firm is expected to post quarterly earnings of $0.26 per share in its upcoming report, which represents a year-over-year change of -36.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Robert Half's revenues are expected to be $1.33 billion, down 3.2% from the year-ago quarter.
Korn Ferry od 1. čtvrtletí fiskálního roku 2027 přejde na reporting podle regionů Americas, EMEA a APAC. Ve 4. čtvrtletí vzrostly výnosy z poplatků o 6,7 % na 759,8 mil. USD.
Key Takeaways Korn Ferry will shift reporting to the Americas, EMEA and APAC segments starting in fiscal 2027.KFY's referral rate rose to 29.1%, while Marquee and Diamond accounts held 40% of fee revenues.Korn Ferry saw Q4 fee revenues rise 6.7%, led by 14% growth in Professional Search & Interim. Korn Ferry (KFY - Free Report) used its fourth-quarter call to do more than highlight another quarter of growth. Management used the discussion to frame a broader operating shift, arguing the firm is now better positioned to sell across clients, geographies and solutions.
The headline numbers were solid, but the more important takeaway was strategic. Executives spent much of the call explaining how a more regionally oriented model is meant to deepen client penetration and sustain growth even as macro conditions remain uneven.
KFY Recasts How It Wants to Be MeasuredPresident and CEO Gary Burnison said Korn Ferry is moving away from presenting itself as a set of separate solutions and toward a more integrated, client-centric firm. He tied that change to the company’s “We Are Korn Ferry” push and said the next phase is meant to make the whole organization work more cohesively around customers.
Beginning in the first quarter of fiscal 2027, external reporting will shift to three regional segments: the Americas, EMEA and APAC. Solution details will still be disclosed, but under broader groupings spanning search, talent and organizational solutions, and workforce solutions.
That was a notable call theme because it signals that management wants investors to judge execution less by isolated business lines and more by how effectively the firm integrates offerings across accounts and markets. Burnison said the organization had been too solution-weighted and needed to pivot more toward geography.
Korn Ferry Leans Harder on Cross-SellingExecutive vice president, CFO and chief corporate officer Robert Rozek pointed to a 29.1% business referral rate in the quarter, up about 320 basis points, as evidence that the cross-selling push is gaining traction. He also said Marquee and Diamond accounts remained at 40% of consolidated fee revenues.
Rozek said the company is reviewing larger new engagements in a highly structured way, with regional, solution and industry leaders involved. In management’s view, that process is helping Korn Ferry win an initial mandate and then expand the relationship across the firm.
The financial backdrop supported that message. Estimated remaining fees under existing contracts rose 10% year over year to $1.883 billion, with management saying growth came from every solution. About 57% of that backlog is expected to be recognized over the next year.
KFY Finds Its Best Momentum in SearchKorn Ferry’s adjusted earnings per share came in at $1.40, which topped the Zacks Consensus Estimate of $1.37 by 2.2%. Fourth-quarter revenues rose 6.7% year over year to $759.8 million, beating the Zacks Consensus Estimate of $739.5 million by 2.7%.
The strongest operating momentum came from Professional Search & Interim, where fee revenues increased 14% to $149.1 million. Executive Search also remained healthy, with fee revenues up 7% to $242.0 million and adjusted EBITDA margin expanding to 26.4% from 23.9% a year earlier.
Burnison said Executive Search is moving upmarket, with higher average fees reflecting work at more senior organizational levels. On interim staffing, he said the business is benefiting both from internal referrals and from higher-value demand in areas such as technology, finance and accounting, HR and supply chain.
Korn Ferry Sees Pockets of External PressureNot every business line moved the same way. Digital fee revenues fell 3% in the quarter to $89.3 million, although subscription and license fee revenues increased to $38.0 million from $34.5 million. Consulting and RPO each posted 7% and 5% fee revenue growth, respectively.
On the macro front, management was explicit that the recent Middle East conflict hurt new business trends outside the Americas. Burnison told analysts that the disruption affected EMEA, the Middle East and APAC, even as demand in the Americas remained strong over the trailing four months.
That backdrop shaped a measured near-term outlook. Korn Ferry guided first-quarter fiscal 2027 fee revenues to $725 million to $745 million and earnings per share to $1.32 to $1.38, while Rozek said adjusted EBITDA margin should stay around 17%.
KFY Uses Q&A to Clarify Margins and AIWhen analysts pressed on the flat fourth-quarter adjusted EBITDA margin, Burnison said the main reason was higher bonus expense tied to stronger-than-expected revenue performance. Management framed that as a trade-off it was willing to accept in exchange for better top-line delivery.
On consulting, Burnison said the firm is challenging itself to move beyond traditional pricing structures and capture more value-based economics over time. He did not present a near-term change, but the comments suggested pricing model evolution is part of the broader strategic agenda.
AI also drew scrutiny. Burnison said Korn Ferry is already seeing efficiency gains across work streams, particularly in search, but stressed that the company is prioritizing customer experience and the protection of its proprietary assessment and client data over simply extracting cost savings.
Korn Ferry Keeps Growth and Capital in BalanceManagement’s overall tone was confident but not carefree. Burnison repeatedly emphasized the size of Korn Ferry’s market opportunity and said the company now thinks in billions rather than hundreds of millions, yet he paired that ambition with caution around geopolitics and client spending conditions.
Capital allocation remained disciplined. Korn Ferry repurchased 1.24 million shares for $78.8 million in the quarter, returned $221 million to shareholders during fiscal 2026 through buybacks and dividends, and invested $85 million in capital spending tied to Talent Suite and productivity tools.
Zacks Signals on KFYKFY carries a Zacks Rank #3 (Hold), while its Value Score is A, Growth Score is B, Momentum Score is A, and VGM Score is A. Under the Zacks framework, the rank is the primary signal for near-term earnings revision momentum, while stronger Style Scores point to more attractive value, growth and momentum characteristics. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
That combination points to balanced near-term prospects rather than a clear bullish or bearish signal. The A-rated VGM profile is favorable on combined style traits, but the Zacks framework places greater weight on estimate revisions, meaning the current Zacks Rank can change as analysts update forecasts after the latest results.
Newell Brands v 1. čtvrtletí snížil srovnatelné tržby o 3,5 %, ale výsledek překonal očekávání a zlepšil se proti předchozím obdobím. Firma čeká návrat růstu srovnatelných tržeb ve 2. čtvrtletí.
Key Takeaways Newell's core sales fell 3.5% in Q1 but improved sequentially and beat management's expectations.Six of Newell's top 10 brands gained share, while six delivered year-over-year POS growth in Q1.Newell plans 25 major innovations in 2026 and expects core sales growth to return in Q2. Newell Brands Inc.’s (NWL - Free Report) turnaround strategy appears to be gaining traction, supported by improving consumer demand, stronger point-of-sale trends and market share gains across several key brands. Although core sales remained negative in the first quarter, management’s commentary suggests that the company’s renewed focus on innovation, advertising investments and retail execution is beginning to translate into better business performance, raising the question of whether Newell is approaching a sustainable growth inflection point.
The numbers suggest meaningful progress. First-quarter core sales declined 3.5% year over year, but the result exceeded management’s expectations and marked a sequential improvement from prior quarters. Six of Newell’s top 10 brands gained market share during the quarter, while six brands also posted year-over-year point-of-sale growth for the first time in more than four years. The Learning & Development segment returned to growth, driven by a 4.9% increase in the Baby business. Additionally, the company benefited from a $25 million net pricing advantage tied to improved customer program management, helping normalize operating margin and expand it by 30 basis points to 4.8%.
A key driver behind the improving sales trajectory is Newell’s strengthened innovation pipeline. The company plans to launch 25 Tier 1 and Tier 2 innovations in 2026, up from 18 in the previous year, with products spanning all business segments. Management noted strong early consumer response to innovations such as Graco’s new car seats and Coleman’s Snap 'N Go cooler. Coupled with higher advertising and promotional spending, these initiatives are supporting stronger retailer relationships, distribution gains and shelf placement opportunities, which should provide additional sales momentum throughout the year.
Despite encouraging signs, challenges remain. Commodity inflation, particularly higher resin and transportation costs, continues to pressure profitability, while consumer spending trends remain uneven across income groups. Nevertheless, Newell’s reduced exposure to China sourcing, expanded domestic manufacturing capabilities and disciplined cost-management efforts position the company well to navigate these headwinds. With management now expecting a return to core sales growth in the second quarter and raising its full-year sales outlook, the turnaround story appears increasingly credible, though sustained execution will be critical to proving that the recovery is durable.
Newell’s Zacks Rank & Share Price PerformanceShares of this Zacks Rank #3 (Hold) company have rallied 43.8% in the past three months, outperforming both the industry and the broader Consumer Staples sector, which rose 0.1% and 2.9%, respectively.
NWL Stock's Past Three-Month Performance
Image Source: Zacks Investment Research
Is NWL a Value Play Stock?Newell currently trades at a forward 12-month P/E ratio of 8.59X, which is notably lower than the industry multiple of 17.84X and the sector average of 16.47X. This valuation positions the stock at a modest discount relative to both its direct peers and the broader consumer staples sector.
NWL P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to ConsiderThe Chefs' Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East and Canada. At present, CHEF sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Chefs' Warehouse’s current fiscal-year sales and earnings implies growth of 8.3% and 24.7%, respectively, from the year-ago reported figures. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.
United Natural Foods, Inc. (UNFI - Free Report) distributes natural, organic, specialty, produce and conventional grocery and non-food products in the United States and Canada. At present, United Natural carries a Zacks Rank of 2 (Buy). UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
The consensus estimate for United Natural’s current fiscal-year earnings implies growth of 254.9% from the year-ago figures.
Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA has a Zacks Rank of 2. Mama's Creations delivered a trailing four-quarter earnings surprise of 129.2%, on average.
The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30% and 73.3%, respectively, from the year-ago figures.
FactSet Research Systems má ve 3. čtvrtletí vykázat zisk 4,45 USD na akcii a tržby 617,59 milionu USD, což je více než 585,52 milionu USD ve stejném období loni. Společnost zároveň zvýšila čtvrtletní dividendu na 1,16 USD na akcii.
FactSet Research Systems Inc. (NYSE:FDS) will release its third quarter earnings report after the closing bell on Wednesday, July 1.
Analysts expect the Norwalk, Connecticut-based company to report quarterly earnings of $4.45 per share, up from $4.27 per share in the year-ago period. The consensus estimate for FactSet Research’s quarterly revenue is $617.59 million. It reported $585.52 million last year, according to Benzinga Pro.
On May 5, FactSet raised its quarterly dividend from $1.10 per share to $1.16 per share.
FactSet Research shares fell 0.2% to close at $218.15 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Considering buying FDS stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Acadia Healthcare zvýšila celoroční odhad upravené EBITDA poté, co tržby v 1. čtvrtletí 2026 vzrostly o 7,6 % na 828,8 milionu USD. Firma zároveň plánuje kapitálové výdaje na rok 2026 ve výši 255–280 milionů USD.
Key Takeaways ACHC raised full-year Adjusted EBITDA guidance after Q1 2026 revenues rose 7.6% to $828.8 million.ACHC is prioritizing returns from existing assets and plans 2026 capital spending of $255-$280 million.ACHC is resolving disputes, strengthening compliance, and improving retention. Acadia Healthcare Company, Inc. (ACHC - Free Report) demonstrates how a mission-driven healthcare company can create long-term shareholder value. As the largest standalone behavioral health provider in the United States, operating 275 facilities and more than 12,400 beds across 40 states, Acadia plays a critical role in addressing the nation's growing mental health and addiction treatment needs. Following a challenging period marked by regulatory scrutiny and industry-wide pressures, it has focused on rebuilding operational strength and restoring investor confidence.
Over the past year, management has taken meaningful steps to protect shareholder value. Acadia resolved some legacy billing disputes, worked toward strengthening compliance standards and improving workforce retention, and brought back experienced industry leader Debbie Osteen as CEO. These actions signal a commitment to accountability, operational discipline and long-term value creation.
Acadia's strategy has also evolved. Rather than pursuing growth, it has shifted toward maximizing returns from its existing footprint, limiting planned 2026 capital expenditures to a range of $255 million to $280 million. This strategic shift is evident in the company’s recent results, with first-quarter 2026 revenues rising 7.6% year over year to $828.8 million and management raising its full-year adjusted EBITDA guidance from $575-$610 million to $580-$615 million.
Demand for mental health and addiction treatment continues to rise, supported by growing awareness and significant unmet patient needs. While some historical expansions weighed on returns, many recently developed facilities are approaching maturity. Acadia now has an opportunity to convert years of investment into improved profitability, creating a potential turnaround opportunity for long-term investors.
How Are Competitors Faring?Peers such as Universal Health Services, Inc. (UHS - Free Report) and LifeStance Health Group, Inc. (LFST - Free Report) are also pursuing growth and operational efficiency initiatives.
Universal Health Services is increasingly focused on extracting greater value from its behavioral health network. Alongside efforts to improve occupancy and outpatient growth, UHS recently announced its $835 million acquisition of Talkspace to expand patient access and broaden treatment options.
LifeStance Health continues to strengthen its outpatient mental health platform through clinician expansion and technology-enabled care, reflecting LFST’s efforts to capture a bigger share of the growing demand for behavioral health services.
ACHC’s Price Performance, Valuation & EstimatesShares of Acadia have gained 20.9% over the past year compared to the industry’s 8.4% decline over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, ACHC trades at a forward price-to-earnings ratio of 15.71X, up from the industry average of 8.45X. ACHC carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ACHC’s 2026 earnings is pegged at $1.50 per share, which has moved 1 cent up in the past 60 days.
Image Source: Zacks Investment Research
Acadia currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
RingCentral rozšiřuje AIR Pro o agentní umělou inteligenci v RingCX, včetně autonomního oslovování zákazníků, inteligentního předávání na živé agenty a nových workflow bez kódu. Novinky mají být obecně dostupné ve 2. pololetí 2026.
Native AI agents added to RingCX workflows giving businesses automated outreach, intelligent handoffs, and more
LAS VEGAS--(BUSINESS WIRE)--RingCentral, Inc. (NYSE: RNG) today announced the expansion of AIR Pro™ to deliver agentic AI capabilities across the RingCentral customer engagement portfolio. The expansion includes new capabilities within RingCX™ that help businesses with end-to-end customer resolution, automated outreach, and intelligent hand-offs. These enhancements also strengthen how customer context is captured and carried within RingCX. When a conversation transfers to a live agent, that agent has a more complete picture, including prior interactions, data from connected systems via APIs, and relevant recordings — without having to ask the customer to repeat themselves. The context layer continuously informs itself, getting smarter with every interaction.
“RingCentral offers the broadest range of customer engagement solutions that address both informal and formal contact center requirements. Our announcement today is about expanding AIR Pro and adding key updates to RingCX as we make progress toward our vision of AI agents and humans working together,” said Jim Dvorkin, SVP of Customer Experience Products at RingCentral. “Our innovations for RingCX continue to be well received by our customers. The addition of native AI agents, along with autonomous outreach, intelligent handoffs, and our AI powered workflow builder for RingCX helps businesses improve customer experiences and achieve measurable results.”
Where Humans and AI Agents Work Together
Highlighted at Customer Contact Week (CCW) Las Vegas 2026, RingCentral rolled out the following updates:
Native AI Agents: Embedded directly into RingCX workflows, native AI agents help with inbound and outbound interactions across voice and digital channels. For example, a business can run multi-step workflows from start to finish, such as confirm an appointment, handle verification, and update a record all within a single call. Autonomous Outreach: Leverage AI agents to proactively initiate conversation outreach triggered by real-time events: appointment reminders, payment notifications, service updates. For example, a credit card payment is missed. AIR Pro calls the customer, confirms the outstanding balance, offers payment options, and processes the payment over the phone. Intelligent Handoffs: When a conversation requires human judgment or empathy, AI agents in RingCX can transfer seamlessly to live agents, carrying full customer history and CRM data so the conversation continues without interruption, repetition, or lost context. AI-powered Workflow Builder: A natural language interface for building RingCX workflows on-demand, customers are able to prompt commands through RingCX’s AI Virtual Assistant (AVA) describing what they need, and it creates a workflow automatically — no coding, no technical resources required. AI-powered RingCX Analytics: Enables business and contact center leaders to prompt questions through RingCentral’s AI Virtual Assistant (AVA) within the RingCX interface to retrieve answers and specific metrics. For example, a newly hired supervisor can ask, "What report should I use to see an agent’s attendance and performance?" and AVA surfaces the answer instantly. New WEM Capabilities
RingCentral’s native WEM solution, called RingWEM, brings together AI Quality Management, AI Interaction Analytics, and AI Workforce Management embedded directly into RingCX – helping businesses reduce average call handle times, and improve customer satisfaction without a fragmented toolset that has long held back contact center performance. New RingWEM capabilities include:
RingWEM with Live Screen Monitoring: This gives supervisors visibility into how agents handle customer interactions, with the ability to whisper, coach, or step in without disrupting the customer experience. For example, it gives supervisors visibility during the call, seeing the agent’s screen in real time, and watching how agents address a problem, while giving coaching suggestions when the conversation is still live. Added Digital Channels
RingCX supports more than 20 digital channels, along with inbound and outbound voice allowing agents to manage various customer interactions from a single, unified interface. RingCX goes beyond the standard support for WhatsApp Messaging, and now includes WhatsApp Voice support.
WhatsApp Voice Support: With WhatsApp Voice in RingCX, customers can move from a messaging conversation to voice without leaving WhatsApp. The agent picks up the call with a complete view of the customer journey, including a summary of each interaction. “As a RingCX and AIR Pro customer, we're expanding our use of AI to drive a consistent customer experience while also enabling more automated AI and human interactions,” said Jaimie Bell, VP of Client Solutions at Office Gurus. “The expansion of AI Agents in RingCX, powered by AIR Pro, is really exciting. We're looking forward to it giving us more control and visibility into deploying AI agents at scale without sacrificing the quality our customers expect. We're early in implementation, and already seeing how AI agents will help us move faster, reduce manual overhead, and deliver a more seamless customer experience.”
RingCX Momentum
As of the end of Q1 2026, more than 1,700 businesses have adopted RingCX, up over 70% year-over-year – with more than half of them utilizing AI.
RingCX customers are achieving measurable results across industries. For example, in healthcare, Sun River Health achieved a 95% first-call resolution rate — 25% above industry standard. In entertainment, The Escape Game reduced costs by 50% while increasing bookings by 7%, and the San Diego Symphony cut box office hold times by 95%.
“The industry is moving beyond AI assistants towards increasingly autonomous AI agents that can participate in customer journeys alongside human workers,” said Hayley Sutherland, Conversational AI Analyst at IDC. “Organizations will need a common framework for managing performance, quality, analytics, and governance across both — and having that native to the contact center platform is the right approach. RingCentral's direction reflects its commitment to both supporting its customers with the capabilities needed today, and taking them where the market is headed.”
Pricing & Availability
Native AI Agents in RingCX and Automated Outreach will be available on a consumption basis, aligned with AIR Pro pricing. RingWEM with Live Screen Monitoring — will be priced on a seat basis or included in the RingCX Ultimate tier. New RingCX capabilities are currently in beta with general availability in 2H 2026. AI-powered RingCX Analytics and RingWEM with Live Screen Monitoring will be available in Q3.
For additional details or demo requests, visit the RingCentral booth #411 at CCW Las Vegas, or click here.
Join the RingCentral “CCW Special Edition” of AI Real Talk—Live or on-demand Elevate Every Customer Experience: Keeping Humans in the Loop While Scaling AI June 23 | 10:00 AM PT / 1:00 PM ET
About RingCentral
RingCentral is a global leader in AI–powered customer engagement, delivering an integrated platform for business phone, SMS, contact center, workforce engagement management, video collaboration, and messaging. Powered by advanced AI capabilities, RingCentral delivers intelligence at every phase of the conversation journey — before, during, and after each human interaction. With RingCentral, businesses can work smarter, respond faster, and connect more meaningfully with their customers. Visit ringcentral.com to learn more.
Joby Aviation zvýšila tržby ve 4. čtvrtletí 2025 na 30,84 milionu USD a pro rok 2026 očekává 105 až 115 milionů USD. Akcie jsou ale stále pod tlakem kvůli ztrátovosti a vysokému ocenění.
Joby Aviation (NYSE:JOBY | JOBY Price Prediction) is graduating from a flight-test story to a revenue story. The Blade acquisition pushed Q4 2025 revenue to $30.84 million, management is guiding $105 million to $115 million for full-year 2026, and a JFK-to-Manhattan eVTOL flight put the brand in front of every commuter in the country.
Yet shares sit at $10, down 24.24% year to date. Can JOBY trade at $20 by 2028?
What’s Holding Joby Back Shares are stuck because of what investors are paying for unprofitable growth. Joby trades at a price-to-sales ratio of 122x with a beta of 2.67, punished whenever rate expectations shift. Shares are flat over the last month at 0%, with a recent 20% drop in June tied to a strong jobs report and renewed Fed tightening concerns.
Insider selling has weighed on sentiment. Director Paul Sciarra sold 416,666 shares at $12.02, and CFO Rodrigo Brumana followed with a $897,000 sale via a 10b5-1 plan. Both were pre-scheduled, but the optics hurt a stock already 47% below its 52-week high.
Wall Street Sees 11% Upside. Our Model Says 16%. Consensus target is $11.12, with 1 strong buy, 2 buys, 5 holds, 2 sells, and 1 strong sell. Our base-case model lands at $11.62 for a 16.2% upside, with a moderate 0.5 confidence score mirroring the analyst split of 27% bullish, 27% bearish, 45% neutral.
Consensus is too anchored on Joby being pre-revenue. The bull case points to $15.05 within twelve months and $25.75 over five years. Wall Street has not repriced for FAA certification, and that is the asymmetry worth watching.
The Path to $20 Per Share Reaching $20 from $10 requires a gain of 100%. With forward EPS of -$1.20, a price of $20 implies a forward P/E of -17x. The negative figure shows why our model excludes EPS and leans on analyst target weighting and the 247Factor of 1.045. For JOBY, price-to-sales is where the bull case has room.
If Joby hits a credible 2028 revenue ramp toward the $458 million projection being modeled post-FAA approval, the current 122x sales multiple compresses sharply at $20.
Three catalysts are in motion: the first point-to-point electric air taxi flight from JFK to Manhattan, selection for commercial operations in 11 states, and a Dubai launch with vertiports at the airport, Palm Jumeirah, and Dubai Mall.
CEO JoeBen Bevirt told investors, “2026 will mark a key inflection point for Joby”, and ARK Invest backed that view with a 119,000-share purchase after the FAA milestone. The primary risk is simple: any FAA Type Certification slip beyond 2026 resets the bull thesis.
Is $20 Realistic? Joby has no earnings power yet, which is the entire problem and opportunity. The stock sits at $10, against a 52-week range of $7.75 to $20.95, and a 50-day moving average of $9.79. Five-year total return is essentially flat at 0.4%.
The market has paid Joby for the option rather than the operating business. If Dubai service launches and the Dayton plant ramps to 4 aircraft per month in 2027, the option converts into cash flow.
Hitting $20 by 2028 requires a 100% gain, and on a beta of 2.67 that is achievable.
Three things must go right: FAA Type Certification by 2026, passenger revenue from Dubai and U.S. eIPP sites in 2027, and Dayton production hitting 4 aircraft per month on schedule. A certification delay forcing another dilutive capital raise derails it.
I view $20 as a stretch target with real catalysts behind it. Returns at this level shouldn’t be expected every year, but the blueprint for Joby reaching $20 in 2028 is clear.
Archer Aviation chce využít letiště Hawthorne u Los Angeles jako provozní centrum své sítě air taxi. Počítá i s až 200 000 čtverečních stop hangárů pro údržbu, odbavení cestujících a další provoz.
Key Takeaways ACHR plans to use Hawthorne Airport as the operational hub for its Los Angeles air taxi network.The site will support takeoff, landing, maintenance, passenger handling and ground operations.ACHR is planning up to 200,000 sq. ft. of hangar space for air mobility and innovation activities. Archer Aviation Inc. (ACHR - Free Report) is giving its air taxi strategy a stronger operating base through its control of Hawthorne Airport near Los Angeles International Airport and Downtown Los Angeles. The company plans to use the site as the operational hub for its Los Angeles network while also developing it as an innovation center for next-generation AI-powered aviation technologies. This makes the airport more than a real estate asset. It can become a testing and coordination point for the company’s broader urban air mobility ambitions.
The move is important because commercial air taxi service will require more than certified aircraft. Archer Aviation will also need take-off and landing access, hangar capacity, maintenance support, passenger handling systems, ground operations and local regulatory coordination. Hawthorne Airport gives the company a place to bring many of these requirements together in one market that could be important for early adoption.
Archer Aviation also expects to prepare the site for planned air taxi operations in the Los Angeles area and potential use around the LA28 Olympic Games. The company has discussed the redevelopment of up to 200,000 square feet of hangar space and the creation of an advanced air mobility center of excellence. Over time, Archer Aviation aims to add AI-supported features such as air traffic coordination, ground operations management, maintenance detection and smoother passenger screening.
The company noted that capital projects at Hawthorne may face cost, permitting, labor, regulatory and schedule risks. If Archer Aviation can manage these challenges, Hawthorne Airport could support its shift from aircraft development toward real-world air taxi operations.
Companies Expanding Air Mobility NetworksAs companies move closer to commercial air mobility services, building operational networks is becoming increasingly important. Companies like Joby Aviation, Inc. (JOBY - Free Report) and Eve Holding, Inc. (EVEX - Free Report) are also expanding networks to support future air mobility operations.
Joby Aviation is developing flight networks and operational capabilities to support the planned rollout of its electric air taxi services.
Eve Holding is working with partners and stakeholders to help establish the network needed for future urban air mobility operations.
Earnings Estimates for ACHR StockThe Zacks Consensus Estimate for 2026 and 2027 earnings per share suggests a year-over-year decline of 61.90% and growth of 7.51%, respectively.
Image Source: Zacks Investment Research
ACHR Stock Trading at a DiscountArcher Aviation is trading at a discount relative to the industry, with a trailing 12-month price-to-book of 1.98X compared with the industry average of 6.03X
Image Source: Zacks Investment Research
ACHR Stock Price PerformanceOver the past three months, ACHR shares have fallen 1.5% compared with the industry’s 0.2% decline.
Image Source: Zacks Investment Research
ACHR’s Zacks RankArcher Aviation currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
This transaction strengthens Organon’s contraception portfolio and expands long-acting reversible options for women
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the completion of a global licensing agreement with Sebela Pharmaceuticals, granting Organon exclusive rights to MIUDELLA®, a hormone-free, copper intrauterine device (IUD). Please see our prior announcement for a summary of the transaction terms.
Approved by the US Food and Drug Administration (FDA) on February 24, 2025, MIUDELLA is the first hormone-free copper IUD to be introduced in the US in over 40 years. Indicated for the prevention of pregnancy for up to three years in females of reproductive potential, MIUDELLA is 99% effective. It features a proprietary SLIMSERTTM technology, which consists of a highly flexible frame and a fully preloaded inserter with a small, tapered insertion tube diameter of 3.7mm.1
MIUDELLA is anticipated to be commercially available in late 2026. The MIUDELLA label includes a Risk Evaluation and Mitigation Strategy (REMS). A REMS is a strategy used by the FDA to manage known or potential risks associated with a product. To mitigate complications due to potential improper insertion, MIUDELLA will only be available in the US through the MIUDELLA REMS program. See additional safety information below.
“MIUDELLA represents an important hormone-free option in contraception, expanding choices for women seeking long‑acting reversible birth control,” said Joe Morrissey, Chief Executive Officer of Organon. “By building on our long history in contraception and leveraging our deep expertise and capabilities, this agreement strengthens Organon’s ability to deliver contraceptive options that meet the needs of women.”
“Developed by Sebela Women’s Health, MIUDELLA represents an effective option for pregnancy prevention,” said Alan Cooke, Chief Executive Officer and President of Sebela Pharmaceuticals. “We are delighted to complete this global license agreement with Organon. Organon offers the scale, launch readiness and access capabilities needed to bring this valuable product efficiently into clinical practice and help ensure MIUDELLA reaches more women who are looking for hormone-free contraception options.”
Truist Securities, Inc. acted as financial advisor to Sebela Pharmaceuticals.
About MIUDELLA
MIUDELLA was investigated in three clinical trials in the US in 1,904 women aged 17 to 45 years. The Phase 3 prospective, multicenter, single-arm, open-label study was conducted in 42 centers in the US with a primary endpoint of contraceptive efficacy through 3 years of use as assessed by the Pearl Index (defined as the number of pregnancies per 100 women over one year).1 In the efficacy cohort of women aged 17 to 35 years from the Phase 3 study (n=1397), the first-year Pearl Index was 0.94 (95% CI, 0.43-1.78) and the cumulative 3-year Pearl Index was 1.05 (95% CI, 0.66-1.60)—in other words, 99% effective, with an overall placement success rate of 98.8%. The most common adverse reactions (≥5%) observed in clinical trials were heavy menstrual bleeding, dysmenorrhea, intermenstrual bleeding, pelvic discomfort, procedural pain, pelvic pain, post-procedural hemorrhage, and dyspareunia. In the first year, 8.5% of participants across all three studies discontinued treatment due to bleeding or pain adverse events, which decreased to 3.2% by year 3. Expulsion rates ranged from 1.9% in year 1 to 0.9% in year 3.
Indication
MIUDELLA® is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 3 years. Selected Safety Information
WARNING: RISK OF COMPLICATIONS DUE TO IMPROPER INSERTION
Improper insertion of intrauterine systems, including MIUDELLA, increases the risk of complications. Proper training prior to first use of MIUDELLA can minimize the risk of improper insertion. MIUDELLA is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the MIUDELLA REMS program to ensure all healthcare providers are trained on the proper insertion of MIUDELLA prior to first use. Further information is available at miudellarems.com and 1-855-337-0772. CONTRAINDICATIONS
Use of MIUDELLA is contraindicated when 1 or more of the following conditions exist: Pregnancy or suspicion of pregnancy; congenital or acquired abnormalities of the uterus, including leiomyomas, resulting in distortion of the uterine cavity; acute pelvic inflammatory disease (PID); postpartum endometritis or postabortal endometritis in the past 3 months; known or suspected uterine or cervical malignancy; for use as postcoital contraception (emergency contraception); uterine bleeding of unknown etiology; untreated acute cervicitis or vaginitis or other lower genital tract infection; conditions associated with increased susceptibility to pelvic infections; Wilson's disease; a previously placed IUS that has not been removed; hypersensitivity to any component of MIUDELLA including to polypropylene, copper, nitinol, an alloy of nickel and titanium, or any of the trace elements present in the copper component of MIUDELLA. Persons with allergic reactions to these components may suffer an allergic reaction to this intrauterine system. Prior to placement, patients should be counseled on the materials contained in the IUS, as well as potential for allergy/hypersensitivity to these materials. WARNINGS AND PRECAUTIONS
Risk of Complications Due to Improper Insertion: Improper insertion of IUSs, including MIUDELLA, increases the risk of perforation, infection, undiagnosed abnormal bleeding, pregnancy loss (if pregnancy occurs with IUS in situ), and expulsion. Proper training prior to first use of MIUDELLA can minimize the risk of improper insertion. MIUDELLA is available only through a restricted program under a REMS. MIUDELLA REMS: MIUDELLA is only available through a restricted program under a REMS called MIUDELLA REMS Program to ensure healthcare providers are trained prior to first use. Notable requirements include the following: Healthcare providers must be certified with the program by enrolling and completing training on the proper insertion of MIUDELLA prior to first use. Pharmacies and healthcare settings that dispense MIUDELLA must be certified by enrolling in the REMS and must only dispense MIUDELLA to certified healthcare providers. Further information is available at www.miudellarems.com and 1-855-337-0772.
Ectopic Pregnancy: Promptly evaluate females who become pregnant for ectopic pregnancy while using MIUDELLA. Ectopic pregnancy may require surgery and may result in loss of fertility. Intrauterine Pregnancy: Increased risk of spontaneous abortion, septic abortion, premature delivery, sepsis, septic shock, and death if pregnancy occurs. Remove MIUDELLA if pregnancy occurs with MIUDELLA in place and the thread ends are visible or can be retrieved from the cervical canal. Sepsis: Severe infection or sepsis, including Group A streptococcal sepsis (GAS), have been reported following insertion of other IUSs; strict aseptic technique is essential during insertion. Pelvic Infection: Promptly examine users with complaints of lower abdominal or pelvic pain, odorous discharge, unexplained bleeding, fever, genital lesions or sores after insertion of MIUDELLA. IUSs have been associated with an increased risk of PID, most likely due to organisms being introduced into the uterus during insertion. Remove MIUDELLA in cases of recurrent PID or endometritis, or if an acute pelvic infection is severe or does not respond to treatment. Subclinical PID: PID may be asymptomatic but still result in tubal damage and its sequelae.
Perforation: Partial or total perforation of the uterine wall or cervix may occur during insertions, although the perforation may not be detected until sometime later. Perforation may also occur at any time during IUS use. Perforation that results in embedment or translocation may reduce contraceptive efficacy and result in pregnancy. Risk is increased if inserted in postpartum and lactating females and may be increased if inserted in females with fixed, retroverted uteri or noninvoluted uteri. If perforation is suspected or if known perforation occurs during placement, the IUS should be removed as soon as possible. Surgery may be required. Delayed detection or removal of MIUDELLA in cases of perforation may result in migration outside the uterine cavity, adhesions, peritonitis, intestinal penetration, intestinal obstruction, abscesses and/or damage to adjacent organs. Expulsion: Partial or complete expulsion of MIUDELLA has been reported, resulting in the loss of contraceptive protection. MIUDELLA should be placed no earlier than 4 weeks post-pregnancy to mitigate the risk of expulsion that may be increased when the uterus is not completely involuted at the time of insertion. Remove a partially expelled MIUDELLA and do not attempt to push a partially expelled MIUDELLA into the uterus. Wilson’s Disease: MIUDELLA may exacerbate Wilson’s disease, a rare genetic disease affecting copper excretion; therefore, the use of MIUDELLA is contraindicated in females with Wilson’s disease. Bleeding Pattern Alterations: Menstrual bleeding may be altered and result in heavier and longer bleeding with spotting. Females complaining of heavy vaginal bleeding should be evaluated and treated, and may need to discontinue MIUDELLA. Magnetic Resonance Imaging (MRI) Safety Information: Patients using MIUDELLA can be safely scanned with MRI only under certain conditions. Medical Diathermy: Medical equipment that contains high levels of Radiofrequency (RF) energy such as diathermy may cause health effects (by heating tissue) in females with a metal-containing IUS including MIUDELLA. Avoid using high medical RF transmitter devices in females with MIUDELLA. ADVERSE REACTIONS
Most common adverse reactions (≥5%) observed in clinical trials were heavy menstrual bleeding, dysmenorrhea, intermenstrual bleeding, pelvic discomfort, procedural pain, pelvic pain, post-procedural hemorrhage, and dyspareunia. Before prescribing MIUDELLA, please read the full Prescribing Information, including Boxed Warning.
About Organon
Organon (NYSE: OGN) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across Women’s Health and General Medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 markets.
Headquartered in Jersey City, New Jersey, Organon is committed to advancing access, affordability, and innovation in healthcare. Learn more at www.organon.com and follow us on LinkedIn, Instagram, X, YouTube, TikTok and Facebook.
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, this press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about the potential benefits of Organon’s exclusive license of global rights to MIUDELLA® and expectations regarding the timing of commercialization thereof. Forward-looking statements may be identified by words such as “anticipated, “may”, “will”, and “expected,” among others. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate, or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include, but are not limited to, weakening of economic conditions that could adversely affect the level of demand for MIUDELLA®; pricing pressures globally, including rules and practices of managed care groups, judicial decisions and governmental laws and regulations related to or affecting Medicare, Medicaid and healthcare reform, pharmaceutical pricing and reimbursement, access to the company’s products, international reference pricing, including most-favored-nation drug pricing, and other pricing related initiatives and policy efforts; the impact of tariffs and other trade restrictions or domestic sourcing requirements; expanded brand and class competition in the markets in which the company operates; the failure of any supplier to provide substances, materials, or services as agreed, or otherwise meet their obligations to the company; the increased cost of supply, manufacturing, packaging, and operations; difficulties developing and sustaining relationships with commercial counterparties, including Sebela Pharmaceuticals; the impact of higher selling and promotional costs; efficacy, safety or other quality concerns with respect to the company’s marketed products, whether or not scientifically justified, leading to product recalls, withdrawals, labeling changes or declining sales; future actions of third parties, including significant changes in customer relationships or changes in the behavior and spending patterns of purchasers of healthcare products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and forgoing healthcare insurance coverage; the failure by the company or its third party collaborators and/or their suppliers to fulfill their or their regulatory or quality obligations; and volatility of commodity prices, fuel, and shipping rates that impact the costs and/or ability to supply the company’s products. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s filings with the SEC, including the company’s most recent Annual Report on Form 10-K and subsequent SEC filings, available at the SEC’s Internet site (www.sec.gov). References and links to websites have been provided for convenience, and the information contained on any such website is not a part of, or incorporated by reference into, this press release. Organon is not responsible for the contents of third-party websites.
About Sebela Pharmaceuticals
At Sebela Pharmaceuticals, we are building a leading gastroenterology company in the US and developing innovative products in women’s health. Braintree Laboratories, Inc., a part of Sebela Pharmaceuticals, has been innovating, developing, manufacturing, and commercializing gastroenterology products for over 40 years. Tegoprazan is Braintree’s lead program in GERD, and in 2025 Sebela Women’s Health obtained FDA approval for Miudella (copper-containing intrauterine system), the first non‑hormonal intra‑uterine device (IUD) for contraception approved in over 40 years. Sebela Pharmaceuticals has operations in Roswell, GA; Braintree, MA; and Dublin, Ireland.
For more information, visit www.sebelapharma.com.
Sebela Forward-Looking Statement
This press release and any statements made for and during any presentation or meeting contain forward-looking statements related to Sebela Pharmaceuticals, Sebela Women’s Health and Braintree Laboratories under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These statements may be identified by the use of forward-looking words such as "anticipate," "planned," "believe," “may”, “will”, "forecast," "estimated," "expected," and "intend," among others. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, risks related to the development, launch, introduction and commercial potential of Miudella; growth and opportunity, including peak sales and the potential demand for Miudella, as well as its potential impact on applicable markets; market size; substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third-party payer reimbursement; dependence upon third parties; our financial performance and results, including the risk that we are unable to manage our operating expenses or cash use for operations, or are unable to commercialize our products, within the guided ranges or otherwise as expected; and risks related to noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development and commercialization of new products. There are no guarantees that Miudella will prove to be commercially successful. While the list of factors presented here is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and neither Sebela Pharmaceuticals, Sebela Women’s Health nor Braintree Laboratories agree to undertake any obligation to update publicly such statements to reflect subsequent events or circumstances except as required by law.
Iron Mountain za poslední tři měsíce vzrostla o 30,2 % díky silným tržbám z úložiště a datových center. Tržby datových center v 1. čtvrtletí 2026 vzrostly o 47,1 % na 254,7 milionu USD.
Key Takeaways Iron Mountain's recurring storage revenues and pricing supported strong first-quarter 2026 growth. IRM's data center revenues jumped 47.1% as leasing stayed strong and utilization remained high.IRM grew digital and asset lifecycle businesses over 50% year over year, boosting service revenues. Iron Mountain Incorporated (IRM - Free Report) shares have rallied 30.2% in the past three months compared with the industry’s growth of 10.2%.
Iron Mountain’s recurring storage rental revenues remain resilient through pricing and strong retention, while rapid data center expansion, robust leasing demand, and growing digital and asset lifecycle management businesses continue to drive growth and diversify revenues beyond traditional records storage.
Analysts seem bullish on this Zacks Rank #3 (Hold) stock. The Zacks Consensus Estimate for its 2026 AFFO per share has been revised northward by 13 cents to $5.85 over the past two months.
Image Source: Zacks Investment Research
Factors Behind IRM Stock’s Price SurgeIron Mountain continues to rely on highly recurring storage rental revenues, supported by pricing, revenue management and strong customer retention. In the first quarter of 2026, consolidated storage rental revenues increased 15.4% year over year, while Global RIM storage rental grew 8.7%. These results indicate that pricing and revenue management continue to help offset gradual declines in physical storage volumes. Management also highlighted that the physical records storage business delivered its best quarterly growth in years, helping fund investment in faster-growing offerings.
The Global Data Center business remains Iron Mountain's primary growth engine, benefiting from sustained enterprise and hyperscale demand for secure, interconnected capacity. In the first quarter of 2026, data center revenues increased 47.1% year over year to $254.7 million, driven primarily by 46% increase in storage rental revenues, while adjusted EBITDA margin remained above 50% at 52.1%. The operating portfolio reached 507.2 megawatt (MW) from 424.2 MW a year ago and was 97.2% leased, reflecting strong utilization. Leasing activity remained healthy, with 21,849 kilowatt (KW) of new and expansion leases signed during the quarter.
Management reported 32 MW of data center leasing from the beginning of the year through April 2026, suggesting demand carried into the early second quarter. Churn remained low at 0.4%, while cash mark-to-market was 12%, pointing to pricing power on renewals. The development pipeline also expanded, with 181.5 MW under construction and 684.2 MW held for future development, bringing total potential data center capacity to 1.37 gigawatt (GW). This robust pipeline supports the company’s strategy to build and energize capacity ahead of demand and sustain high growth rates as more sites come online.
Iron Mountain is broadening beyond traditional records storage through digital and asset lifecycle management capabilities that management is increasingly cross-selling across its large customer base. Management said that the data center, digital and ALM businesses grew more than 50% year over year in first-quarter 2026, while consolidated service revenues rose 30.6% year over year to $841 million.
Within Global RIM, service revenues increased 16.5% year over year, indicating healthy demand for higher-value services alongside storage. Recent acquisitions in IT asset disposition and logistics capabilities extend the lifecycle offering set and deepen customer relationships, which can improve wallet share over time, even as paper-based workflows evolve. The company’s global footprint and broad customer mix also help scale these newer offerings across regions and industries.
Key Concerns for Iron MountainCompetition from other industry players is likely to lead to aggressive pricing pressure and hurt Iron Mountain’s prospects. High interest expenses and adverse foreign currency movements remain a concern.
Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are Lamar Advertising (LAMR - Free Report) and Vornado Realty Trust (VNO - Free Report) , each carrying a Zacks Rank of 2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for LAMR’s 2026 FFO per share is pegged at $8.81, which indicates year-over-year growth of 6.66%.
The Zacks Consensus Estimate for VNO’s full-year FFO per share is pinned at $2.34, which calls for an increase of 0.86% from the year-ago period.
Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.
Cboe Global Markets v 1. čtvrtletí zvýšil čisté tržby o 29 % na 728,9 mil. USD, tažené deriváty a rekordním objemem opcí SPX. Akcie přesto za měsíc spadly o 28,4 %.
Key Takeaways CBOE grew Q1 net revenue 29% to $728.9M, led by a 32% increase in derivatives revenue.Cboe's SPX options reached record volume, while Data Vantage revenue climbed to $181.3M.CBOE is cutting costs through restructuring and had $569.4M remaining for share repurchases. Cboe Global Markets, Inc. (CBOE - Free Report) shares have lost 28.4% over the past month compared with the industry's decline of 10%.
The stock has been weighed down by concerns over its valuation compression, competitive threats, and selling pressure after a strong rally that reached a 52-week high in May. Investor sentiment has also been affected by market-share erosion and expectations of lower market volatility that could reduce trading activity. However, the solid earnings growth, record trading volumes, a profitable derivatives and market-data business, and prudent capital deployment position the company well for long-term growth.
Shares of some of its peers, including Intercontinental Exchange Inc. (ICE - Free Report) , CME Group Inc. (CME - Free Report) , and Nasdaq, Inc. (NDAQ - Free Report) , have lost 14.1%, 15.8% and 9.2%, respectively, in the past month.
1-Month Price Performance: CBOE, ICE, CME, NDAQ & Industry
Image Source: Zacks Investment Research
CBOE’s Average Target Price Suggests UpsideBased on short-term price targets offered by 14 analysts, the Zacks average price target is $317.50 per share. The average suggests a potential 24% upside from the last closing price.
Image Source: Zacks Investment Research
CBOE ValuationShares of Cboe Global are currently trading at a discount. Its forward price-to-earnings (P/E) ratio is 18.69X, which is below the industry average of 18.72X.
Image Source: Zacks Investment Research
Shares of Intercontinental Exchange are trading at a discount, while CME and Nasdaq are trading above the industry average.
CBOE’s Growth Projection EncouragesThe Zacks Consensus Estimate for Cboe Global’s 2026 earnings per share (EPS) indicates a year-over-year increase of 25%. The consensus estimate for revenues is pegged at $2.75 billion, implying a year-over-year improvement of 13.1%.
The consensus estimate for 2027 EPS and revenues indicates an increase of 5.5% and 2.9%, respectively, from the corresponding 2026 estimates.
Earnings have grown 14.7% in the past five years, better than the industry average of 10.6%. The expected long-term earnings growth rate is 16.8%, %, better than the industry average of 12.2%. It also has a Growth Score of A.
Optimist Analyst Sentiment on CBOE10 analysts covering the stock have raised estimates for 2026 and 2027 over the past 60 days, with no downward revisions. Thus, the Zacks Consensus Estimate for 2026 and 2027 earnings has moved up 8.8% and 9.1%, respectively, over the same period.
CBOE’s Favorable Return on CapitalReturn on equity for the trailing-12 months was 24.9%, which compared favorably with the industry’s average of 16%. This reflects its efficiency in utilizing shareholders’ funds.
Return on invested capital in the trailing-12 months was 14.6%, better than the industry average of 6.7%, reflecting CBOE’s efficiency in utilizing funds to generate income.
What Drives CBOE’s Growth?Cboe Global’s organic strength lies in a diversified business mix that ensures uninterrupted revenue generation and recurring non-transaction revenues. The company is sharpening its focus on core derivatives, data, clearing and off-exchange businesses through portfolio optimization, including the planned sale of its Canada and Australia operations. At the same time, CBOE is investing in high-growth opportunities such as prediction markets, tokenized products and expanded clearing services.
Trading activity across Cboe’s derivatives complex continues to be the primary organic growth engine. Net revenue rose 29% year over year to $728.9 million, with derivatives net revenue up 32% in the first quarter of 2026. Proprietary SPX options set another quarterly record with average daily volume up 34% year over year to 4.9 million contracts, supported by both shorter-dated and longer-dated demand as market conditions shifted. Management raised its 2026 organic total net revenue growth target to low double-digit to mid-teens.
Growing demand for market data, connectivity services and analytics solutions is driving solid growth in the Data Vantage segment. In the first quarter of 2026, Data Vantage revenue increased to $181.3 million from $152.5 million a year ago, supported primarily by new customer additions and increased product adoption. Management lifted its 2026 Data Vantage organic net revenue growth target to low double-digit.
The multi-quarter realignment is now paired with additional actions aimed at reducing complexity and improving execution. Management expects these initiatives to reduce its workforce by approximately 20% and be substantially completed by the end of 2026. Management also lowered 2026 expense guidance and expects meaningful savings from restructuring initiatives.
CBOE’s strategic investments are well supported by solid capital management. The company has been strengthening its balance sheet with a strong cash position supporting continued investment in technology, sales and product initiatives as well as capital returns, while lowering its debt balance. As of March 31, 2026, it had $569.4 million remaining under existing share repurchase authorizations.
ConclusionCboe Global’s growth strategy of expanding its product line across asset classes, broadening geographic reach, diversifying the business mix with recurring revenues, and leveraging technology reflects its operational expertise. A VGM Score of B instils optimism.
Coupled with cheap valuation, optimistic analyst sentiment, favorable ROE and favorable growth estimates, the time appears right for potential investors to bet on this Zacks Rank #1 (Strong Buy) insurer. You can see the complete list of today’s Zacks #1 Rank stocks here.
Quest Diagnostics vykázala v prvním čtvrtletí silný růst tržeb z lékařského kanálu a dvouciferný růst tržeb testu AD-Detect na Alzheimerovu chorobu. Zároveň ale zůstává problémem vysoké zadlužení.
Key Takeaways DGX posted strong physician channel growth and expanded hospital and consumer testing initiatives.DGX saw double-digit AD-Detect blood test revenue growth and expanded oncology MRD offerings.DGX is advancing AI, automation and Project Nova while managing a sizable debt load. Quest Diagnostics (DGX - Free Report) is well-poised for growth in the coming quarters, supported by its continued focus on meeting the evolving needs of its core customers — physicians, hospitals and consumers. The company is seeing continued momentum in Advanced Diagnostics, including the strong uptake of the AD-Detect blood test. Efforts to drive operational improvements through the adoption of AI, automation and other technologies also sound very encouraging. Yet, Quest Diagnostics’ solvency level remains a concern. Macroeconomic pressures can weigh on its operations, too.
Over the past year, this Zacks Rank #3 (Hold) stock has rallied 7.7% compared with the industry’s 8.2% growth and the S&P 500 composite’s 23.2% rise.
The renowned provider of diagnostic information services has a market capitalization of $21.59 billion. Quest Diagnostics has an earnings yield of 5.50%. The company’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 3.50%.
Tailwinds Supporting DGXGrowth Momentum in Base Business: Quest Diagnostics delivered high single-digit growth in physician channel revenues in first-quarter 2026, driven by strong demand for innovative testing solutions, expanded health plan access and enterprise account growth. The company also recorded growth in end-stage renal disease, a newer clinical area focused on lab testing for dialysis patients. Volume growth was driven by Fresenius Medical Care’s dialysis network and contributions from newly added independent dialysis clinics and other providers.
In the hospital channel, the company’s flexible solutions allow customers to free up capital while accessing diagnostic innovation and expertise. In early 2026, Quest Diagnostics began scaling its Co-Lab Solutions, including reference laboratory testing, professional laboratory management services, laboratory workforce and supply-chain management, and analytics across all 21 hospitals of Corewell Health.
Image Source: Zacks Investment Research
The consumer-testing platform, QuestHealth.com, continues to gain strong momentum. Quest Diagnostics is deepening partnerships with leading consumer health and wellness brands like WHOOP and OURA Health, integrating its extensive laboratory testing and technology directly into their mobile platforms.
Strong Potential of Advanced Diagnostics: Quest Diagnostics drives growth across its customer channels through fast-growing, advanced diagnostics spanning five clinical areas — advanced cardiometabolic, autoimmune, brain health, oncology, and women's and reproductive health. In brain health, revenues from the AD-Detect blood test for Alzheimer's disease continued to grow at a double-digit rate in the first quarter of 2026.
The cardiometabolic and endocrine portfolio growth was driven by robust demand for tests of Lp(a) and ApoB, as well as for kidney, liver and reproductive hormones.
In oncology, the company continues to build its presence in blood-based minimal residual disease (MRD) testing. In January 2026, new research presented at the ASCO Gastrointestinal Cancers Symposium highlighted the strong clinical value of Quest Haystack MRD in monitoring colorectal cancer. The company also launched the Flow Cytometry MRD blood test for myeloma.
Operational Excellence, a Strategic Priority: Quest Diagnostics’ Invigorate program consistently targets 2% annual savings through structured plans to drive savings and improve productivity across the value chain. The company is deploying automation and AI technologies to improve quality, service, efficiency and the workforce experience. The new Quest AI Companion tool transforms complex biomarker data and reference ranges on test reports into clear, plain language. Quest Diagnostics is scaling the planning and design work for Project Nova, a multi-year initiative to transform its order-to-cash processes and systems and is on track to implement the first wave of solutions in the fall of 2027.
What Ails DGX?Escalating Debt Level: At the end of the first quarter of 2026, long-term debt totaled $5.16 billion, while the cash and cash equivalent balance was only $393 million. The current portion of the debt was $503 million. Debt-to-capital ratio was 42.5%, down sequentially 1.6%. A higher debt level induces higher interest payments, which come along with the risk of failure to pay the same. The times interest ratio, which indicates the company’s capacity to pay interest, was 6.3% in the quarter.
Unstable Macroeconomic Backdrop: As the U.S. healthcare system continues to evolve, Quest Diagnostics faces several inherent risks. Government payers, such as Medicare and Medicaid, have taken steps to reduce the utilization and reimbursement of healthcare services, including clinical testing services. The industry-wide trend of consolidation has resulted in larger insurance plans with significant bargaining power, making it difficult for Quest Diagnostics to negotiate fee arrangements and possibly limiting access to its newer innovative solutions. With the new U.S. administration in place, any changes in U.S. healthcare regulation could have a material adverse effect on the company’s business.
DGX Stock Estimate TrendThe Zacks Consensus Estimate for Quest Diagnostics’ 2026 earnings per share (EPS) has remained constant at $10.72 in the past 30 days.
The consensus estimate for the company’s 2026 revenues is pegged at $11.83 billion. This suggests 7.2% growth from the year-ago reported number.
Key PicksSome better-ranked stocks in the broader medical space are Globus Medical (GMED - Free Report) , Align Technology (ALGN - Free Report) and Integra LifeSciences (IART - Free Report) .
Globus Medical has an earnings yield of 5.9% compared to the industry’s negative 3.5% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 26.3%. GMED shares have rallied 35% against the industry’s 6.3% fall over the past year.
GMED sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology, sporting a Zacks Rank #1, has an estimated long-term earnings growth rate of 10.3% compared with the industry’s 5.5% growth. Shares of the company have dropped 6.8% against the industry’s 7.8% growth. ALGN’s earnings outpaced estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 7.8%.
Integra LifeSciences, carrying a Zacks Rank #2 (Buy), has an earnings yield of 13.6% against the industry’s negative 3.5% yield. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 16.7%. IART shares have rallied 48.3% against the industry’s 6.4% decline over the past year.
Quest Diagnostics získala v New Yorku schválení pro test Haystack MRD na ctDNA, který pomáhá odhalit zbytkové nebo vracející se onemocnění u solidních nádorů. Test je nyní povolen pro pacienty ve všech 50 státech USA.
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD for patients with solid tumor cancers
, /PRNewswire/ -- Quest Diagnostics® (NYSE: DGX), a leading provider of diagnostic information services, today announced that the New York State Department of Health's (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) has approved the company's Haystack MRD® test, a circulating tumor DNA (ctDNA) liquid biopsy test, for use in identifying residual or recurring disease in patients with a range of solid tumor cancers.
New York maintains a highly rigorous clinical laboratory oversight program, requiring formal technical review and approval of laboratory developed tests before they may be offered to patients in the state. With this approval, Haystack MRD is now authorized for patient testing in all 50 U.S. states. The test was developed under CLIA regulations and has been available for clinician ordering since late 2024 in 49 states and the District of Columbia.
"This approval represents the culmination of our many years of hard work and commitment to delivering a highly accurate test that can meaningfully improve patient care," said Dan Edelstein, Vice President and General Manager for Haystack Oncology, a Quest Diagnostics company. "Haystack MRD was designed to give oncologists the confidence to detect residual disease earlier, catch recurrence before it becomes clinically apparent, and help identify response to treatment. New York's approval is another proof point for Haystack MRD's quality and technical sophistication, and we look forward to extending access to this important innovation for clinicians and patients in the state."
In addition, Haystack MRD's clinical utility has been demonstrated in rigorous investigational settings, including the landmark study of non-operative management of patients with locally advanced mismatch repair–deficient (dMMR) solid tumors, which was led by Dr. Andrea Cercek and colleagues at Memorial Sloan Kettering Cancer Center and published in The New England Journal of Medicine in May 2025. In that study, ctDNA testing, using Haystack MRD, was found to be a "reliable liquid biopsy surrogate" that identified clinical complete response at a median of 1.4 months, compared to more than 6 months using imaging methods.
"In our study of non-operative management for dMMR solid tumors, the use of MRD testing provided additional molecular information that complemented traditional assessments such as imaging and endoscopy," said Dr. Cercek, Medical Oncologist, Memorial Sloan Kettering Cancer Center. "For patients who may avoid surgery, having multiple tools to evaluate treatment response and monitor for recurrence is important. These findings highlight the crucial role of MRD testing in informing patient management and underscore the need for continued study as these approaches are integrated into clinical practice."
About Haystack Oncology
Haystack Oncology represents the culmination of over 20 years of collaboration to advance technical and clinical development in liquid biopsy technologies by cancer genomics pioneers at Johns Hopkins School of Medicine. The company, a wholly owned subsidiary of Quest Diagnostics, developed Haystack MRD, a tumor-informed, next-generation MRD test that detects ultralow levels of ctDNA to uncover residual or recurrent disease with exceptional sensitivity and specificity. Haystack Oncology works with biopharmaceutical companies to accelerate and inform clinical development programs and advance important therapeutics to global markets, from early phase clinical development to companion diagnostics. Haystack MRD was developed and validated in a CLIA-certified laboratory and is available for commercial use as a lab-developed test (LDT) by Quest Diagnostics. The FDA granted Haystack MRD Breakthrough Device Designation in 2025 for use in Stage II colorectal cancer. Haystack MRD is also available for clinical trials as an investigational device by Haystack Oncology in laboratories located in Baltimore, Maryland; Hamburg, Germany; and Helsinki, Finland. www.haystackmrd.com
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
Duquesne Family Office Stanleyho Druckenmillera nově přidala Arm Holdings a drží Sea Limited i STMicroelectronics. Všechny tři sázejí na AI výpočetní kapacitu napříč datovými centry a digitálními službami.
Stanley Druckenmiller’s Duquesne Family Office disclosed positions in Arm Holdings (NASDAQ: ARM | ARM Price Prediction), Sea Limited (NYSE: SE), and STMicroelectronics (NYSE: STM) in its Q1 2026 13F, filed May 15, 2026. According to the filing, Arm was an addition during the quarter at roughly a 0.5% portfolio weight, while Sea and STMicro were larger existing positions at approximately 2.7% each. Because 13Fs are point-in-time snapshots reported about 45 days after quarter end, these reflect holdings only as of March 31 and may have changed since.
The connecting thesis across all three is AI compute at different points on the value chain: Arm’s CPU intellectual property for hyperscaler data centers, STMicro’s specialty silicon and AWS data center partnership, and Sea’s AI-enabled commerce, fintech, and gaming ecosystem in Southeast Asia and Latin America.
Arm Holdings: An Add, but the Math Is Stretched Bull case: Arm posted Q4 FY2026 revenue of $1.49 billion, up 20.1% year over year, with non-GAAP EPS of $0.60 and data center royalty revenue more than doubling. CEO René Haas framed “Arm AGI CPU” demand as exceeding expectations, with more than $2 billion in customer commitments across FY27 and FY28. Analyst sentiment is overwhelmingly bullish.
Bear case: The stock is up 267.8% year to date to $407.72. The Wall Street consensus target is $281.58, roughly 30.9% below the current price, while our model’s base case target is $412.58, implying just 1.2% upside. With a P/E near 474 and a beta of 3.79, the margin of safety is thin.
Sea Limited: Held, Not Added, but the Setup Improved Bull case: Sea delivered Q1 2026 revenue of $7.10 billion, up 46.6% year over year, with Shopee GMV of $37.3 billion (up 30.2%) and Monee loans outstanding of $9.9 billion, up 71.3%. Analysts skew strongly positive, with a target price of $140.50, against a current price of $89.04. The forward P/E of 31 looks reasonable for this growth rate.
Bear case: Shares are down 30.6% year to date and 42.0% over one year, and Q1 EPS of $0.67 missed the $0.77 estimate by 13.0% as reinvestment compressed margins.
STMicroelectronics: Held, and the Story Has Re-Rated Bull case: The multi-year, multi-billion-dollar AWS engagement reframes STMicro as an AI infrastructure name, and CEO Jean-Marc Chery has guided data center revenue to above $500 million in 2026 and well above $1 billion in 2027. Shares are up 206.6% year to date to $79.91.
Bear case: The consensus analyst target of $64.36 sits below the current price, the trailing P/E is 490, and quarterly earnings growth was negative 33.3% year over year.
The Verdict for Retirement-Focused Investors Druckenmiller’s disclosed Q1 positioning is best read as a research signal for further diligence. Sea offers the cleanest risk/reward: a reasonable forward multiple, unanimous analyst support, and price well below its 52-week high. STMicro’s AWS story is compelling, but the recent rally has already priced in much of the optionality. Arm is the hardest to follow at current levels, where even bullish analysts model meaningful downside. These are research starting points worth deeper due diligence, not templates for portfolio action.
Trace Neuroscience zahájila globální klinický program pro TRCN-1023 u ALS, včetně fáze 1/2 FUNCTION ALS v Evropě a studie LAUNCH ALS v Číně. První pacienti už dostali dávku.
Phase 1/2 FUNCTION ALS trial initiated in Europe with additional global regions anticipated in 2026
First patients dosed in LAUNCH ALS, an investigator-initiated trial in China conducted in partnership with Tenacia Biopharmaceutical, to support accelerated global clinical development strategy
TRCN-1023 is designed to restore function of the UNC13A protein, a genetically validated target in 97% of people living with ALS
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Trace Neuroscience, Inc., a biopharmaceutical company expanding the promise of genomic medicine for people living with neurodegenerative diseases, today announced the initiation of its global clinical development program for TRCN-1023, an investigational antisense oligonucleotide (ASO) designed to restore UNC13A protein function for the treatment of amyotrophic lateral sclerosis (ALS).
The global TRCN-1023 clinical program includes the Phase 1/2 FUNCTION ALS trial, which has received clinical trial authorization in the United Kingdom and Netherlands, as well as LAUNCH ALS, an investigator-initiated trial (IIT) underway in China. The LAUNCH ALS trial is being conducted in partnership with Tenacia Biopharmaceutical, which provides deep expertise in neuroscience drug development and operational execution in China, and in collaboration with principal investigator Yilong Wang, M.D., Ph.D. at Beijing Tiantan Hospital, a leading neurological hospital in China. The first patients were dosed in LAUNCH ALS earlier this month.
“Our team helped establish UNC13A as one of the most compelling genetically validated targets in ALS, and we built Trace Neuroscience to translate that biology into a medicine,” said Eric Green, M.D., Ph.D., co-founder and CEO of Trace Neuroscience. “We are thrilled to now be advancing TRCN-1023 into the clinic with a global early development strategy that is poised to generate a robust clinical data package with the urgency that ALS demands.”
TRCN-1023 is a highly potent and durable ASO designed to re-establish healthy communication between nerves and muscle cells. Administered by intrathecal injection, TRCN-1023 is a targeted intervention that binds directly to UNC13A messenger RNA to regulate its processing and guide formation of functional UNC13A protein, potentially improving synaptic transmission and thereby nerve and muscle function.
“UNC13A is among the most promising targets in ALS research today with a strong grounding in human genetics and mechanistic biology,” said Dame Pamela Shaw, M.D., Professor of Neurology at the University of Sheffield and FUNCTION ALS Chief Investigator. “There is compelling rationale for restoring this protein's function, which has relevance to the vast majority of ALS patients. I look forward to contributing to a stronger understanding of TRCN-1023’s biological and clinical impact through the FUNCTION ALS trial.”
“People with ALS need meaningful therapeutic innovation beyond today’s limited treatment options. The potency, durability and biological rationale behind TRCN-1023 make it a particularly exciting drug candidate to bring into the clinic,” said Dr. Wang, LAUNCH ALS principal investigator who also serves as Executive Vice President at Beijing Tiantan Hospital and Professor of Neurology at Capital Medical University. “I am proud to partner with the Trace Neuroscience and Tenacia Biopharmaceutical teams to advance this program and accelerate a potential new treatment for people with ALS worldwide.”
About the FUNCTION ALS Phase 1/2 Clinical Trial & LAUNCH ALS IIT
FUNCTION ALS is a global Phase 1/2 randomized, double-blind, placebo-controlled clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamic activity of TRCN-1023 in people living with ALS. The study is expected to enroll approximately 30 participants across sites in North America and Europe. Key eligibility criteria include age 18-75, symptom onset within the past two years or less, and slow vital capacity (SVC) of at least 60%. Individuals with SOD1 or FUS mutations are not eligible. Participants will receive TRCN-1023 or placebo, with 24 weeks of follow-up. Designed with input from people living with ALS and their caregivers, FUNCTION ALS incorporates biomarker analyses, digital movement and speech assessments, and operational measures intended to reduce participant burden.
LAUNCH ALS is an IIT conducted in collaboration with principal investigator Dr. Yilong Wang at Beijing Tiantan Hospital to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic activity of TRCN-1023 in people with ALS. The study is expected to enroll approximately 25 participants. Eligibility criteria for enrollment are consistent with the criteria for the FUNCTION ALS trial.
About ALS
Amyotrophic lateral sclerosis (ALS, also known as motor neuron disease (MND) or Lou Gehrig’s disease), is a progressive and terminal neurodegenerative disease impacting nerve cells in the brain and spinal cord that reduces muscle function and control. As ALS advances, the ability to speak, swallow, move and breathe is increasingly impaired. In the U.S., approximately 30,000 people are living with ALS, and approximately 1 in 400 people will be diagnosed during their lifetime. Sporadic ALS that occurs without a clear family history or identified gene change is the most common form, accounting for 9 out of 10 cases, and has very limited treatment options.
About Trace Neuroscience
Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells. Trace Neuroscience launched in 2024 with funding from leading life sciences investors and is headquartered in South San Francisco, California. For more information, please visit www.traceneuro.com and follow the company on LinkedIn and X.
Apollo omezí odkupy v hlavním retailovém private credit fondu Apollo Debt Solutions na 5 % podílů poté, co žádosti o odkup ve 2. čtvrtletí vyskočily na 16,8 %.
Apollo is limiting investor redemptions in its main retail-focused private credit fund after withdrawal requests rose to 17% during the second quarter.
The private markets giant said it will cap withdrawals at 5% of shares in the Apollo Debt Solutions vehicle, after investors rushed to pull out about $2.4 billion, or 16.8%, during the three-month period.
Why Apollo capped withdrawals"Taken together, we expect net outflows from ADS will be approximately $400 million for the second quarter of 2026 and year-to-date, representing 3% of NAV," Apollo said in a filing with the Securities and Exchange Commission published on Monday.
It highlighted a "notable regional split" in second-quarter withdrawal requests, with U.S. onshore clients looking to pull out about 4.3%, while redemptions from offshore investors jumped to 12.5%.
Apollo Global Management.
The move comes after the $26 billion fund — a non-traded business development company which offers wealthy retail investors exposure to higher-yielding private credit assets — said withdrawal requests in the previous quarter rose to more than 11%.
Why private credit funds are under pressureThe redemption spike once again spotlights the liquidity pressures that have engulfed global private markets this year.
So-called 'semi-liquid' private debt vehicles have been subject to a wave of redemption pressure this year, as investors look to pull their money amid growing anxieties over asset quality, and as funds struggle to reconcile the less-liquid nature of private assets and the retail wealth channel.
watch now
Earlier this month, Blackstone said it had restricted investor withdrawals from its flagship $79 billion Blackstone Private Credit Fund, or BCRED, to 5%, after they surged to 10% during the second quarter.
Across the Atlantic, Switzerland's Partners Group recently warned it may curb redemptions in several of its private asset vehicles following a surge in exit requests.
"We're discovering in real time that you can't offer near‑daily liquidity on genuinely illiquid assets without eventually testing the plumbing, and 2026 is the year those structures get rewritten," said Sunaina Sinha Haldea, global head of private capital advisory at Raymond James.
"Redemption pressure in evergreen private credit isn't just a credit story, it's a structural one," Haldea told CNBC via email.
She warned that the 'wrap-it-for-retail-and-the-money-will-come' phase in private credit markets is over, adding that weaker evergreen private credit funds risk facing gates, outflows and lost shelf space, as fundraising consolidates around private markets managers with strong governance, liquidity controls and client education.
Danielle Poli, managing director, co-portfolio manager at Oaktree Capital, said institutional capital was reaffirming its commitment to private credit, in contrast to jitters within the retail wealth channel.
Poli said institutional investors were considering increasing their allocations to the space to take advantage of scarcer capital in the market, adding that the retail wealth component makes up less than a quarter of the private credit market.
"These are longer-term private instruments that give you an attractive yield if you hold them. That's the trade-off," she told CNBC's "Squawk Box Europe" on Tuesday.
Poli said she expected the market to see a degree of differentiation between private asset managers based on their lending discipline, loan terms and how they considered the impact of a different rate environment. "That's very healthy and natural," she added.
Correction: This article was updated to reflect that redemption requests had spiked to 17%. It was also reworded to clarify Apollo is not halting all redemption requests.
Mid-America Apartment Communities nabízí výnos z dividend kolem 4,6 % a podle článku je výplata kryta cash flow. Firma má 27letou sérii bez snížení dividendy a očekává se další růst, i když jen nízkým tempem.
If Mid-America Apartment Communities (NYSE:MAA | MAA Price Prediction) lives up to its billing as a retiree’s hedge against a hawkish Fed, the dividend has to be the load-bearing wall. With the 10-year Treasury at 4.49% and the Warsh Fed potentially pivoting back toward hikes, MAA’s ~4.6% yield on Sun Belt apartments needs to be durable. Let’s see if it is.
Dividend Snapshot Metric Value Annual Dividend $6.12 per share Dividend Yield ~4.6% Consecutive Quarterly Payments 128 Consecutive Annual Increases ~15 years Most Recent Raise ~1% (Dec 2025) Aristocrat Status No (not yet) Core FFO Cleanly Outruns the Payout REIT dividends are funded by cash flow rather than GAAP earnings, so the headline payout ratio looks scary until you adjust. The $6.12 dividend against FY2025 GAAP EPS of $3.78 is over 100%, normal for a depreciation-heavy REIT. What matters is Core FFO.
Metric Value Assessment FFO Payout Ratio (2025) ~70% Healthy AFFO Payout Ratio (2025) ~78.6% Adequate 2026 FFO Payout (Guided) ~71.7% Healthy Management’s 2026 Core FFO midpoint of $8.53 leaves roughly $2.41 per share above the dividend. That cushion absorbs the $0.25/share interest expense headwind from refinancing without breaking a sweat.
Balance Sheet Built for a Hawkish Fed Metric Value Assessment Net Debt/EBITDA 4.5x Manageable Avg Debt Maturity 6.1 years Strong Effective Rate on Debt 3.9% Locked in low Liquidity ~$840M cash + revolver capacity Solid buffer With debt locked at 3.9% for an average of 6.1 years, a Warsh rate-hike scenario pressures the refinancing math at the margin while leaving the dividend intact.
A 27-Year Streak Without a Cut Year Annual Dividend 2026 $6.12 2025 $6.06 2024 $5.88 2023 $5.60 2022 $4.78 MAA paid through 2008-2009 without a cut and has hiked every year since 2010. Recent growth has decelerated to ~1%, which is the fair tradeoff for a payout that’s never been broken.
Management’s Dividend Doctrine CEO Brad Hill on the Q1 2026 call: “We’re really focused on generating high-quality compounding earnings growth that supports a steady and growing dividend. We really think that’s the best way to drive total shareholder return over the full cycle.” COO Tim Argo reported Q1 2026 occupancy at 95.5% and net delinquency at just 0.3% of billings. Those are the numbers that fund the check.
Verdict: Safe, With Slow Growth Baked In Dividend Safety Rating: Safe. The ~72% FFO payout, 4.5x leverage, and Sun Belt demand backdrop (deliveries down 40% YoY) all point one way. The income case holds up for investors who can accept low-single-digit raises while supply digests through 2027. The risk case sharpens if a hawkish Fed crushes job growth in Texas and Florida, since blended lease pricing is already running negative 0.3%. On balance, this dividend is built to outlast the rate cycle.
Burlington zvýšil celoroční upravený odhad EPS na 11,45 až 11,80 USD po silném čtvrtletí. Tržby vzrostly o 14 % na 2,85 miliardy USD a srovnatelné tržby o 6 %.
This is a fair market value price provided by Massive. Learn more.
52-Week Range$222.48▼
$351.85P/E Ratio35.09
Price Target$353.56
Frugal shoppers continue to spend, and Burlington Stores NYSE: BURL continues to benefit.
By selling branded clothing, footwear, accessories, and home merchandise at prices well below traditional retailers, Burlington is delivering exceptional sales, earnings, and store expansion as a standout off-price retailer. Investors have noticed, sending the stock price surging over the past year.
Get Burlington Stores alerts:
But with higher valuation and rising expectations, the richly valued stock leaves little room for error. Investors looking to get in now need to balance the presence of cyclical risk and fierce competition with the prospects of a well-run company with proven results.
Burlington Delivers Another Strong QuarterSo far this year, the news remains positive. In fact, the company’s recent three-month results, reported in late May, were strong enough to lead to a higher full-year forecast.
With more than 1,200 off-price stores across the country, Burlington said total sales in its first fiscal quarter rose 14% to $2.85 billion, and comparable store sales, or stores that have been open for more than a year, increased 6%. Both were signs that customer traffic and the company’s pricing and selection strategies were working even with more demanding consumers.
Net income for the quarter came in at $115 million compared with $101 million in the year-ago period. Diluted earnings per share (EPS) rose to $1.79 from $1.58 a year earlier, while adjusted earnings came in at $128.9 million, or $2.01 per share, up 26%, and well above the company's own previous guidance of $1.60 to $1.75. It was the company's 14th consecutive quarter of double-digit earnings-per-share growth, the company said, signaling better operations beyond a single-quarter jump.
Indeed, the latest quarter continued a performance that was playing out last year. Burlington closed fiscal 2025 with total sales up 9%, comparable store sales up 2%, net income of $610 million, and an EPS of $9.51. In the fourth quarter of fiscal 2025 alone, sales rose 11%, comparable sales increased 4%, and earnings per share reached $4.84, up 20%.
Margins and Guidance Continue to ImproveBurlington's core business is buying branded goods when available, moving it quickly through its stores, and keeping prices under control. When the three steps work together, growing margins are key to converting sales into higher profits. Formerly known as the Burlington Coat Factory, the company has more recently shifted from e-commerce exposure to all-in-store experiences with some smaller-format store strategies.
The company showed that its strategy is working. Gross margin in the first quarter expanded to 44.1% from 43.8% a year earlier. The margin in the preceding three months was 80 basis points higher than the year before. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in the first quarter rose more than 16% to $284 million.
Management's response to the first-quarter results reinforced these increases. With the first-quarter results, Burlington raised its full-year fiscal 2026 adjusted EPS guidance to a range of $11.45 to $11.80, up from levels set three months earlier. This fiscal year’s projection compares with an adjusted EPS of $10.17 last year.
A Premium Valuation Limits UpsideOverall MarketRank™83rd Percentile
Analyst RatingModerate Buy
Upside/Downside3.8% Upside
Short Interest LevelHealthy
Dividend StrengthN/A
News Sentiment0.76 Insider TradingSelling Shares
Proj. Earnings Growth15.37%
See Full Analysis
Investors have been noticing. The stock is up more than 16% this year and nearly 50% over the past year.
Its current price-to-earnings (P/E) ratio is above 34, with a trailing EPS of $9.73, meaning there’s little room for error as the rest of the year plays out.
Analyst sentiment remains positive, though the expected upside is limited.
Burlington carries a Moderate Buy consensus based on 15 buy ratings and five hold ratings, with an average price target of $353.56, a high target of $411, and a low target of $310.
With shares recently trading around $340, the consensus price amounts to little more than a 5% gain.
Competition and Economic Risks RemainRetail also carries risks of its own. Burlington competes with some formidable opponents. TJX Companies NYSE: TJX and Ross Stores NASDAQ: ROST, both with larger reach, more established buying organizations, and deeply ingrained customer habits.
Off-price retail requires ongoing competition for branded closeouts, inventory updates, and a balanced execution with thousands of daily decisions. While Burlington has been closing the gap with its larger peers, the margin for error is narrow.
The retail sector also contains macroeconomic risk. If inflation, wholesale costs, or a softening labor market begin to squeeze off-price traffic, even a well-run Burlington can feel pinched through smaller basket sizes, more markdown pressures, and more competition for value-oriented shoppers.
Patience May Be RewardedInvestors should recognize that Burlington is a capital appreciation story. It does not pay a dividend, and the return investors receive depends on earnings growth and the market's acceptance of a P/E value slightly above its two top competitors.
Burlington's first-quarter fiscal 2026 report did much to strengthen its execution success. But the stock is well-valued while the economy and competition remain ever-potent factors.
For investors who can accept cyclical risk and are looking to capture a core slice of the American consumer, patience and stock pullbacks could provide a welcome bargain for this off-price retailer.
Should You Invest $1,000 in Burlington Stores Right Now?Before you consider Burlington Stores, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Burlington Stores wasn't on the list.
While Burlington Stores currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Urban Outfitters v 1. čtvrtletí překonal odhady: EPS vzrostl na 1,30 USD a tržby dosáhly 1,4813 mld. USD. Firma zároveň ve 2. čtvrtletí očekává růst celkových tržeb v horní jednociferné oblasti.
It has been about a month since the last earnings report for Urban Outfitters (URBN - Free Report) . Shares have added about 3.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Urban Outfitters due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for Urban Outfitters, Inc. before we dive into how investors and analysts have reacted as of late.
URBN Q1 Earnings Beat Estimates on Strong Retail & Subscription GrowthUrban Outfitters reported strong first-quarter fiscal 2027 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. Also, both metrics improved from the prior-year quarter’s reported figures. The company delivered record first-quarter sales and profits, marking its seventh consecutive quarter of record performance.
Management highlighted that broad-based momentum across the Retail, Subscription and Wholesale segments, along with disciplined execution and strong customer engagement, supported the quarter’s performance.
URBN’s Quarterly PerformanceThis lifestyle specialty retailer delivered earnings per share of $1.30, rising 12.1% year over year and surpassing the Zacks Consensus Estimate of $1.20 by 8.3%. Net sales increased 11.4% year over year to $1,481.3 million, beating the consensus mark of $1,456 million by 1.7%. Strength spanned Retail, Wholesale and Subscription, supported by positive comparable sales at all retail brands and continued subscriber growth at Nuuly.
Total Retail segment net sales rose 8% year over year to $1.22 billion, while comparable Retail segment sales increased 5.6%. Growth in comparable sales was driven by high-single-digit gains in digital channel sales and mid-single-digit growth in retail store sales. The Comparable Retail segment sales increased 9.8% at FP Group, 9.3% at Urban Outfitters and 1.9% at Anthropologie.
Within the FP Group, total sales increased 16.6% year over year to $411.7 million due to continued momentum across both Wholesale and Retail segments. Free People brand sales increased 12%, while FP Movement brand sales jumped 32% during the quarter.
The Wholesale segment posted net sales growth of 24.8% to $93.2 million, driven by a 26.2% increase in FP Group wholesale revenues due to higher sales to specialty customers.
Nuuly, the company’s women’s apparel subscription rental service, continued to witness strong momentum. Subscription segment net sales increased 34.5% year over year to $167.3 million, driven by a 33.3% increase in average active subscribers from the prior-year quarter.
Urban Outfitters Sees Gross Margin Dip on Prior-Year BenefitGross profit rose 10.9% year over year to $542.6 million in the fiscal first quarter, mainly driven by higher net sales during the period. However, the gross margin declined 16 basis points year over year to 36.6%. This decrease was largely due to a one-time gain of $4.8 million, or 36 basis points, recognized in the prior-year quarter that did not repeat this quarter. Excluding this item, the underlying gross margin expanded by 20 basis points, supported by lower markdowns at FP Group and Urban Outfitters, partly offset by deleveraging in initial merchandise costs related to tariffs.
The Retail segment gross profit increased 7% year over year to $460.9 million, though the segment gross margin slipped 18 bps to 37.7%. The Wholesale segment’s gross profit rose 31% to $33.8 million, with the gross margin expanding 178 bps to 36.3%, driven by higher sales to regular-price customers. Subscription segment gross profit climbed 39% to $47.9 million, while the segment gross margin improved 85 bps to 28.7%.
Selling, general and administrative (SG&A) expenses increased 11.7% year over year to $402.9 million. The increase was primarily driven by higher store payroll expenses to support the Retail segment sales growth, increased marketing investments to support customer acquisition and sales growth in the Retail and Subscription segments, and higher technology investments tied to AI initiatives.
As a percentage of net sales, SG&A expenses deleveraged 5 bps to 27.2%. The quarter included a benefit of $6.9 million, or 47 bps, related to the reversal of a litigation accrual, partially offset by deleverage from higher marketing and technology spending.
URBN reported operating income of $139.7 million, up 8.9% from $128.2 million in the prior-year quarter. However, the operating margin contracted 22 bps year over year to 9.4%, reflecting SG&A deleverage despite higher gross profit dollars.
Urban Outfitters Showcases Store GrowthIn the first quarter of fiscal 2027, the company opened 11 stores and closed three stores. Store openings included two Anthropologie, three Free People and six FP Movement stores, while closures included one Free People, one Urban Outfitters and one Menus & Venues location.
The company plans to open 54 stores and close around 19 stores in fiscal 2027. Net new store growth will be primarily driven by the expansion of FP Movement, Free People and Anthropologie locations. Specifically, the company intends to open 21 FP Movement, 12 Free People, 13 Anthropologie and eight Urban Outfitters stores in fiscal 2027.
Urban Outfitters’ Financial Health SnapshotAs of April 30, 2026, Urban Outfitters had cash and cash equivalents of $301.4 million compared with $189.4 million in the prior-year period. Total shareholders’ equity stood at $2.61 billion as of the quarter-end. As of April 30, 2026, total inventory increased 9.5% from the prior-year period. The Retail segment’s inventory rose 10.6%, while comparable Retail segment inventory increased 10%. In contrast, the Wholesale segment’s inventory declined 1.2%. The increase in the Retail segment inventory was primarily driven by higher net sales and early inventory receipts aimed at mitigating potential shipping disruptions related to the Middle East conflict.
During the first quarter of fiscal 2027, the company repurchased and retired 4.6 million shares for approximately $300 million. As of April 30, 2026, 10 million common shares remained authorized for repurchase under the existing program.
URBN Lays Out Q2 TargetsUrban Outfitters’ management expects second-quarter fiscal 2027 total company sales to grow in the high-single-digit range, supported by continued momentum across the Retail, Wholesale and Subscription businesses.
The Retail segment’s comparable sales are projected to increase in the mid-single-digit range, driven by high-single-digit positive comparable sales growth at Urban Outfitters and FP Group, while Anthropologie is expected to deliver low to mid-single-digit positive comparable sales growth. Nuuly is expected to post mid to high-20% revenue growth on the back of continued subscriber momentum, while the Wholesale segment is projected to generate mid-teens growth.
For the fiscal second quarter, URBN expects the gross profit margin to be flat to decline 25 basis points year over year. The anticipated pressure primarily reflects lower initial merchandise margins due to higher tariffs than the last year, along with elevated fuel surcharge costs tied to the Middle East conflict.
Management noted that current oil surcharges are expected to remain in place for the remainder of fiscal 2027 and are estimated to create a 70-basis-point unfavorable impact per quarter through higher inbound freight and delivery expenses.
Management expects fiscal second-quarter SG&A growth to be at or slightly ahead of sales growth due to higher marketing investments across brands to support customer acquisition, along with increased technology and AI-related investments.
URBN’s FY27 OutlookFor fiscal 2027, management continues to expect positive high-single-digit total company sales growth. This outlook is expected to be supported by mid-single-digit Retail segment comparable sales growth, mid-20% revenue growth at Nuuly and high-single-digit growth in the Wholesale segment.
URBN expects the fiscal 2027 gross profit margin to increase by 25 basis points year over year, with the second half anticipated to benefit from improved initial merchandise margins. The company also expects to receive $100 million in tariff refunds in the fiscal second quarter related to previously imposed IEEPA tariffs, which management plans to record as a one-time benefit.
For the full year, SG&A growth is expected to be in line with sales growth, while inventory growth is projected to remain at or below the pace of sales growth as the company focuses on improving product turns.
Capital expenditure for fiscal 2027 is planned at approximately $475 million. About 35% of the spending is expected to support retail store expansion and store-related investments, nearly 50% will be allocated toward logistics investments and automation capabilities, while the remaining 15% will support technology initiatives and home office expansion.
Management also expressed confidence in the underlying health of the business, highlighting strong momentum at Free People and FP Movement, continued progress at Urban Outfitters in North America and Europe, improving trends at Anthropologie and Nuuly’s path toward its long-term $1 billion revenue opportunity. The company believes its diversified portfolio positions URBN for continued positive comparable sales growth, margin expansion and record profitability in fiscal 2027.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
VGM ScoresAt this time, Urban Outfitters has a average Growth Score of C, however its Momentum Score is doing a lot better with an A. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Urban Outfitters has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerUrban Outfitters belongs to the Zacks Retail - Apparel and Shoes industry. Another stock from the same industry, Fossil Group (FOSL - Free Report) , has gained 5.2% over the past month. More than a month has passed since the company reported results for the quarter ended March 2026.
Fossil Group reported revenues of $224.8 million in the last reported quarter, representing a year-over-year change of -3.6%. EPS of -$0.03 for the same period compares with -$0.10 a year ago.
For the current quarter, Fossil Group is expected to post a loss of $0.29 per share, indicating a change of -190% from the year-ago quarter. The Zacks Consensus Estimate has changed -81.3% over the last 30 days.
Fossil Group has a Zacks Rank #2 (Buy) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D.
, /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced the launch of its new TOPCon 3.0 high-power-density photovoltaic module, tailored for utility-scale power plants as well as commercial and industrial (C&I) PV systems. With a power output of up to 670 Wp and a conversion efficiency of up to 24.8%, the new product is scheduled for global mass shipment starting in August 2026.
The TOPCon 3.0 high-power-density module delivers higher energy yield and lower Levelized Cost of Electricity (LCOE), improving project economics and long-term returns.
Higher power density: With a power output of up to 670 Wp, the module features a multi-cut technology based on large-format rectangular cells and enhanced light utilization, while maintaining a standard module size of 2382 × 1134 × 30 mm for optimum logistics and easy system integration.
Higher bifaciality: Cell poly-patterned technology and optimized back-side design enable PV module bifaciality of up to 90%, delivering an additional 0.4%–0.5% system-level energy gain.
Lower temperature coefficient: Advanced passivation technologies on cell edge and surface lower the PV module temperature coefficient to -0.26%/°C, improving PV system performance in high-temperature environments.
Together, these advanced cell and module technologies deliver high reliability and reduce degradation to ≤1% in the first year and 0.35% annually thereafter, ensuring over 88.85% output after 30 years.
For demanding conditions such as glare-sensitive, high-load, corrosive, and dusty environments, the TOPCon 3.0 module portfolio can be equipped with anti-glare glass, IoT (Internet of Things)-enabled junction box, and steel, composite, or anti-dust frames, enhancing PV system safety and visibility.
Dr. Shawn Qu, Executive Chairman and Chief Technology Officer of Canadian Solar, said, "With the launch of our TOPCon 3.0 module, we continue to advance high-efficiency PV technology, delivering up to 1.6% higher energy yield and up to 1.4% lower LCOE, translating into stronger lifecycle value and more predictable long-term returns for our global partners."
The TOPCon 3.0 high-power-density module will be showcased at Intersolar Europe from June 23 to 25 in Munich, Germany. Visit Canadian Solar at booth B2.250 to explore the new generation of high-efficiency PV technology.
About Canadian Solar Inc.
Canadian Solar is one of the world's largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 25 years, Canadian Solar has successfully delivered nearly 177 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar had shipped over 20 GWh of battery energy storage solutions to global markets as of March 31, 2026, and had a $3.5 billion contracted backlog as of May 8, 2026. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 12.2 GWp of solar power projects and 6.4 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 24 GWp of solar and 81 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.
Safe Harbor/Forward-Looking Statements
Certain statements in this press release, including those regarding the Company's expected future shipment volumes, revenues, gross margins, and project sales are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "may", "will", "expect", "anticipate", "future", "ongoing", "continue", "intend", "plan", "potential", "prospect", "guidance", "believe", "estimate", "is/are likely to" or similar expressions, the negative of these terms, or other comparable terminology. These forward-looking statements include, among other things, our expectations regarding global electricity demand and the adoption of solar and battery energy storage technologies; our growth strategies, future business performance, and financial condition; our transition to a long-term owner and operator of clean energy assets and expansion of project pipelines; our ability to monetize project portfolios, manage supply chain fluctuations, and respond to economic factors such as inflation and interest rates; our outlook on government incentives, trade measures, regulatory developments, and geopolitical risks; our expectations for project timelines, costs, and returns; competitive dynamics in solar and storage markets; our ability to execute supply chain, manufacturing, and operational initiatives; access to capital, debt obligations, and covenant compliance; relationships with key suppliers and customers; technological advancement and product quality; and risks related to intellectual property, litigation, and compliance with environmental and sustainability regulations. Other risks were described in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 10, 2026. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.
CANADIAN SOLAR INC. INVESTOR RELATIONS CONTACT
Wina Huang
Investor Relations
Canadian Solar Inc.
[email protected]
e-STORAGE dodá společnosti Apex Clean Energy v Michiganu bateriové úložiště o výkonu 75 MW a kapacitě 381 MWh. Projekt má začít s dodávkami na počátku roku 2027 a do provozu vstoupit v polovině roku 2027.
, /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, its energy storage solutions business, will supply a 75 MW / 381 MWh DC battery energy storage system (BESS) to Apex Clean Energy in Branch County, Michigan. The system will be co-located with Apex's operating Coldwater Solar facility.
Under the agreement, e-STORAGE will deliver a complete, integrated solution that combines SolBank 3.0 battery blocks with Power Conversion Systems and e-STORAGE's proprietary EQ‑S Energy Management System into one coordinated utility‑scale platform. Deliveries are scheduled to begin in early 2027, with commercial operation targeted for mid-2027. e-STORAGE will provide its proprietary 'SolBank' battery pack powered by its lithium-Ion phosphate-based battery cells, all produced at Canadian Solar's manufacturing facilities, giving the customer full supply chain visibility and compliance.
Coldwater Storage enters service against a firm policy backdrop: Michigan law requires utilities to bring 2,500 MW of energy storage online by 2030, and the state's largest coal units are slated to retire through 2032, removing dispatchable capacity from the MISO grid that storage must replace. Once operational, the project will store low‑cost energy and discharge it when demand peaks, helping firm the supply that Michigan is shifting toward solar and wind.
Ken Young, CEO of Apex, said: "Power demand is rising rapidly, and storage projects like Coldwater enable our grid to keep pace. e-STORAGE has the technology and the scale to deliver this project, and we're glad to be working once again with our partners at Canadian Solar."
Jeff Roy, President of e-STORAGE, said: "Michigan is rebuilding its power generation mix on a fixed timeline, and this collaboration shows how that target turns into reliable capacity on the ground. By supplying the batteries, power conversion, and our EQ-S controls as one integrated system, we serve as Apex's single accountable technology partner across the project's lifecycle."
About Canadian Solar Inc.
Canadian Solar is one of the world's largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 25 years, Canadian Solar has successfully delivered nearly 177 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar had shipped over 20 GWh of battery energy storage solutions to global markets as of March 31, 2026, and had a $3.5 billion contracted backlog as of May 8, 2026. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 12.2 GWp of solar power projects and 6.4 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 24 GWp of solar and 81 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.
About e-STORAGE
e-STORAGE is a subsidiary of Canadian Solar and a leading company specializing in designing, manufacturing, and integrating battery energy storage systems for utility-scale applications. e-STORAGE offers proprietary battery energy storage solutions, comprehensive EPC services, and innovative solutions aimed at improving grid operations. For more info, please refer to the Media&PR section of www.csestorage.com and follow our LinkedIn page.
Safe Harbor/Forward-Looking Statements
Certain statements in this press release, including those regarding the Company's expected future shipment volumes, revenues, gross margins, and project sales are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the "Safe Harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as "may", "will", "expect", "anticipate", "future", "ongoing", "continue", "intend", "plan", "potential", "prospect", "guidance", "believe", "estimate", "is/are likely to" or similar expressions, the negative of these terms, or other comparable terminology. These forward-looking statements include, among other things, our expectations regarding global electricity demand and the adoption of solar and battery energy storage technologies; our growth strategies, future business performance, and financial condition; our transition to a long-term owner and operator of clean energy assets and expansion of project pipelines; our ability to monetize project portfolios, manage supply chain fluctuations, and respond to economic factors such as inflation and interest rates; our outlook on government incentives, trade measures, regulatory developments, and geopolitical risks; our expectations for project timelines, costs, and returns; competitive dynamics in solar and storage markets; our ability to execute supply chain, manufacturing, and operational initiatives; access to capital, debt obligations, and covenant compliance; relationships with key suppliers and customers; technological advancement and product quality; and risks related to intellectual property, litigation, and compliance with environmental and sustainability regulations. Other risks were described in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 10, 2026. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.
CANADIAN SOLAR INC. INVESTOR RELATIONS CONTACT
Wina Huang
Investor Relations
Canadian Solar Inc.
[email protected]
HubSpot v 1. čtvrtletí zvýšil výnosy o 23 % na 881,0 milionu USD, z toho 862,3 milionu USD ze předplatného. Počet předplatitelů vzrostl meziročně o 16 % na téměř 300 000.
HubSpot (HUBS +2.34%) was one of the many software stocks that fell victim to the SaaSpocalypse narrative earlier this year. Its stock is down by almost 70% so far in 2026, but that doesn't mean the company has lost market share. In fact, it's continuing to deliver impressive financial results, so the current fire sale on its stock likely won't last long.
Image source: Getty Images.
HubSpot generates recurring revenue from a wide range of businesses HubSpot provides its clients with a customer relationship management (CRM) platform, and it has been tapping into artificial intelligence to expand its offerings. That last detail is important in the context of its recent decline: The premise of the SaaSpocalypse that spooked investors was the theory that people and companies would be able to use AI to create inexpensive replacements for popular subscription software offerings, pulling the rug out from under the software-as-a-service business model.
Today's Change
(
2.34
%) $
4.05
Current Price
$
177.34
Customers have to pay subscription fees to continue using HubSpot, but once a business starts using one CRM platform, it's a difficult and costly matter to switch to another. HubSpot booked $881.0 million in revenue in Q1, and $862.3 million of that came from subscriptions. Both figures were up by 23% year over year.
That revenue growth also came with an expanding customer base. HubSpot finished the quarter with just under 300,000 subscribers, which was up by 16% year over year.
AI momentum is strengthening for HubSpot HubSpot has been in the CRM business since its founding in 2006. It has gone through several economic cycles over the past two decades, and capitalized on several opportunities; artificial intelligence will be the next one. As CEO Yamini Rangan noted in the company's Q1 press release: "The AI innovations we launched at Spring Spotlight, including Customer Agent, Prospecting Agent, and Data Agent, are delivering outcomes for customers and will strengthen our AI momentum."
That doesn't sound like a company that is afraid that artificial intelligence will displace what it offers. HubSpot is actively using this technology to enhance its products and attract new customers. Adding AI functions could also improve HubSpot's ability to raise prices or get its customers to upgrade their plans. Businesses have already been spending more on HubSpot on average each year; in Q1, the company reported a 6% year-over-year increase in its average subscription revenue per customer.
HubSpot has even reframed itself as "the agentic customer platform for scaling businesses." The agentic piece is a new angle that aims to position it as a participant in the AI boom.
Management anticipates that its revenue will increase by 18% in 2026. That would be a deceleration relative to its Q1 growth, but still a respectable increase. HubSpot could also beat its guidance in future quarters and raise its full-year outlook; the AI momentum Rangan mentioned suggests this is possible.
It would be harder to feel optimistic about the stock if HubSpot were still trading above $500 per share, as it was at the start of the year. However, its drop to under $200 per share gives it a valuation that's more attractive based on the company's fundamentals.
Bath & Body Works začne od 12. července prodávat své vůně, mýdla a svíčky ve více než 600 prodejnách Ulta Beauty. Partnerství má podpořit růst tržeb obou firem.
Item 1 of 2 An Ulta Beauty store sign is pictured in the Manhattan borough of New York City, New York, U.S., March 8, 2022. REUTERS/Carlo Allegri/File Photo
[1/2]An Ulta Beauty store sign is pictured in the Manhattan borough of New York City, New York, U.S., March 8, 2022. REUTERS/Carlo Allegri/File Photo Purchase Licensing Rights, opens new tab
NEW YORK, June 23 (Reuters) - Ulta Beauty (ULTA.O), opens new tab shoppers will soon be able to purchase Bath & Body Works' (BBWI.N), opens new tab signature fragrances, hand soaps and candles in more than 600 stores from July 12 as both companies pursue turnaround plans that include more partnerships.
Part of Bath & Body Works' "Consumer First Formula" aims to give shoppers more ways to find the company's lotions and candles, while the "Ulta Beauty Unleashed" strategy intends to launch more brand partnerships to drive sales growth.
The Reuters Inside Track newsletter is your essential guide during the World Cup. Sign up here.
The partnership brings Bath & Body Works fine fragrance mist, body cream, hand soap, three-wick candles and plug-in air fresheners to Ulta Beauty stores.
"Home fragrance is a really important part of the industry, and it's not an area that Ulta has played in all that much, so we see a real opportunity," Bath & Body Works CEO Daniel Heaf said.
Bath & Body Works began selling its products on Amazon.com in February, and the e-commerce platform is helping Bath & Body Works "bring new consumers to the brand," Heaf said.
"Amazon is about convenience," Heaf said. "Ulta Beauty is about discovery, trial, and the physical experience. It gives the consumers a chance to see the brand, smell the fragrances and interact with the assortment."
Ulta Beauty Chief Merchandising and Digital Officer Lauren Brindley said: "We see a meaningful whitespace opportunity to better serve guests across high-quality home fragrance, hand soaps, lotions and body care, categories that beautifully complement our assortment."
Ulta Beauty currently sells other candle brands including NEST New York for $65 and its own brand, Ulta Beauty Collection, for $20, according to its website. Bath & Body Works sells candles for $25.
There is no set end date for the partnership, Heaf said.
Reporting by Arriana McLymore in New York; Editing by Jamie Freed
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Arriana McLymore is a New York-based reporter covering e-commerce, online marketplaces, alternative revenue streams for retailers and in-store innovation. She previously reported on telecoms and the business of law.
The company logo of the Space systems specialist OHB in Oberpfaffenhofen near Munich, southern Germany, April 18, 2016. REUTERS/Michael Dalder Purchase Licensing Rights, opens new tab
June 22 (Reuters) - German satellite maker OHB (OHBG.DE), opens new tab said on Monday it was launching a share sale with KKR (KKR.N), opens new tab to bring in new investors and seek a higher valuation as interest in space stocks rises after Elon Musk's blockbuster SpaceX listing.
The combined offering would more than triple OHB's free float and imply a market value of 6.3 billion euros, positioning the company to capitalise on a surge in investor appetite for the sector.
The Reuters Inside Track newsletter is your essential guide during the World Cup. Sign up here.
OHB said it will issue up to 1.7 million new shares at 300 euros each, raising up to 510.7 million euros. KKR-owned Orchid Lux HoldCo will sell up to 1.23 million existing shares, according to a bookrunner for the deal.
The global investment firm will trim its stake to around 20% from 28.6% and net up to 368 million euros, more than it paid for the entire stake in 2023.
The total deal size includes a greenshoe option and would increase OHB's free float to 19.2% from 5.7%, the bookrunner said.
The offer price was a 26% discount to OHB's closing price of 405.5 euros.
The Fuchs family, OHB's majority shareholder, waived its subscription rights but will not sell any shares.
SpaceX (SPCX.O), opens new tab surged past $2 trillion in its record-setting initial public offering on June 12, lifting investor appetite for space stocks. "Everyone is aiming for higher valuations after the SpaceX IPO," CEO Marco Fuchs told Reuters earlier this month.
Shares from KKR and most of the new stock will be placed with institutional investors through Wednesday, while existing shareholders can exercise subscription rights from June 25 to July 8.
($1 = 0.8728 euros)
Reporting by Gianluca Lo Nostro and Alexander Hübner; Editing by Joe Bavier and Matt Scuffham
Our Standards: The Thomson Reuters Trust Principles., opens new tab
KKR má v privátním úvěrování jen malou expozici: alternativní úvěry tvoří 149 miliard USD z 758 miliard USD spravovaných aktiv. Firma navíc drží převážně zajištěné a prvotně zajištěné úvěry.
The private credit market had been a boon for alternative investment firms. KKR (KKR 0.76%) and others raised billions of dollars from investors, which they then invested in private loans. However, the private credit sector has come under pressure over the past year due to high-profile bankruptcies and growing concerns that AI will disrupt software companies, leading to a surge in defaults.
That has investors on edge. They're flooding private credit fund sponsors with redemption requests, forcing these firms to restrict withdrawals. While the sector's growing issues are a concern for KKR, here's why the leading alternative investment manager appears to be in a strong position to weather this storm.
Image source: Getty Images.
Not all private credit is the same There are many misconceptions about private credit. The sector has grown over the last decade due to a combination of rising industry capital needs and traditional lenders pulling back amid rising regulations and capital requirements. This growing gap opened the door for alternative capital providers to underwrite loans for these borrowers.
At the core, private credit is simply a senior loan to asset owners and businesses in return for a prioritized, fixed-income return. The sector's issues all boil down to the lender. Some private credit lenders have looser underwriting standards, while others are stricter. Similarly, some lenders make loans based on a borrower's income, while others make only collateralized loans. A conservative lender making collateralized loans is taking on significantly less default risk than one making unsecured loans based on the borrower's current ability to repay.
Today's Change
(
-0.76
%) $
-0.71
Current Price
$
92.79
Built to mitigate risk KKR has been investing in private credit for more than 20 years. The global investment firm had $293 billion in credit assets under management (AUM) at the end of the first quarter. However, alternative credit is only $149 billion in its AUM, and direct lending is a mere $39 billion of that amount (which includes loans made by its public and private business development companies (BDCs)). As a result, private credit accounts for a fraction of its total AUM of $758 billion. Further, the company focuses on making lower-risk loans, including senior-secured, first-lien direct lending and collateralized ABF (Asset Backed Financing) loans. KKR has also been very disciplined in its underwriting and diversifies across industries (software is just 5% of its credit portfolio).
The global investment firm's strategy has yielded exceptional results. Every single one of its current vintage of funds is delivering returns that significantly exceed their respective benchmarks. That track record of success is attracting more capital to its funds, even as investors withdraw from other funds. KKR's CFO, Rob Lewin, noted on the first quarter conference call that it was one of its larger quarters for credit inflows, driven by its ABF business.
A compelling opportunity worth capitalizing on KKR's stock price has lost more than a third of its value over the past year due to concerns about private credit, even though it's a small yet sound part of the business. Meanwhile, KKR is more than an asset manager as it also has a leading insurance franchise (Global Atlantic) and a growing portfolio of strategic holdings. These businesses generated $4.6 billion of adjusted net income over the last 12 months, with only a small portion coming from direct lending. Given its low exposure to private credit (and high-quality operations), KKR's sell-off is a great buying opportunity.
Ares Management cílí na více než 750 miliard USD v AUM do roku 2028, zatímco KKR míří alespoň na 1 bilion USD v AUM do roku 2030. Obě firmy ale dál brzdí rostoucí náklady.
Key Takeaways ARES is expanding across credit, real assets and secondaries, with a goal of $750B AUM by 2028.KKR is scaling across private equity, credit and insurance, targeting at least $1T AUM by 2030.ARES and KKR have raised earnings estimates, but rising expenses remain a near-term headwind for both. Ares Management Corporation (ARES - Free Report) and KKR & Co. Inc. (KKR - Free Report) are prominent alternative asset managers with diversified investment platforms across private equity, credit and real assets. ARES primarily focuses on alternative investment solutions spanning credit, private equity, real assets, secondaries and insurance-related strategies. In contrast, KKR operates a broader model that integrates alternative asset management with capital markets and insurance solutions. Both firms benefit from strong institutional relationships, wide-ranging investment capabilities and expanding sources of perpetual capital. However, differences in business mix, growth strategies and revenue drivers could shape their relative performance going forward.
The asset-management industry is navigating a shifting operating backdrop. Rising investments in technology and artificial intelligence are increasing cost pressures, while the rapid growth of ETFs, especially actively managed products, is intensifying competition. Additionally, concerns around private credit markets may weigh on near-term flows into select alternative investment strategies. Still, favorable market conditions and steady inflows continue to support AUM growth across the industry.
Against this backdrop, investors naturally ask: Which firm, ARES or KKR, is better positioned for long-term growth? To answer that, we need to examine their fundamentals more closely.
The Case for ARESAres Management has been strengthening its platform through strategic acquisitions and partnerships. In February 2026, the company acquired BlueCove Limited to strengthen its credit platform and partnered with Slate Asset Management to acquire a Polish retail real estate portfolio, expanding its European footprint. Earlier, the company acquired GCP International in 2025 to broaden its real assets platform. Together, these initiatives have diversified Ares Management's investment offerings, expanded its global footprint and strengthened its position across key alternative asset classes, supporting long-term growth prospects.
Supported by these strategic acquisitions and partnerships, Ares Management's AUM has witnessed consistent growth over the years. Strong fundraising activity through the wealth management channel, growing insurance-related assets, and continued demand for private credit, real assets and secondaries strategies have supported its AUM growth. Further, the company's expanding perpetual capital base and broad distribution network are expected to drive fundraising and deployment activity. With management targeting AUM of more than $750 billion by 2028, ARES appears well positioned to sustain growth over the long term.
Organic growth remains a key strength for Ares Management. Higher management and performance fees from a growing fee-paying asset base have continued to support revenue growth. The acquisition of GCP International has further enhanced the company's real assets and digital infrastructure capabilities, adding incremental management fee revenues. Management continues to target annual organic growth of 16-20% or more in fee-related earnings and more than 20% growth in realized income over the medium term. Going forward, continued expansion in private credit and real assets is expected to support revenue growth and earnings generation.
However, ARES' expense base has been rising due to higher compensation and benefits costs, ongoing investments in fundraising and platform expansion, and expenses associated with integrating acquired businesses. These factors are likely to keep costs elevated and could pressure near-term profitability.
The Case for KKRKKR has been expanding its platform through strategic acquisitions to enhance its investment capabilities and drive asset growth. In May 2026, the company acquired Arctos Partners, an investment firm managing approximately $16 billion in AUM, expanding its capabilities across sports investing, GP solutions and secondaries. Earlier, in July 2025, KKR acquired a majority stake in HealthCare Royalty Partners, adding nearly $3 billion to its AUM and expanding its healthcare-focused investment capabilities. These initiatives have supported KKR's efforts to scale its alternative investment platform, diversify revenue streams and accelerate AUM growth, positioning the company well for long-term expansion.
Building on these initiatives, KKR's AUM balance has grown steadily over the years, reflecting the strength of its diversified investment platform. The company's expanding presence across private equity, credit, infrastructure, real estate and insurance has supported AUM growth, while fundraising and capital deployment activity have remained healthy. Further, a growing perpetual capital base and continued expansion of investment capabilities are expected to support future asset growth. The Arctos acquisition is also expected to increase KKR's exposure to perpetual and long-dated capital and strengthen its wealth and institutional distribution capabilities. Management's goal of reaching at least $1 trillion in AUM by 2030 further underscores confidence in the company's long-term growth prospects.
Organic growth also remains a key strength for KKR. The company continues to benefit from the expansion of its traditional private equity and third-party businesses while adding capabilities across infrastructure, real estate, growth and core investing strategies. These efforts have increased deal activity and broadened KKR's revenue base over time. Continued expansion across these investment platforms is expected to support revenue growth and earnings generation over the long term.
Nevertheless, an elevated expense base remains a headwind for KKR. Higher commission, reinsurance and employee compensation expenses have increased costs, while continued fundraising activity is expected to drive higher placement fees. This could pressure the company's near-term earnings growth.
How Do Earnings Estimates Compare for ARES & KKR?The Zacks Consensus Estimate for ARES’ 2026 and 2027 earnings implies a year-over-year rise of 27.3% and 24.4%, respectively. Earnings estimates for 2026 have been revised upward, while for 2027, it has remained unchanged over the past month.
ARES Estimates Revision Trend
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for KKR’s 2026 and 2027 earnings implies a year-over-year rise of 24.6% and 23.5%, respectively. Earnings estimates for both years have been revised upward over the past month.
KKR Estimates Revision Trend
Image Source: Zacks Investment Research
ARES & KKR: Price Performance, Valuations & Other ComparisonsOver the past three months, ARES and KKR shares gained 20.8% and 6.8%, respectively, compared with the industry’s growth of 10.3%.
Price Performance Comparison
Image Source: Zacks Investment Research
From a valuation standpoint, ARES is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 19.14X, while KKR is currently trading at a forward 12-month P/E multiple of 15.7X. Both are trading at a premium compared with the industry average of 13.66X; however, KKR stock is cheaper than ARES.
Price-to-Earnings F12M
Image Source: Zacks Investment Research
Meanwhile, both Ares Management and KKR & Co reward their shareholders handsomely. In February 2026, ARES raised its quarterly dividend by 20.5% to $1.35 per share. It has a dividend yield of 4.2%. Similarly, KKR raised its annualized dividend by 5.4% to 78 cents per share in May 2026. It has a dividend yield of 0.8%.
Dividend Yield
Image Source: Zacks Investment Research
ARES or KKR: Which Stock Offers More Value?Ares Management and KKR & Co. both benefit from diversified alternative investment platforms, growing perpetual capital bases and healthy fundraising activity, supporting long-term AUM growth. Both companies are also expanding through acquisitions to strengthen their investment capabilities and broaden their market reach.
However, ARES appears to have a slight edge, supported by stronger earnings growth expectations and a significantly higher dividend yield. While KKR trades at a lower valuation and offers solid growth prospects, ARES provides a more compelling combination of growth and income.
Therefore, despite its premium valuation, Ares Management appears better positioned to deliver attractive long-term shareholder returns, making it the more favorable choice for investors seeking both growth and income.
ARES and KKR currently carry a Zacks Rank #3 (Hold) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Murphy USA těží z nikotinu: tržby z této kategorie ve stejných prodejnách vzrostly o 11,5 % a pomáhají zvyšovat marže. Celkový příspěvek zboží v 1. čtvrtletí stoupl na 210,2 mil. USD.
Key Takeaways MUSA's same-store nicotine contribution climbed 11.5%, outpacing non-nicotine growth.Murphy USA benefited from higher merchandise margins and resilient nicotine demand.MUSA's valuation and rising EPS estimates support its long-term outlook. Murphy USA's (MUSA - Free Report) merchandise business is increasingly being driven by one category, nicotine. While discretionary consumer spending remains under pressure, the company's nicotine offerings continue to generate strong sales and higher-margin profits, helping offset weakness in other in-store categories. Recent results indicate that nicotine has evolved beyond a traffic driver into one of Murphy USA's most significant earnings contributors.
During the first quarter, MUSA reported merchandise contribution of $210.2 million, up 7.3% year over year. On a same-store basis, merchandise contribution increased 4.9%, supported by both higher sales and expanding unit margins, which improved to 20.0% from 19.6% in the prior-year quarter. Nicotine remained the standout performer, with same-store contribution rising 11.5%, far exceeding the 2.7% growth recorded in non-nicotine merchandise. Management noted that nearly every merchandise metric benefited from nicotine's continued strength, while discretionary categories such as snacks and other non-essential products remained soft as consumers carefully managed household budgets.
Murphy USA's value-focused operating model has further reinforced this trend. Management highlighted that elevated fuel prices have attracted more value-conscious customers to its stores, creating additional opportunities for nicotine purchases. Unlike discretionary merchandise, nicotine products typically experience more stable demand regardless of broader economic conditions. As a result, the category continues to provide MUSA with a dependable source of inside-store profitability even as the retail environment remains cautious.
MUSA Stands Out Among PeersMUSA is not the only convenience retailer benefiting from nicotine demand, but the category appears to be contributing more meaningfully to the recent merchandise growth than it does for several competitors.
Casey's General Stores (CASY - Free Report) has expanded its assortment of cigarettes, modern oral nicotine products and other tobacco offerings. However, Casey's still relies heavily on prepared food and beverages as its primary engine for inside-store sales growth. While nicotine remains an important category, the company's long-term strategy is centered on foodservice expansion, resulting in a more diversified merchandise mix.
ARKO Corp. (ARKO - Free Report) also generates a portion of its in-store sales from tobacco and nicotine products. Similar to MUSA, ARKO serves value-oriented consumers and views tobacco as an important traffic driver. At the same time, the company has been investing in foodservice, loyalty programs and private-label products to reduce its dependence on traditional tobacco categories. Compared with ARKO, MUSA's latest results suggest nicotine remains a more immediate catalyst for merchandise margin expansion, supported by robust demand for modern nicotine products and its everyday low-price strategy.
Although Casey's and ARKO both recognize nicotine as an important merchandise category, MUSA currently appears to be extracting greater earnings leverage from the segment, helping offset softer discretionary spending while supporting stronger merchandise contribution growth.
Valuation and Earnings Outlook Remain FavorableMUSA's long-term outlook remains supported by resilient nicotine demand, continued retail expansion and disciplined execution. While non-nicotine discretionary categories could recover as consumer spending improves, nicotine currently provides the company with a stable source of higher-margin merchandise contribution and strengthens earnings resilience.
The stock also appears attractively valued relative to its growth prospects. MUSA trades at a forward price-to-earnings ratio of 17.84, well below Casey's 39.59 and ARKO's 22.11.
Image Source: Zacks Investment ResearchAnalysts have also become increasingly optimistic about the company's earnings trajectory, raising 2026 EPS estimates by 26.57% and 2027 estimates by 7.35% over the past 60 days.
Image Source: Zacks Investment Research
From a stock performance perspective, MUSA has delivered solid returns but has trailed some peers. Over the past six months, ARKO’s shares have surged 60.9%, outperforming Casey's and MUSA, which gained 46.7% and 35.5%, respectively.
Image Source: Zacks Investment Research
Murphy USA's combination of attractive valuation, strong earnings momentum and nicotine-driven merchandise growth supports its favorable long-term outlook. MUSA currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
AST SpaceMobile oznámila, že BlueBirdy 11, 12 a 13 mají v první polovině srpna odstartovat na Falconu 9 z Cape Canaveral. Mise rozšíří síť satelitního mobilního širokopásmového připojení.
BlueBirds 11, 12, and 13 will launch into low Earth orbit aboard a Falcon 9 rocket from Cape Canaveral, Florida
The mission continues the momentum established by the successful June 2026 launch of BlueBirds 8, 9, and 10, which are already operating in orbit
MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced that BlueBird satellites 11, 12, and 13 are targeted to launch from Cape Canaveral, Florida in the first half of August.
The mission will carry the next batch of next-generation satellites to low Earth orbit, further expanding the company's space-based cellular broadband network designed to provide voice, data, video, directly to standard, unmodified smartphones everywhere.
“With each successful launch, we move closer to our goal of making space-based cellular broadband accessible wherever people live, work, and travel," said Scott Wisniewski, President of AST SpaceMobile. “BlueBirds 11, 12, and 13 build on the momentum of our recent constellation and represent another important milestone as we prepare for commercial service. The progression from BlueBirds 8, 9, and 10 to this next mission, together with the continued production and assembly of satellites through BlueBird 37, reflects the strength of our manufacturing capabilities and our ability to steadily expand the network while we work to connect the unconnected and under-connected around the world."
BlueBirds 11, 12, and 13 feature commercial communications arrays measuring approximately 2,400 square feet, matching the scale of the BlueBird satellites currently operating in orbit. These next-generation satellites are expected to deliver nearly double the peak data speeds of AST SpaceMobile's initial Block 1 BlueBird satellites, which recently achieved peak download speeds of 98.9 Mbps directly to standard smartphones.
The satellites leverage AST SpaceMobile's next-generation stackable satellite architecture, including advanced composite carbon structures designed to support efficient multi-satellite launches and accelerated constellation deployment. Combined with the company's multi-provider launch strategy, the architecture is designed to provide flexibility in deploying AST SpaceMobile's global constellation.
AST SpaceMobile has agreements with nearly 60 mobile network operators globally with over 3 billion subscribers combined and strategic partnerships with AT&T, Verizon, Vodafone, Rakuten, Google, Bell, Telus, stc Group, and American Tower.
The exact timing of orbital launches is subject to change based on a number of factors, including launch readiness of the launch provider, weather conditions, and other factors, many of which are beyond the company’s control.
About AST SpaceMobile
AST SpaceMobile is building the first and only global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on our extensive IP and patent portfolio, and designed for both commercial and government applications. Our engineers and space scientists are on a mission to enable 4G and 5G space-based cellular broadband to every device, everywhere, for today’s nearly 6 billion mobile subscribers globally. For more information, follow AST SpaceMobile on YouTube, X (Formerly Twitter), LinkedIn and Facebook. Watch this video for an overview of the SpaceMobile mission.
Forward-Looking Statements
This communication contains “forward-looking statements” that are not historical facts, and involve risks and uncertainties that could cause actual results of AST SpaceMobile to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “would,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside AST SpaceMobile’s control and are difficult to predict.
Factors that could cause such differences include, but are not limited to: (i) expectations regarding AST SpaceMobile’s strategies and future financial performance, including AST’s future business plans or objectives, expected functionality of the SpaceMobile Service, anticipated timing of the launch of the Block 2 BlueBird satellites, anticipated demand and acceptance of mobile satellite services, prospective performance and commercial opportunities and competitors, the timing of obtaining regulatory approvals, ability to finance its research and development activities, commercial partnership acquisition and retention, products and services, pricing, marketing plans, operating expenses, market trends, revenues, liquidity, cash flows and uses of cash, capital expenditures, and AST SpaceMobile’s ability to invest in growth initiatives; (ii) the negotiation of definitive agreements with mobile network operators relating to the SpaceMobile Service that would supersede preliminary agreements and memoranda of understanding and the ability to enter into commercial agreements with other parties or government entities; (iii) the ability of AST SpaceMobile to grow and manage growth profitably and retain its key employees and AST SpaceMobile’s responses to actions of its competitors and its ability to effectively compete; (iv) changes in applicable laws or regulations; (v) the possibility that AST SpaceMobile may be adversely affected by other economic, business, and/or competitive factors; (vi) the outcome of any legal proceedings that may be instituted against AST SpaceMobile; and (vii) other risks and uncertainties indicated in the Company’s filings with the Securities and Exchange Commission (SEC), including those in the Risk Factors section of AST SpaceMobile’s Form 10-K filed with the SEC on March 2, 2026, its Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 11, 2026 and the future reports that it may file from time to time with the SEC.
AST SpaceMobile cautions that the foregoing list of factors is not exclusive. AST SpaceMobile cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors in AST SpaceMobile’s Form 10-K filed with the SEC on March 2, 2026, its Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 11, 2026 and the future reports that it may file from time to time with the SEC. AST SpaceMobile’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, AST SpaceMobile disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
AST SpaceMobile ve 1. čtvrtletí 2026 utržila 14,73 mil. USD, což bylo o 59,72 % pod očekáváním, a čistá ztráta se prohloubila kvůli nákladům na konvertibilní dluhopisy ve výši 88,65 mil. USD. Akcie za týden klesly o 17,32 %.
AST SpaceMobile (NASDAQ:ASTS) is the only public company beaming 4G and 5G directly to unmodified smartphones from low Earth orbit. CEO Abel Avellan calls it “the only technology positioned to capture the massive direct to device broadband opportunity in full.”
Shares are up just 11.06% year to date despite a constellation buildout that should reach approximately 45 satellites in orbit by year-end 2026. Can ASTS reclaim $100 by January 2027?
What’s Holding AST SpaceMobile Back The stock has stalled. ASTS fell 17.32% in the past week and is down 8.44% over the last month, retreating from a January 2026 peak of $115.77. Q1 2026 revenue of $14.73M missed expectations by 59.72%, and net loss widened with $88.65M in induced conversion expense on convertible notes.
Insiders have been sellers. The CFO unloaded 45,809 shares at $93.81 on June 12, and the president sold 25,904 shares at $126.64 in late May. With a beta of 2.634, ASTS moves violently. Right now it is moving down.
Wall Street Is Cautious. The Setup May Be Underestimated The consensus target sits at $81.47, pinned to today’s price. Analyst ratings split 2 Buy, 7 Hold, and 2 Strong Sell, with only 18% bullish sentiment.
Our base case sees $91.65 within a year (13.63% upside), with a bull case at $108.33. Confidence is moderate at 0.5. The hold-heavy consensus anchors to trailing financials while 2026 guidance steps up to $150M-$200M, backed by over $1.2 billion in aggregate contracted revenue commitments. That step function analysts tend to update slowly.
The Path to $100 Reaching $100 from today’s price of $80.66 requires a meaningful gain. That sits inside the one-year bull case.
Forward EPS is -$1.89, so $100 implies a forward multiple that is not meaningful. ASTS trades on constellation milestones and revenue ramp. The bull case rests on three catalysts: the mid-June launch of BlueBird 8, 9, and 10, the path to 45 satellites in orbit by year-end, and Block 2 satellites that are expected to nearly double the 98.9 Mbps peak data speeds already achieved.
Avellan framed it plainly: “AST SpaceMobile is accelerating manufacturing, regulatory progress, commercial partnerships, and government programs.”
With $3.03B in cash and nearly 60 global MNO partners covering more than 3 billion subscribers, the funding gap has narrowed. The primary risk is execution: any launch slip or MNO conversion failure reprices the story fast.
Valuation Today Price-to-sales sits at 368.59, which only makes sense if the $150M-$200M 2026 revenue guide is the floor. Shares sit 39% below the 52-week high of $133.86 and well above the $36.08 low. The five-year return of 666.73% reflects how quickly this stock rerates on constellation news.
Is $100 Realistic? The bold target is $100, requiring a gain of $100.11 on January 21, 2027.
Three things must go right: mid-June BlueBird launches must hit orbit on schedule, 2026 revenue must track to the upper half of $150M to $200M, and at least one large MNO MOU must convert to a definitive agreement. Launch failure or further dilutive financing derails it. Returns at this level shouldn’t be expected every year, but the blueprint for reaching $100 in 2027 is clear.
Nu Holdings ve 1. čtvrtletí 2026 zvýšila počet zákazníků na 135 milionů a průměrné měsíční tržby na zákazníka na 16 USD. Akcie přesto letos klesly asi o 25 %.
Nu Holdings (NU +0.24%) is one of the world's fastest-growing fintech companies. It owns NuBank, the largest digital-only bank in Latin America. By streamlining its digital services and offering a fee-free credit card, it expanded much faster than its brick-and-mortar competitors. It also expanded its ecosystem with more loans, e-commerce services, and crypto trading tools.
From 2021 to 2025, Nu's year-end customer base grew from 54 million to 131 million, its activity rate (active customers divided by total customers) expanded from 76% to 83%, and its monthly average revenue per customer (ARPAC) more than tripled from $4.50 to $15. Even as it added customers at that blistering pace, its average cost per active customer held steady.
Image source: Getty Images
In the first quarter of 2026, Nu's total customers rose to 135 million, its activity rate held steady at 83%, and its monthly average revenue per customer grew to $16.
Those growth rates were incredible, yet Nu's stock has still declined about 25% this year and trades at just 12 times next year's earnings. Is it an undervalued growth play in this frothy market?
Why did Nu's stock decline? From 2021 to 2025, Nu's revenue grew at a 75% CAGR. It turned profitable in 2023, and its EPS nearly doubled in 2024 and rose 45% in 2025. From 2025 to 2028, analysts expect its revenue and EPS to grow at CAGRs of 31% and 35%, respectively.
Today's Change
(
0.24
%) $
0.03
Current Price
$
12.62
Those growth rates are impressive, but three issues are compressing its valuations. First, it's expanding more aggressively into Mexico and Colombia to reduce its dependence on its core Brazilian market.
That expansion increased its credit risks, since both markets require higher funding costs and credit loss allowances than Brazil. Nu's expansion of its lower-margin secured lending and payroll-backed loan businesses exacerbated that pressure.
Second, Nu earns most of its revenue in Brazilian Reais, Mexican Pesos, and Colombian Pesos but reports its earnings in U.S. dollars. As a result, it faces persistent headwinds from a strong U.S. dollar -- which will only become stronger if the Fed raises its rates this year. Lastly, the market still values Nu like a conventional bank rather than a high-growth fintech company.
Is Nu's stock a screaming bargain? I believe Nu's stock is a bargain at these levels. It's in the process of securing full bank charters in Mexico and a conditional approval in the U.S. to reduce its funding costs and expand its reach. It also recently launched a new $1.0 billion buyback program.
It won't bounce back anytime soon, but it could attract a lot more attention once its Mexican and Colombian markets mature, the dollar weakens, and investors value it as a growth play again.
10x Genomics uzavřela víceletou spolupráci s Cleveland Clinic na diagnostice rakoviny močového měchýře. Studie využije platformy Flex Apex a Xenium k hledání biomarkerů, které mohou předpovídat odpověď na léčbu.
Key Takeaways 10x Genomics is collaborating with the Cleveland Clinic on bladder cancer diagnostic applications.The study will use Flex Apex and Xenium to find biomarkers tied to treatment response.The partnership could expand 10x Genomics' role in precision oncology and diagnostics. 10x Genomics (TXG - Free Report) recently entered into a multi-year research collaboration with the Cleveland Clinic to advance novel diagnostic applications for bladder cancer. The study will use the company's Flex Apex and Xenium platforms, with potential expansion to Atera, to identify biomarkers that may predict patient response to antibody-drug conjugates and immunotherapies.
From an investor's perspective, the collaboration marks another step in 10x Genomics' strategy to expand its technologies into clinical and diagnostic applications. The partnership could strengthen the company's position in precision oncology, broaden the use cases for its single-cell and spatial platforms and create long-term growth opportunities in cancer diagnostics.
Likely Trend of TXG Stock Following the NewsShares of TXG have traded flat since the announcement on Wednesday. In the year-to-date period, shares of the company surged 113.1% against the industry’s 20.1% decline. The S&P 500 increased 8.5% in the same time frame.
The collaboration with Cleveland Clinic is likely to strengthen 10x Genomics' long-term growth prospects by generating clinical evidence for the use of its single-cell and spatial technologies in precision oncology. Successful identification of predictive biomarkers could accelerate the adoption of Flex Apex, Xenium and Atera in translational research and future diagnostic applications, expand the company's presence in the high-growth oncology diagnostics market and create new revenue opportunities beyond its core research business.
TXG currently has a market capitalization of $4.08 billion.
Image Source: Zacks Investment Research
More on the NewsUnder the multi-year collaboration, 10x Genomics and the Cleveland Clinic are likely to initially analyze tumor samples from patients with advanced bladder cancer undergoing emerging therapeutic regimens. The study is likely to leverage TXG's Flex Apex and Xenium platforms and could later expand to the recently launched Atera platform. The partners aim to identify clinically relevant biomarkers that may predict patient responses to antibody-drug conjugates and immunotherapies, paving the way for future diagnostic development across multiple tumor types.
The research is likely to integrate single-cell transcriptomic profiling with spatial gene expression and protein measurements to generate a comprehensive view of tumor biology and the tumor microenvironment. Investigators are likely to assess tumor microenvironment composition, immune cell infiltration and the expression of therapeutic targets to better understand mechanisms underlying treatment response and resistance.
The collaboration is expected to generate a rich multimodal dataset linking molecular insights with clinical outcomes, supporting the development of next-generation precision oncology diagnostics and advancing the scientific understanding of bladder cancer.
Favorable Industry Prospect for TXGPer a report by Precedence Research, the global bladder cancer therapeutics diagnostics market size accounted for $5.68 billion in 2025 and is predicted to increase from $6.01 billion in 2026 to approximately $10.04 billion by 2035, expanding at a CAGR of 5.86%.
The bladder cancer diagnostics market is expanding rapidly, driven by the rising prevalence and awareness of the disease, alongside advances in precision medicine, personalized treatment approaches and non-invasive diagnostic technologies.
A Recent Development by TXGRecently, 10x Genomics announced the acquisition of Proteintech Genomics, a division within Proteintech Group that develops high-plex proteomic solutions for single-cell and spatial biology applications. The move expands TXG's capabilities in proteomics and supports its broader strategy of advancing multiomics research through integrated RNA and protein analysis.
Proteintech Genomics brings technologies, including the Human Discovery Panel, an antibody-based single-cell protein panel compatible with 10x Genomics' Flex chemistry workflows.
Some better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , West Pharmaceutical (WST - Free Report) and Intuitive Surgical (ISRG - Free Report) .
Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported a first-quarter 2026 adjusted earnings per share (EPS) of $1.12 per share, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
GMED has an estimated long-term earnings growth rate of 10.2% compared with the industry’s 12.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
West Pharmaceutical, currently flaunting a Zacks Rank #1, reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
WST has an estimated long-term earnings growth rate of 13.9% compared with the industry’s 9.5% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
ISRG has a long-term estimated growth rate of 14.6% compared with the industry’s 12.6% growth. The company’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Domino's Pizza letos klesla o 25 % a obchoduje se poblíž 52týdenního minima, zatímco její P/E 17 je nejnižší za více než 10 let. V 1. čtvrtletí zklamala tržbami i ziskem, ale hrubá marže vzrostla na 40,4 %.
Domino's Pizza (DPZ +3.21%) has not delivered for investors in 2026, but it is flashing a signal that long-term investors should take note of.
The world's largest pizza chain has been struggling over the past few years. This year, the stock price has plummeted 25% year to date as of June 19 and is trading at $312 per share, which is close to a 52-week low.
But even more notable is its valuation. Domino's stock is trading at 17 times earnings and 16 times forward earnings. That is not only a 52-week low valuation but also the lowest valuation for Domino's stock in more than 10 years.
The last time the price-to-earnings (P/E) ratio was this low was in 2012, some 14 years ago. Does this mean that Domino's stock is a buy?
Image source: Getty Images.
Domino's stock is as cheap as it's been in years Domino's stock really tanked in late April after the pizza chain released first-quarter earnings that missed revenue and earnings estimates. Overall, global sales were up about 3.5% year over year. U.S. sales were up 3%, with same-store U.S. sales increasing 1%. The miss was mainly due to lower international sales, as international same-store sales were down 0.4%.
Also, Domino's lowered its U.S. same-store growth guidance for the fiscal year from 3% to a more nebulous low-single-digits range -- which could be 3%, but it sounds worse. It cited macroeconomic pressures and challenges. Overall global sales are targeted for mid-single digits.
Domino's has been investing heavily in its website and app to increase its digital sales, including a new, more intuitive app. Last year, online orders accounted for 85% of all sales in the U.S.
Today's Change
(
3.21
%) $
9.07
Current Price
$
292.10
It has also expanded its relationship with third-party delivery services, adding DoorDash as a delivery provider, along with Uber Eats. The third-party delivery services expand Domino's market and result in higher margins, as third-party orders are, on average, higher due to a premium placed on menu items ordered through third-party apps.
Also, in Q1, Domino's increased its gross margin by 60 basis points year over year to 40.4% due to strong expense management and lower costs of sales. Further, CFO Sandeep Reddy said on the earnings call that the operating margin will continue to expand this year.
Also worth noting is that a challenging economic environment could lead more budget-conscious families to seek cheaper options to feed their families.
Domino's stock is a compelling option worth considering given its decade-low valuation, its expense management, and its digital and third-party delivery strategies. Wall Street analysts see the stock as a buy, with a median price target of $400 per share, which would suggest 28% upside.
Dave Kovaleski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Domino's Pizza, DoorDash, and Uber Technologies. The Motley Fool has a disclosure policy.
Domino's oznámila změnu ve vedení: od 1. října 2026 se novým CEO stane Joe Jordan. Russell Weiner přejde do role výkonného předsedy a David Brandon v roce 2027 odejde z představenstva.
Joe Jordan to Become Chief Executive Officer
Russell Weiner to Retire as CEO and Become Executive Chairman
David Brandon to Retire from the Board Following 28 Years of Service
, /PRNewswire/ -- Domino's Pizza Inc. (Nasdaq: DPZ), the largest pizza company in the world, today announced that Russell Weiner has informed the Company's Board of Directors of his intention to retire as Chief Executive Officer following a distinguished career with Domino's. Consistent with its multi-year succession planning process, the Domino's Board of Directors has appointed Joe Jordan, currently Chief Operating Officer and President – Domino's U.S., as Chief Executive Officer, effective October 1, 2026. Jordan will also join the Company's Board of Directors at that time. Russell Weiner will transition from Chief Executive Officer to Executive Chairman Designate on October 1, 2026, and become Executive Chairman following the Company's 2027 annual shareholder meeting. David Brandon, Executive Chairman, will retire and not stand for reelection to the Board in 2027, concluding 28 years of service to Domino's.
Domino's has announced the next chapter of the company's leadership. Joe Jordan (left), currently COO and President of Domino's U.S., has been appointed CEO effective Oct. 1, 2026, succeeding Russell Weiner (right), who will retire as CEO and transition to Executive Chairman in 2027. Current Executive Chairman David A. Brandon (middle) will retire from the Board in 2027 after nearly three decades of service to the company. "Joe is a proven leader whose experience spans virtually every aspect of our business," said David Brandon, Executive Chairman. "After a thoughtful succession planning process, the Board unanimously concluded that Joe is the right leader to serve as Domino's next CEO. He embodies Domino's culture of developing leaders from within, has earned the trust of franchisees across our global system and is uniquely qualified to guide the Company through its next phase of growth. At the same time, Russell is one of the most innovative, strategic leaders in our industry, and Domino's will continue to benefit from his creativity, franchisee relationships and extensive knowledge of the QSR category in his role as Executive Chairman."
Joe Jordan has spent nearly 15 years in leadership roles across Domino's marketing, U.S. and international operations, technology and franchisee support. He has built a proven track record of driving growth and innovation across the business, from delivering strong same store sales growth to leading Domino's international business through a period of record expansion, opening more than 3,000 stores worldwide during his tenure. Most recently, he has overseen key strategic initiatives, including the relaunch of the Company's loyalty and e-commerce platforms and the launch of Domino's global digital marketplace partnerships, leveraging strong relationships across the Company's system.
"I am honored by the Board's confidence and grateful for the opportunity to lead Domino's," said Joe Jordan, Chief Operating Officer and President – Domino's U.S. "What makes Domino's special is the strength of the people behind the brand, starting with our franchisees and including our team members and leaders around the world. I have also been fortunate to work closely with Russell over the past four years and am grateful for his leadership and contributions to Domino's. I look forward to continuing to benefit from his experience and perspective in his role on the Board. Domino's is one of the most innovative and resilient global systems in the restaurant industry and I am excited to build that foundation as we focus on reaccelerating growth and continuing to deliver delicious pizza and exceptional value to customers worldwide."
Russell Weiner will continue serving as Chief Executive Officer through September 30, 2026, after which he will become Executive Chairman Designate until Domino's annual shareholder meeting in April 2027, when he will assume the role of Executive Chairman. Weiner will help ensure continuity as the Company transitions to its next generation of leadership and will provide counsel to Joe Jordan and the Board, supporting Domino's continued growth leveraging his 18 years with the brand.
"Since joining Domino's in 2008, Russell has played a pivotal role in the Company's growth and success," said David Brandon. "Among his many contributions to the brand prior to becoming CEO, Russell led the highly successful, and somewhat infamous, 'Pizza Turnaround' campaign that was launched in 2010 and created many years of positive momentum for our brand and business. As CEO, Russell was the architect of the Hungry for MORE strategy, which continues to drive sales and store growth and expand Domino's dominant market share of the pizza category. During his tenure as CEO, the Company achieved net store growth of more than 3,200 locations, increased global retail sales by nearly $3 billion, and delivered close to a 30% increase in operating income. We owe Russell a great debt of thanks for his leadership and many accomplishments and look forward to his continued involvement as Executive Chairman of the Board."
David Brandon will retire from the Board and as Executive Chairman following the Company's 2027 annual shareholder meeting. He has served as Chairman of Domino's Board of Directors since 1999 and as Executive Chairman since 2022. He also served as Chief Executive Officer from 1999 to 2010. During his 28 years of leadership and board stewardship, Brandon helped transform Domino's into a global category leader, guiding the Company from its 2004 initial public offering through a period of significant international expansion and technological innovation, including the introduction of online ordering, Domino's Tracker and mobile ordering.
"Dave's impact on Domino's cannot be overstated," said Russell Weiner, Chief Executive Officer. "He led the Company through its transformation from a domestic pizza chain to a global technology and delivery leader, championing the digital innovations that revolutionized how customers order pizza. Beyond his strategic vision, Dave has been an invaluable mentor to countless leaders across our system. His relentless focus on franchisee success and operational excellence has shaped the culture that drives Domino's today, and his legacy will endure for generations to come."
With a leadership team that combines deep operational expertise, strategic vision and strong franchisee relationships, Domino's enters its next chapter focused on accelerating growth, strengthening its global leadership position and continuing to raise the bar on delicious food at renowned value for customers around the world.
About Domino's Pizza®
Founded in 1960, Domino's Pizza is the largest pizza company in the world, with a significant business in both delivery and carryout. It ranks among the world's top public restaurant brands with a global enterprise of more than 22,300 stores in over 90 markets. Domino's had global retail sales of over $20.4 billion in the trailing four quarters ended March 22, 2026. Its system is comprised of independent franchise owners who accounted for 99% of Domino's stores as of the end of the first quarter of 2026. In the U.S., Domino's generated more than 85% of U.S. retail sales in 2025 via digital channels and has developed many innovative ordering platforms.
Order – dominos.com
Company Info – biz.dominos.com
Media Assets – media.dominos.com
Tencent testuje v čínském Weixinu AI asistenta Xiaowei, který má uživatelům pomáhat přes text, hlas i mini-programy. Firma tím chce posílit pozici v tvrdě konkurenčním trhu AI.
Tencent on Monday said it is testing an AI assistant within WeChat in China as the tech giant looks to step up efforts to challenge rivals in the country's competitive artificial intelligence market.
Xiaowei, "a native AI assistant," is being tested "on a small scale" in Weixin, the Chinese version of WeChat, Tencent said in a statement translated by CNBC.
Users can interact with Xiaowei with text or voice, communicate with friends and launch "mini-programs," Tencent added. Mini-programs are apps that run inside of WeChat.
Tencent executives have been mulling further integration of AI into WeChat since last year, with investors watching closely to see if this can be a new revenue stream and a way to monetize AI.
watch now
WeChat and Weixin have more than 1.4 billion monthly active users combined, with the majority in China. It is an indispensable part of daily life in China, where people use the app to message friends, make payments, book restaurants and much more.
By integrating an AI tool into an app with a huge user base, Tencent has an opportunity to capture a large number of them for its services.
"Putting an assistant inside Weixin is the first time Tencent uses the advantage it has held all along, and that matters a lot," Howard Yu, the LEGO professor of management and innovation at IMD, told CNBC by email.
"A standalone chatbot gives you an answer. An assistant wired into Weixin completes the task. And it's this second advantage that no rival can copy," Yu added.
The company did not give further details about the capabilities Xiaowei would have or what AI models it is based on.
Tech companies are talking up the potential of so-called AI agents, which they see as digital assistants that are able to carry out complex tasks on a user's behalf across different apps and services.
The new AI assistant is part of a bigger move from Tencent to challenge rivals like Alibaba, DeepSeek and Zhipu in China, which has become an incredibly competitive AI market. This year, Tencent poached an OpenAI researcher to become its chief AI scientist.
Tencent also develops its own family of models under the brand name Hunyuan.
Viking Therapeutics zahájila fázi 1 studie VK3019, nového agonisty receptorů amylinu a kalcitoninu, u zdravých dospělých s BMI alespoň 30. Studie má prověřit bezpečnost, snášenlivost a farmakokinetiku.
Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019
Potential to further expand Viking's treatment options for weight loss
, /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today the initiation of a Phase 1 single ascending dose (SAD) clinical trial of VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA). VK3019 is being developed as a potential treatment option for weight loss. The study initiation follows the filing and clearance of VK3019's investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA).
The Phase 1 trial is a randomized, double-blind, placebo-controlled SAD study in healthy adults with BMI ≥30. The primary objectives of the study include evaluating the safety, tolerability, and pharmacokinetics of single subcutaneous doses of VK3019. Exploratory pharmacodynamic assessments include evaluations of changes in body weight after a single-dose administration.
"The initiation of VK3019's Phase 1 study marks an important expansion of our portfolio of novel therapies designed to optimize the weight loss journey for patients and their physicians," said Brian Lian, Ph.D., chief executive officer of Viking. "Therapies that target amylin and calcitonin receptors may potentially be used alone or in combination with GLP-1 or dual GLP-1/GIP agonists to improve the induction of weight loss as well as for longer-term weight management. Given the complexity of managing obesity and related metabolic conditions, broadening the potential treatment options is crucial to meeting the diverse needs of individuals seeking safe and sustainable weight loss."
Preclinical data from Viking's internally developed DACRAs showed impressive effects on body weight, food intake, and metabolism in healthy rats and diet-induced obese (DIO) mice compared to control-treated animals. Results showed Viking's DACRAs reduced food intake in lean rats within 0 to 72 hours after a single dose. At 72 hours, these compounds reduced body weight by up to 8% compared to controls.
In addition to the Phase 1 trial of VK3019, Viking is currently conducting the Phase 3 VANQUISH studies of subcutaneous VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, in patients with obesity or who are overweight. The VANQUISH program consists of two trials evaluating VK2735: one in adults with obesity (VANQUISH-1), and another in adults with obesity and type 2 diabetes (VANQUISH-2). Each study is a randomized, double-blind, placebo-controlled, multicenter trial designed to assess the efficacy and safety of VK2735 administered by subcutaneous injection once weekly for 78 weeks.
In parallel with the development of a subcutaneous formulation, Viking is advancing an oral tablet formulation of VK2735. If successful, oral VK2735 would represent the first oral dual agonist to reach the market. The company believes the availability of both oral and injectable formulations is a key differentiating feature of VK2735, compared with competitive agents, as no other dual or triple agonist is currently available in both formulations. Using the same active ingredient across formulations may also reduce the risk of unexpected side effects compared with switching between therapies that do not share the same active agent. The company plans to initiate a Phase 3 trial to evaluate oral VK2735 for the treatment of obesity and overweight later this year.
Based on VK2735's promising efficacy and differentiated pharmacokinetic (PK) profile, the company is evaluating a range of novel dosing regimens for both the induction and the long-term maintenance of weight loss. In October 2025, Viking initiated a Phase 1 study designed to explore the feasibility of various VK2735 maintenance dosing regimens. Providing flexible dosing options for long-term therapy may improve treatment persistence following achievement of individual weight loss goals. The company believes this may lead to improved adherence to therapy and increase the probability of realizing the long-term benefits of weight loss, such as reduced cardiovascular risks, improved physical function, and enhanced quality of life. The company expects to report the results of the study in 3Q26.
About VK3019
VK3019 is an investigational dual amylin and calcitonin receptor agonist (DACRA) in development as a potential new treatment option for weight loss. It is currently being evaluated in a single ascending dose study assessing safety, tolerability, and pharmacokinetics of VK3019 for the treatment of metabolic disorders and obesity.
About Amylin and Calcitonin
Amylin and calcitonin receptors play an important role in food intake and metabolic control. Amylin is a peptide hormone co-secreted with insulin from pancreatic β-cells that slows gastric emptying and suppresses postprandial glucagon secretion, promoting satiety and regulating blood glucose. After a meal, amylin is secreted from the pancreas and circulates in the blood to activate specific receptors in the brainstem. This results in suppression of glucagon release from the pancreas, reduced food intake, and slowed gastric emptying. The net effect of these actions is to decrease blood glucose and is associated with longer-term reductions in body weight. Calcitonin is a peptide hormone produced by the thyroid gland known for its role in regulating calcium homeostasis. To date, the addition of calcitonin receptor activation by DACRAs has demonstrated additional metabolic benefits not seen with amylin receptor activation alone, such as improved fasting glucose regulation and insulin sensitivity, and can result in a more acute reduction of food intake and greater body weight loss.
About GLP-1 and Dual GLP-1/GIP Agonists
Activation of the glucagon-like peptide 1 (GLP-1) receptor has been shown to decrease glucose, reduce appetite, lower body weight, and improve insulin sensitivity in patients with type 2 diabetes, obesity, or both. Semaglutide is a GLP-1 receptor agonist that has been approved by the U.S. Food and Drug Administration and is currently marketed in various dosage strengths and forms as Ozempic®, Rybelsus®, and Wegovy®. More recently, research efforts have explored the potential co-activation of the glucose-dependent insulinotropic peptide (GIP) receptor as a means of enhancing the therapeutic benefits of GLP-1 receptor activation. Tirzepatide is a dual GLP-1/GIP receptor agonist that has been approved by the U.S. Food and Drug Administration and is currently marketed in various dosage strengths and forms as Mounjaro® and Zepbound®.
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. In a Phase 2a trial for the treatment of non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids (VLCFAs) and other lipids, as compared to placebo.
For more information about Viking Therapeutics, please visit www.vikingtherapeutics.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding Viking Therapeutics, Inc., under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its clinical and preclinical development programs, anticipated timing for reporting clinical data and cash resources. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks associated with the success, cost and timing of Viking's product candidate development activities and clinical trials, including those for VK2735, VK3019, VK0214, VK2809, and the company's other incretin and other receptor agonists; risks that prior clinical and preclinical results may not be replicated; risks regarding regulatory requirements; and other risks that are described in Viking's most recent periodic reports filed with the Securities and Exchange Commission including Viking's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent Quarterly Reports on Form 10-Q, including the risk factors set forth in those filings. These forward-looking statements speak only as of the date hereof. Viking disclaims any obligation to update these forward-looking statements except as required by law.
Akcie Sweetgreen za tři měsíce vzrostly o 60 %, protože investory povzbudily známky zlepšení v obratu firmy. Společnost ale zůstává ztrátová a poslední čtvrtletí opět zklamalo.
This is a fair market value price provided by Massive. Learn more.
52-Week Range$4.49▼
$16.70P/E Ratio72.26
Price Target$8.04
Shares of Sweetgreen Inc. NYSE: SG have surged 60% over the past three months, rebounding from a steep selloff that began in late 2024 as concerns about slowing consumer demand mounted. The rally has some questioning whether the company's efforts to revive the business are finally gaining traction or if the stock is simply rebounding from deeply oversold levels.
Sweetgreen's core business remains unprofitable, and the company has missed Wall Street expectations more often than not since going public, including the most recent quarter, reported on May 8.
Get Sweetgreen alerts:
However, encouraging comments about its turnaround efforts seem to have sparked fresh optimism.
Sweetgreen Shares Have Surged Since Hitting March LowThe fast-casual chain, known for its salads and other healthy menu items, went public in late 2021, and its shares initially soared. However, the gains were short-lived, and the stock spent much of the next few years under pressure as the company struggled to turn a profit.
In 2024, things started to look up. The stock went from trading around $10 in January to above $44 by November. But as concerns about slowing consumer demand emerged, those gains quickly unraveled. By March 2026, the stock had plunged to an all-time low of $4.49. Since then, shares have rebounded sharply, surging nearly 100%.
The catalyst doesn't appear to be the company's most recent earnings report. Sweetgreen posted a first-quarter loss of 27 cents per share, wider than the 21-cent-per-share loss reported a year earlier and Wall Street's estimate for a 23-cent loss. Revenue of roughly $162 million fell nearly 3% year over year and missed expectations by about $2 million. The results marked the company's fourth consecutive earnings and revenue miss and its third straight quarter of declining revenue.
Turnaround Plan Is Showing Signs of TractionDespite the disappointing earnings report, the company's comments on its Sweetgrowth Transformation Plan, launched in November 2025 to help turn the business around, appeared to spark optimism among investors.
During the earnings call, co-founder and Chief Executive Jonathan Neman said, "We are beginning to see signs that the actions we are putting in place are gaining traction. We are seeing improvement in execution across our restaurants, greater consistency in the guest experience, and stronger alignment across our teams."
He added, "We saw improvement as the quarter progressed with a further step up in April."
Neman also expressed enthusiasm about the recent addition of wraps to the menu, which he described as Sweetgreen's "most significant menu expansion in several years." The company expects wraps to help drive traffic while making the brand more accessible because of its lower price point.
Sentiment Has Improved, But Wall Street Remains CautiousInvestors appeared encouraged by the company's comments about improving trends. In the weeks following the report, five analysts raised their price targets on the stock, while two upgraded their ratings.
Even with the recent upgrades, Wall Street remains somewhat cautious. The consensus rating on Sweetgreen is Hold, based on 12 Hold ratings, four Buys, and three Sells. The majority of analysts aren't anticipating upside over the next year. The average 12-month price target of just above $8 is roughly 5% below the current share price. Price targets range from a low of $4.50 to a high of $15.
There are other indicators that suggest sentiment may be improving as well. The number of shares sold short has fallen from roughly 25 million, or nearly 27% of float, at the end of March to less than 20 million, or roughly 20% of float, as of the most recent reporting period at the end of May. While the stock remains heavily shorted, some bearish investors appear to be backing away from the name.
Insiders also appear to be expressing confidence in the company. Over the past three months, Sweetgreen insiders purchased roughly $3.4 million worth of company stock. No insider sales were reported.
Despite Recent Rally, Stock Remains Well Below HighsEven after the recent rally, Sweetgreen shares are still trading around $9, well below their July 52-week high of $16.70 and far below the more than $44 level reached in November 2024.
The stock's steep decline has left Sweetgreen trading at a discount to several peers in the fast-casual restaurant sector, which could help explain the renewed interest in the shares.
On a price-to-sales basis, Sweetgreen stock trades at less than 1.6X sales, compared with roughly 8.3X for CAVA Group Inc. NYSE: CAVA, 3.4X for Chipotle Mexican Grill, Inc. NYSE: CMG, and 6.1X for Wingstop Inc. NASDAQ: WING. Shake Shack Inc. NYSE: SHAK, which plummeted after reporting disappointing Q1 results, is the closest comparison, trading at 1.7X sales.
Sweetgreen's rebound likely began as investors saw value in a stock that had been heavily sold off. More recently, however, signs of progress in the company's turnaround efforts appear to have provided additional support for the rally.
Sweetgreen, Inc. (SG) Price Chart for Wednesday, June, 24, 2026
While the company's financial results still leave plenty of room for improvement, investors seem increasingly focused on what comes next. The second-quarter earnings report in August should provide a clearer indication of whether the recent improvement in traffic trends continued and whether Sweetgreen is beginning to translate those gains into stronger financial performance.
Should You Invest $1,000 in Sweetgreen Right Now?Before you consider Sweetgreen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sweetgreen wasn't on the list.
While Sweetgreen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
SummaryReddit delivered 69% YoY revenue growth in Q1 2026, with 91.5% gross margin and $311 million free cash flow.Monetization is accelerating, driven by ARPU expansion and improved ad products, while user growth is no longer the primary revenue driver.International ARPU and user frequency present significant upside, with 2030 revenue projected at $8 billion–$10 billion and FCF at $3.2 billion–$3.6 billion.At 11x 2030 FCF, RDDT is undervalued given its high-margin model, strategic AI relevance, and compounding free cash flow potential. stockcam/iStock Unreleased via Getty Images
Reddit (RDDT) has crossed the line from interesting internet community to high-growth, highly profitable, cash-generative platform. In Q1 2026, Reddit grew revenue ~70% YoY, with 90+% gross margin, and nearly ~50% operating cash flow margin, while spending only $1 million of
9.65K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of RDDT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Not financial advice
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Outdoor Holding ve čtvrtém čtvrtletí snížila ztrátu z pokračujících činností, když tržby vzrostly o 10,1 % na 13,9 milionu USD a provozní náklady prudce klesly. Firma zároveň sází na AI nástroje, úpravy platformy GunBroker a zpětné odkupy akcií.
Key Takeaways POWW narrowed its continuing operations loss as Q4 revenues rose and operating expenses fell sharply.Outdoor Holding says GunBroker gains include platform upgrades, MasterFFL revenues and new AI tools.POWW ended fiscal 2026 with $68.1M in cash and plans disciplined buybacks and platform investment. Outdoor Holding Company (POWW - Free Report) used its fourth-quarter call to argue that fiscal 2026 marked a reset year, with lower costs, stronger cash generation and a cleaner legal backdrop reshaping the GunBroker.com business.
Management’s message centered less on the quarter’s reported loss and more on the earnings power of a leaner marketplace model as platform upgrades, FFL-related services and AI tools move into fiscal 2027.
POWW Banks on a Leaner Cost BaseChairman and CEO Steven Urvan framed the quarter as proof that the company’s post-divestiture model can produce stronger profitability even in a cautious consumer environment. He said adjusted EBITDA rose sequentially through fiscal 2026 and that the fourth-quarter annualized run rate exceeded the $25 million target he set last August.
That argument rested heavily on expense control. The company reported a fourth-quarter loss of $0.03 per share, wider than the estimate of a loss of $0.02, delivering a negative surprise of 50%. Fourth-quarter revenues rose 10.1% to $13.9 million, which beat the consensus mark of $12.7 million by 9.4%. Meanwhile, total operating expenses fell to $15.1 million from $38 million a year earlier.
Chief financial officer Paul Kasowski added that fiscal 2026 adjusted EBITDA reached $22.3 million, up from $15.3 million in fiscal 2025, reflecting lower SG&A, lower legal expense and lower bad debt expense.
Outdoor Holding Pushes Platform UpgradesManagement tied much of its forward narrative to improving GunBroker’s marketplace economics rather than chasing broad expansion. Urvan and Kasowski pointed to better search and filtering, stronger seller analytics and promotional tools, and refined buyer personalization across the platform.
A key operational step was the integration with MasterFFL, which management said streamlines transfers for products subject to federal firearms license rules. Kasowski said that the effort moves from a cost center in earlier quarters to a revenue source in fiscal 2027, though the new revenue stream will carry lower profitability than the marketplace’s legacy margin profile.
The company is also leaning harder into AI. Urvan said an AI-powered listing tool launched in March to standardize descriptions and improve conversion, while an AI-driven virtual customer service offering is expected within about a month of the call.
POWW Sees Share Gains in FirearmsManagement used demand commentary to highlight market-share gains rather than broad market strength. In prepared remarks, Urvan said firearm unit sales increased more than 8.7% in the quarter, ahead of the 1.6% rise in adjusted NICS checks, while the company’s adjusted NICS share improved by 40 basis points.
Kasowski said fourth-quarter GMV climbed to $229 million, up 11.8% from a year earlier and 6.2% from the prior quarter, with firearms driving most of the increase. He also said sales growth in pistols and rifles supported results, though a greater mix of firearms modestly pressured the take rate to 6.06% from 6.15%.
In Q&A, Urvan told a ROTH Capital analyst that demand in the marketplace has remained better this year and that the company continues to outperform the market by making the buying and selling experience more seamless. He avoided previewing first-quarter numbers but sounded confident that share gains are continuing.
Outdoor Holding Clears Legacy IssuesAnother major theme was balance sheet flexibility after working through legacy matters. The company ended fiscal 2026 with $68.1 million in cash and cash equivalents, up sharply from $30.2 million a year earlier, even after a $4.4 million DCP settlement and more than $1 million of share repurchases in the fourth quarter.
Urvan said the company has now resolved most inherited litigation matters, leaving the Arizona class action and shareholder derivative litigation as the main open items. He told analysts that indemnification costs tied to former officers could remain uneven, but said management does not see more large settlements like the DCP payment on the horizon.
That cleanup matters because management wants greater freedom in capital allocation. Urvan said the company expects to keep buying back stock in a disciplined way while selectively investing in platform features that can lift traffic, transactions and revenue.
POWW Maps Out Fiscal 2027 PrioritiesThe fiscal 2027 agenda came through clearly in both the release and the call. Management identified premium seller offerings, pricing and promotional tools, data analytics, universal payments and broader buyer engagement as the main operating priorities for the year ahead.
In Q&A with Kanen Wealth Management, Urvan added more detail on potential growth levers. He said MasterFFL is now generating revenues, advertising remains underdeveloped compared with prior years, and universal payments could meaningfully reduce friction for customers who still rely on money orders rather than card transactions.
The tone was notably more assertive when management discussed scalability. Urvan and Kasowski argued that the marketplace’s operating base is now much more fixed, which means incremental revenues should convert into higher profitability more efficiently than in prior periods.
Outdoor Holding Leaves a Sharper MessageTaken together, management used the call to make a straightforward case: fiscal 2026 was about stabilizing the business, lowering the cost structure and restoring financial control, while fiscal 2027 is about monetizing that reset through product, payments and AI execution.
The company did not offer formal quarterly guidance on the call, but the emphasis on market-share gains, recurring cash flow and fewer legal distractions left investors with a clearer sense of management’s priorities and confidence level entering the new fiscal year.
POWW and the Zacks SignalsPOWW carries a Zacks Rank #3 (Hold), with a Value Score of F, Growth Score of B, Momentum Score of D and VGM Score of D, based on the provided Zacks data. A Zacks Rank #3 points to a more balanced near-term setup than the stronger Zacks Rank #1 (Strong Buy) or #2 (Buy) categories, while the Style Scores indicate better relative growth characteristics than value or momentum traits. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Style Score framework says higher grades are generally associated with better expected performance, and that the strongest combinations tend to be Rank #1 or #2 stocks paired with A or B Style Scores or VGM Scores. That leaves POWW with a mixed signal after the quarter, and that ranking can still change as earnings estimate revisions adjust following the latest results.
Regions Financial letos zvýšila dividendu o 6 % na 26 centů na akcii a dál cílí na výplatní poměr 40–50 % zisku. Na odkupy akcií jí zbývá ještě 2,6 mld. USD.
Key Takeaways RF has raised its dividend five times in five years and targets a 40%-50% earnings payout ratio.Regions Financial has $2.6B remaining under its share repurchase authorization as of March 2026.RF held $67.9B in liquidity sources against $6.3B in total debt as of March 31, 2026. Regions Financial (RF - Free Report) remains focused on rewarding shareholders through dividend payments and share buybacks while pursuing growth opportunities. In July 2025, the company hiked its quarterly dividend by 6% to 26 cents per share. Over the past five years, the company has increased its dividend five times.
RF has a five-year annualized dividend growth rate of 12.3% and a payout ratio of 44%. It currently offers a dividend yield of 3.7%, higher than the industry's 2.5%. Further, management expects to maintain a dividend payout target of 40-50% of earnings in 2026. The company’s consistent dividend growth and targeted payout ratio reflect its commitment to returning capital to shareholders while maintaining financial flexibility.
Dividend Yield
Image Source: Zacks Investment Research
Apart from dividends, RF continues to enhance shareholder returns through share repurchases. On Dec. 10, 2025, the company's board of directors approved a new share repurchase program authorizing the repurchase of up to $3 billion of its common stock through Dec. 31, 2027. As of March 31, 2026, $2.6 billion of shares remained available under the repurchase authorization.
Regions Financial has also been pursuing strategic growth initiatives to strengthen its franchise and support long-term growth. At the 2026 RBC Capital Markets conference, management outlined plans to open 135-150 branches over the next five years and renovate more than 1,000 existing locations, focusing on high-growth Southeastern and Texas markets. The company also continues to invest in wealth management, treasury management, payments and capital markets businesses, supporting its fee-based revenue growth. RF's strong capital and liquidity position enable it to pursue these growth initiatives while continuing to return capital to shareholders.
As of March 31, 2026, Regions Financial had total debt (including both long-term and short-term borrowings) of $6.3 billion, while liquidity sources totaled $67.9 billion. Further, the company's senior unsecured debt carries investment-grade ratings of BBB+ from Standard & Poor's, Baa1 from Moody's and A- from Fitch. These ratings provide RF with favorable access to funding markets at attractive rates and suggest that the company can continue meeting its debt obligations even if economic conditions worsen.
Thus, RF’s consistent dividend growth, active share repurchases and disciplined payout strategy reflect strong capital management and financial stability. Backed by solid liquidity, investment-grade credit ratings and a steady earnings base, the company is well-positioned to sustain capital distribution activities and reinforce investor confidence in its long-term prospects.
Other Banks' Capital Distribution ApproachCitizens Financial Group (CFG - Free Report) also maintains a disciplined capital distribution approach. In October 2025, the company increased its common stock dividend by 9.5% to 46 cents per share. As of March 31, 2026, Citizens Financial had available liquidity of $12.3 billion, supporting shareholder distributions while maintaining regulatory capital buffers. Citizens Financial also has a share repurchase program in place. On June 12, 2025, the board increased the program's capacity to $1.5 billion. As of March 31, 2026, nearly $1 billion remained available under the authorization.
Popular (BPOP - Free Report) has been consistent in rewarding shareholders through capital distributions. In August 2025, the company hiked its dividend by 7.1% to 75 cents per share. As of March 31, 2026, the company had liquidity of $5 billion, compared with short-term debt of $1.1 billion and no long-term debt. Popular also maintains a share repurchase program. In July 2025, Popular launched a new buyback program, adding $500 million to the 2024 authorization. As of March 31, 2026, $126 million remained available under the authorization.
RF’s Price Performance & Zacks RankOver the past six months, shares of Regions Financial have gained 2.9% compared with the industry’s growth of 3.3%.
Price Performance
Image Source: Zacks Investment Research
Currently, RF carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Intuitive Machines chce získat 500 milionů USD prodejem nových akcií, aby překlenula období záporných peněžních toků až do dosažení kladného volného peněžního toku. Rozředění akcionářů může být jen 7,8 %.
Intuitive Machines (LUNR 6.40%) spooked the stock market earlier this month, and its timing couldn't have been worse. (At least, from one perspective. More on that in a moment.)
Shares of the space stock -- which, in 2024, became the first American company to land a spacecraft on the moon, and the first American anything to return to the moon in 50 years -- are down an astounding 46% in June.
Yes, this is partly because the SpaceX (SPCX +0.54%) IPO sucked all the oxygen out of the room last Friday, and vacuumed up all the investor cash that used to be invested in other space stocks. Still, Intuitive got the sell-off started all on its own when it announced plans on June 3 to raise $500 million in cash by selling a bunch of new shares.
Image source: Getty Images.
Timing is everything I've got good news for Intuitive shareholders, as well as this bad news: Intuitive Machines announced its share sale soon after hitting an all-time high near $46. Assuming it's made good on its plans and been selling as many shares as it could, as fast as humanly possible, the company may still come out of this sell-off just fine in the end.
Why is that?
Consider that, at the end of 2025, Intuitive stock was trading around $16 per share. Successful contract wins combined with SpaceX IPO fever drove that price up nearly threefold through the end of May.
Did this make the stock overvalued? I think so (and this is coming from an owner of Intuitive Machines stock). Still, by the time Intuitive announced its share sale, the stock was within pennies of $40 a share -- meaning that raising $500 million might have required issuing no more than 12.5 million shares, diluting shareholders by only 7.8%.
What's more, the potential $500 million windfall from such a sale would generate plenty of cash to bridge the gap between when Intuitive is still burning cash and when it finally becomes free cash flow positive on its own (analysts expect this to happen in 2027 or early 2028). This would mean that Intuitive never has to raise cash again.
Today's Change
(
-6.40
%) $
-1.34
Current Price
$
19.61
What could go wrong? The question facing investors now is: Did Intuitive Machines manage to sell its shares and raise cash before its stock price collapsed after the SpaceX IPO?
The truth is, we don't yet know. The fact that Intuitive Machines' stock price fell so rapidly and consistently after it announced its share sale certainly suggests that the company was flooding the market with new shares this month. If it did, and if it raised enough cash fast enough, then Intuitive Machines may have accomplished its goal in time.
We'll have to wait for the company's next earnings report to know for sure, however. Intuitive Machines is due to report second-quarter results on Aug. 6. Tune in then to find out.
Sitka Gold oznámila další silné výsledky vrtání v Blackjacku: DDRCCC-26-125 vrátil 94,5 m s 1,62 g/t zlata včetně 2,0 m s 11,85 g/t. Firma dál rozšiřuje mineralizaci v rámci 60 000m programu.
Sitka reports results for six additional diamond drill holes; continues to intercept significant intervals of high-grade gold mineralization in step out drilling at the Blackjack deposit
Drillhole DDRCCC-26-125 returned 94.5 m of 1.62 g/t Au including 2.0 m of 11.85 g/t Au, and a separate interval of 197.0 m of 1.06 g/t Au including 2.0 m of 9.95 g/t Au
Drillhole DDRCCC-26-123 returned 214.5 m of 0.97 g/t Au, including 106.9 m of 1.36 g/t Au and 2.0 m of 15.45 g/t Au
Drillhole DDRCCC-26-126 returned 153.1 m of 1.33 g/t Au, including 110.0 m of 1.63 g/t Au including 2.0 m of 12.35 g/t Au
Over 18,000 m of expansion drilling completed at the Blackjack deposit across 40 holes since the last MRE for Blackjack was published in January 2025; effectively doubling the meterage completed since the last resource estimate was calculated
Six drill rigs are currently turning on the Project at Blackjack, Rhosgobel and Saddle
Approximately 17,600 m of diamond drilling have been completed to date this year in 30 drill holes across the Blackjack and Rhosgobel deposits as part of the ongoing 60,000 m drill program planned for 2026
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Sitka Gold Corp. (TSXV: SIG) (FSE: 1RF) (OTCQX: SITKF) ("Sitka" or the "Company") is pleased to announce assay results from six drill holes completed during its 2026 exploration campaign and to provide an update on the 60,000 metre diamond drilling program currently underway at its 100% owned, road accessible RC Gold Project ("RC Gold" or the "Project") in Canada's Yukon Territory. Analytical results for drill holes DDRCCC-26-122 through DDRCCC-26-127 have been received and compiled and are reported herein. These results continue to expand and infill the mineralized zone at Blackjack (see Figures 1 to 3). Highlights of the reported drill holes include DDRCCC-26-123 which returned 214.5 m of 0.97 g/t Au, including 106.9 m of 1.36 g/t Au and 2.0 m of 15.45 g/t Au, DDRCCC-26-125 which returned 94.5 m of 1.62 g/t Au including 2.0 m of 11.85 g/t Au, and a separate interval of 197.0 m of 1.06 g/t Au including 2.0 m of 9.95 g/t Au, and DDRCCC-26-126 which returned 153.1 m of 1.33 g/t Au, including 110.0 m of 1.63 g/t Au and 2.0 m of 12.35 g/t Au.
Currently, six drills are turning across the project with the goal of expanding on known gold mineralization and defining new mineralization. So far this year a total of approximately 17,600 metres have been completed in 30 drill holes at the Blackjack and Rhosgobel deposits as part of the fully-funded 60,000 metres drill program planned for 2026. Assays are pending for all remaining holes.
"These results continue to demonstrate the impressive scale, continuity and high-grade nature of the Blackjack gold deposit and further strengthen our confidence in the overall growth potential of the RC Gold Project," said Cor Coe, Director and CEO of Sitka Gold Corp. "The first holes completed this year at Blackjack have returned several broad, high-grade gold intercepts that highlight the robust nature of the mineralization and continue to expand the known limits of this wide-open deposit. Furthermore, we have now completed more than 18,000 metres of additional drilling at Blackjack since the most recent resource estimate was published in early 2025. For perspective, the current resource estimate of 1.29 million ounces of indicated gold grading 1.01 g/t gold and 1.04 million ounces of inferred gold grading 0.94 g/t gold* was based on 18,800 metres of drilling, meaning we have now effectively doubled the amount of drilling completed since that estimate was calculated. With six drills currently operating and only a portion of our fully funded 60,000 metre drill program completed, we expect a steady flow of results from Blackjack, Rhosgobel and several additional targets as we continue advancing one of Yukon's largest and fastest-growing gold systems."
*see Table A in the About the RC Gold Project section below
Figure 1: Plan map of drilling completed at the Blackjack deposit, highlighting results from drill holes reported in this news release. Over 18,000 metres of drilling across 40 drill holes has been completed in expansion drilling at Blackjack since the last MRE was published in January 2025.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_002full.jpg
Figure 2: Cross section of DDRCCC-26-123 and DDRCCC-26-126 showing broad high-grade gold intervals intercepted in the latest drilling at Blackjack.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_003full.jpg
Figure 3: Cross section of DDRCCC-26-125 showing broad high-grade gold intervals intercepted in the latest drilling at Blackjack.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_004full.jpg
Figure 4: Examples of visible gold observed in DDRCCC-26-122 (564.83m), DDRCCC-26-123 (243.75m), DDRCCC-26-125 (557.13m), and DDRCCC-26-126 (266.53m). Observations of visible gold are common in the drill core across the Clear Creek Intrusive Complex.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_005full.jpg
The 2026 drill program continues to successfully intersect broad zones of Reduced Intrusion-Related Gold mineralization at the Blackjack and Rhosgobel deposits and continues to expand and define the known gold mineralization at each area. Visible gold* has been observed associated with the RIRGS mineralization in all but one drill hole at both targets. The program will continue to define and expand these broad zones of mineralization as well as target new zones of previously defined mineralization such as the Pukelman/Contact zones, Saddle zone and Bear Paw Breccia zone.
* While visible gold observations are very encouraging and confirm the presence of gold mineralization, they are not intended to imply potential gold grades. Gold assays will be published after they are received from the lab for mineralized intervals in which visible gold particles were noted.
Figure 5: Longitudinal section showing locations of several of the intrusion targets and the current gold resources within the Clear Creek Intrusive Complex. A 60,000 metres diamond drilling program planned for 2026 will focus on further expansion of the 2 km long Blackjack-Eiger area with 15,000 metres of drilling. An additional 30,000 metres of drilling is planned at Rhosgobel to follow up on the initial diamond drilling conducted by Sitka in 2025. 10,000 metres of drilling has been allocated for the Pukelman-Contact zone and 5,000 metres of drilling will follow up on initial drilling results from Bear Paw and test other high-priority targets.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_009full.jpg
Figure 6*: A plan map of the Clear Creek Intrusive Complex (CCIC) showing the updated resource areas at Blackjack and Eiger, and the six additional areas that have drill targets indicated by the mauve hatched areas. The map highlights the numerous drill targets that Sitka has outlined within the CCIC which all are connected by the road network on the project and occur in an area measuring five (5) km north-south and twelve (12) km east-west. Additional areas highlighted by strong gold in soil anomalies are being advanced to the drill ready stage with additional geological work planned in 2026.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6144/302502_1a5c3325e4a44aca_010full.jpg
Sitka's 100% owned, flagship RC Gold Project consists of a 447 square kilometre contiguous district-scale land package located in the heart of Yukon's Tombstone Gold Belt. The project is located approximately 100 kilometres east of Dawson City, which has a 5,000 foot paved runway, and is accessed via a secondary gravel road from the Klondike Highway which is usable year-round and is an approximate 2 hour drive from Dawson City. It is one of the largest consolidated land packages strategically positioned mid-way between the Eagle Gold Mine and the past producing Brewery Creek Gold Mine.
The RC Project hosts an indicated MRE of 1,291,000 ounces of gold and an inferred MRE of 3,829,000 ounces of gold (see Table A below) hosted within three at surface, road-accessible pit constrained deposits. In addition to gold resources, the Rhosgobel deposit also hosts 2,926,000 ounces of silver and 51,345 tonnes of tungsten trioxide (see Table B below). The 60,000 metre drill program planned for 2026 is focused on expanding all three known deposits in addition to testing other high potential targets in close proximity to the current resources.
* Notes for Blackjack Resources:
Mineral resource estimate prepared by Ronald G. Simpson of GeoSim Services Inc. with an effective date of January 21, 2025.
Mineral Resources are estimated consistent with CIM Definition Standards and reported in accordance with NI 43-101.
Mineral resources are not mineral reserves and do not have demonstrated economic viability.
Mineral resources are constrained by an optimized pit shell using the following assumptions: US$2000/oz Au price; a 45° pit slope; assumed metallurgical recovery of 85%; mining costs of US$2.00 per tonne; processing costs of US$10.00 per tonne; G&A of US$4.00/t.
The base case cut-off of 0.3 g/t Au is believed to provide a reasonable margin over operating and sustaining costs for open-pit mining and processing.
Totals may not sum due to rounding.
** Notes for Rhosgobel and Eiger Resources:
Mineral resource estimate prepared by Ronald G. Simpson of GeoSim Services Inc. with an effective date of February 25, 2026
Mineral Resources are estimated consistent with CIM Definition Standards and reported in accordance with NI 43-101.
Mineral resources are not mineral reserves and do not have demonstrated economic viability.
Mineral resources are constrained by an optimized pit shell using the following assumptions: US$3000/oz Au price; a 45° pit slope; assumed metallurgical recovery of 85%; mining costs of US$2.50 per tonne; processing costs of US$14.00 per tonne; G&A of US$4.00/t.
The base case cut-off of 0.3 g/t Au is based on a gold price of US$2500/oz and believed to provide a reasonable margin over operating and sustaining costs for open-pit mining and processing
Totals may not sum due to rounding.
All of these deposits begin at surface and are potentially open pit minable. Initial bottle roll metallurgical testing confirmed the non-refractory characteristics of the gold mineralization and returned gold extraction rates averaging around 85% for the Blackjack and Eiger deposits. Further metallurgical testwork in 2024 for Blackjack and Eiger returned recoveries ranging from 77.6 to 93% for gravity followed by cyanidation. Initial bottle roll testing for Rhosgobel has confirmed non-refractory characteristics of the gold mineralization with two composite samples returning gold recoveries of 89% and 96%. Additional metallurgical testing at Rhosgobel has returned an average gold recovery of 94.3% using conventional whole ore cyanidation leaching and an initial recovery of 84.7% tungsten in rougher concentrate using conventional floatation. Metallurgical testing for potential silver recovery has not yet been completed.
Notes:
Mineral resource estimate prepared by Ronald G. Simpson of GeoSim Services Inc. with an effective date of May 11, 2026.
Mineral Resources are estimated consistent with CIM Definition Standards and reported in accordance with NI 43-101.
Mineral resources are not mineral reserves and do not have demonstrated economic viability.
Mineral resources are constrained by an optimized pit shell using the following assumptions: US$3000/oz Au price; a 45° pit slope; assumed metallurgical recovery of 85%; mining costs of US$2.50 per tonne; processing costs of US$14.00 per tonne; G&A of US$4.00/t.
The base case cut-off of 0.3 g/t Au is based on a gold price of $2500/oz and believed to provide a reasonable margin over operating and sustaining costs for open-pit mining and processing
Totals may not sum due to rounding.
For the purposes of the current resource model, it is assumed that a likely mill flowsheet would consist of a gravimetric, flotation, and cyanidation circuit.
Upcoming Events
Sitka Gold will be attending and/or presenting at the following events*:
TAKESTOCK Investor Series Stampede Special, Calgary, AB: June 30, 2026
Yukon Mining Alliance - Property Tours and Conference, Dawson City, Yukon: July 12-15, 2026
Diggers and Dealers: Kalgoorlie, Western Australia: August 3 - 5, 2026
*All events are subject to change.
About Sitka Gold Corp.
Sitka Gold Corp. is a well-funded mineral exploration company headquartered in Canada. The Company is managed by a team of experienced industry professionals and is focused on exploring for economically viable mineral deposits with its primary emphasis on gold, silver and copper mineral properties of merit. Sitka is currently advancing its 100% owned, 447 square kilometre flagship RC Gold Project located within the Tombstone Gold Belt in the Yukon Territory. The Company has also announced plans to spin-out the Alpha Gold Project in Nevada and the Burro Creek Gold and Silver Project in Arizona into a new discovery-focused exploration company to be named at a later date.
A 60,000-metre diamond drilling program planned for 2026 is currently underway at the Company's flagship RC Gold Project, located in Yukon Canada, where six diamond drill rigs are currently operating.
*For more detailed information on the Company's properties please visit our website at www.sitkagoldcorp.com.
Quality Assurance/Quality Control
On receipt from the drill site, the HTW/NTW-sized drill core was systematically logged for geological attributes, photographed and sampled at Sitka's core logging facility. Sample lengths as small as 0.3 m were used to isolate features of interest, otherwise a default 2 m downhole sample length was used. Each sample is identified by a unique sample tag number which is placed in the bag containing the core to be assayed. Core was cut in half lengthwise along a predetermined line, with one-half (same half, consistently) collected for analysis and one-half stored as a record. Standard reference materials, blanks and duplicate samples were inserted by Sitka personnel at regular intervals into the sample stream. Bagged samples were placed in secure bins to ensure integrity during transport. They were delivered by Sitka personnel or a contract expeditor to ALS Laboratories' preparatory facility in Whitehorse, Yukon, with analyses completed in North Vancouver.
ALS is accredited to ISO 17025:2005 UKAS ref. 4028 for its laboratory analysis. Samples were crushed by ALS to over 70 per cent passing below two millimetres and split using a riffle splitter. One-thousand-gram splits were pulverized to over 85 per cent passing below 75 microns. Gold determinations are by fire assay with an inductively coupled plasma atomic emission spectroscopy (ICP-AES) finish on 50 g subsamples of the prepared pulp (ALS code: Au-ICP-22). Any sample returning over 10 g/t gold was re-analyzed by fire assay with a gravimetric finish on a 50 g subsample (ALS code: Au-GRA21). In addition, a 51-element analysis was performed on a 0.5 g subsample of the prepared pulps by an aqua regia digestion followed by an inductively coupled plasma mass spectroscopy (ICP-MS) finish (ALS code: ME-MS41). Select intervals at the Rhosgobel Deposit were selected for additional XRF analysis on a lithium borate fusion (ALS code: XRF-15b) for WO3.
All other scientific and technical content of this news release has been reviewed and approved by Gilles Dessureau, P.Geo., V.P. Exploration of the Company, and a Qualified Person (QP) as defined by National Instrument 43-101.
ON BEHALF OF THE BOARD OF DIRECTORS OF
SITKA GOLD CORP.
"Cor Coe"
CEO and Director
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary and Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions and the Company's anticipated work programs.
These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, market uncertainty and the results of the Company's anticipated work programs.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302502
Source: Sitka Gold Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Alto Ingredients v 1. čtvrtletí zvýšila výnos z klíčových surovin na 53,4 % z 48,2 % díky vyšším cenám kukuřičného oleje a nižším nákladům na kukuřici. Pekin Campus zvedl výnos na 54 % z 48 %.
Key Takeaways Alto Ingredients lifted its return on essential ingredients to 53.4% from 48.2% a year earlier.Higher corn oil prices, driven by renewable biofuels demand, added $2.2 million to quarterly revenues.The Pekin Campus return improved to 54% from 48%, reflecting better byproduct economics. Alto Ingredients, Inc. (ALTO - Free Report) generated more value from every bushel of corn it processed in the first quarter of 2026, even as weather-related disruptions at its Pekin campus weighed on production volumes. The improvement reflected the company's ability to derive higher returns from its co-products while benefiting from lower feedstock costs.
The company’s consolidated return on essential ingredients, which measures co-product revenues relative to total corn costs consumed, increased to 53.4% in the first quarter of 2026 from 48.2% in the year-ago period. The improvement came even as the company faced softer demand and increased competition in high-quality alcohol markets.
Much of the improvement was driven by stronger pricing across Alto Ingredients’ co-product portfolio. In particular, higher corn oil prices, supported by demand from renewable biofuels producers, provided a $2.2 million boost to revenues during the quarter. At the same time, the company also benefited from lower corn costs, which further enhanced returns from its corn-processing operations.
The Pekin Campus accounted for a significant portion of the gains. Its essential ingredients return improved to 54% from 48% a year earlier, reflecting better economics across the company's mix of byproducts. With stronger co-product economics and a lower-cost grain environment, Alto Ingredients was able to extract greater value from the same underlying corn input.
The results highlight the importance of co-products in Alto Ingredients' corn-processing economics, with stronger pricing helping it derive greater value from each bushel of corn processed.
What Do the Latest Metrics Say About Alto Ingredients?Alto Ingredients, which competes with Green Plains Inc. (GPRE - Free Report) and MGP Ingredients, Inc. (MGPI - Free Report) , has seen its shares rally 352.3% in the past year compared with the industry’s 3% growth. Shares of Green Plains have risen 166.1%, while MGP Ingredients has declined 44.2% during the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, Alto Ingredients’ forward price-to-sales ratio of 0.39 is lower than the industry’s average of 3. The company is trading at a discount to Green Plains (with a forward price-to-sales ratio of 0.53) and MGP Ingredients (0.70).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Alto Ingredients’ current fiscal-year earnings per share (EPS) implies a year-over-year surge of 671.4%, while the consensus mark for the next fiscal year’s EPS implies growth of 53.7%.
Image Source: Zacks Investment Research
Alto Ingredients currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Booz Allen Hamilton odkoupí Ultra I&C Mission Solutions od Cobham Ultra Group za 720 milionů USD. Akvizice posílí jeho portfolio obranných technologií.
MCLEAN, Va.--(BUSINESS WIRE)--Booz Allen Hamilton (NYSE: BAH) today announced that it has entered into a definitive agreement with the Cobham Ultra Group, an Advent portfolio company, to acquire its Ultra I&C Mission Solutions business (Ultra Mission Solutions) for $720 million. Ultra Mission Solutions is a defense technology business specializing in mission‑critical software, encryption, and edge‑compute products.
"By integrating Ultra Mission Solutions into our robust portfolio, we are further strengthening our ability to rapidly build and field the commercial products that will keep America ahead,” said Horacio Rozanski, Chairman and CEO of Booz Allen.
Share As global threats intensify, commercial technologies have become increasingly central to modern warfighting. The U.S. and its allies require solutions that seamlessly integrate this wave of new technologies to generate operational utility on the battlefield. Together, Booz Allen and Ultra Mission Solutions will provide an enhanced set of products to unlock this advantage for national security missions at greater speed and scale.
“Technological superiority is essential to U.S. national security, and maintaining our advantage requires a relentless focus on speed and outcomes,” said Horacio Rozanski, Chairman and CEO of Booz Allen. “Booz Allen is strategically investing to accelerate delivery of our defense tech products into national security missions. Now, by integrating Ultra Mission Solutions into our robust portfolio, we are further strengthening our ability to rapidly build and field the commercial products that will keep America ahead.”
For years, both Booz Allen and Ultra Mission Solutions have been focused on building products and capabilities that help warfighters integrate, secure, and operationalize technology at the edge and across domains. Booz Allen’s portfolio of AI-driven battle management, resilient communications, and edge infrastructure solutions—including the Modular Detachment Kit (MDK), EdgeXtend™ and Sit(x)®—will expand with Ultra Solutions’ mission-ready tech stack. Ultra Mission Solutions’ core offerings, including Apex, ADSI®, ACTS™, Rain™, and Knox™, unify command and control (C2), edge compute, secure data movement, and encryption into a modular architecture capable of operating in contested or disconnected environments. These solutions will now integrate into a unified platform available to national security clients worldwide.
“We are investing in reliable, scalable solutions that help unite the defense technology ecosystem. This combination provides a foundation for our continued investment to harness advantage from commercial technology innovation,” said Steve Escaravage, president of Booz Allen’s defense technology business.
The acquisition will enable increased product integration and commercially available solutions accessible through outcomes-based procurement, Foreign Military Sales (FMS), and other go-to-market channels.
“Our customers operate where failure isn't an option, and meeting that standard has always defined our work,” said Mladen Brkic, president of Ultra Mission Solutions. “As part of Booz Allen, we'll bring greater scale and investment to our employees, products and the critical technologies customers rely on in the most contested conditions and wherever the mission demands it.”
Booz Allen expects revenue from this acquisition to grow at a strong double-digit rate for the next several years with EBITDA margins well above 20%. The transaction is expected to close in the second quarter of Booz Allen’s fiscal year 2027 (ending September 30, 2026) and is subject to customary closing conditions. Following the closing of the transaction, Ultra Mission Solutions will operate as a wholly owned subsidiary of Booz Allen.
“Ultra Mission Solutions has established itself as a trusted partner to the U.S. military and its allies with a portfolio of capabilities designed for the next generation of national security missions,” said Mike Marshall, managing director at Advent. “We are proud to have invested in those leading-edge solutions and are confident that Booz Allen is the right home to scale that vision further."
Booz Allen retained Jefferies LLC as exclusive financial advisor, PwC as accounting and tax advisor, King & Spalding LLP as legal advisor, and Renaissance Strategic Advisors as strategic industry advisor. Ultra Mission Solutions and Advent retained Baird as exclusive financial advisor, KPMG as accounting and tax advisor, and Latham & Watkins LLP as legal advisor.
About Booz Allen Hamilton
Booz Allen is an advanced technology company. We build commercial-grade products and solutions for America’s most critical defense, civil, and national security priorities. For more information, visit www.boozallen.com. (NYSE: BAH)
About Ultra Mission Solutions
Ultra I&C Mission Solutions (Ultra Mission Solutions) is a defense technology business that develops mission-critical software, edge-compute, and encryption products that help warfighters integrate, secure, and operationalize data at the tactical edge. The business operates across three lines of business—Mission Software, Edge Compute, and Encryption Management—delivering AI-enabled command and control (C2), ruggedized multifunction processors, and modular encryption-management solutions for U.S. Army, Air Force, Navy, and allied programs. An independent, U.S.-owned enterprise with over 100 years of heritage, Ultra Mission Solutions employs approximately 220 people, including roughly 135 specialized engineers, across five U.S. facilities, with its headquarters in Austin, Texas.
About Advent
Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $100 billion in assets under management* and have made 448 investments across 44 countries. Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans.
Advent has a long-established investment strategy in the defense sector, where it has consistently backed businesses supporting national security priorities. Since 2020, Advent has invested more than $15 billion enterprise value across the global defense sector, including investments in Cobham, Ultra Electronics, Vantor, and Attalon.
*Assets under management (AUM) as of December 31, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.
Forward-Looking Statements
Certain statements contained in this release include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include statements that do not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,” “expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements, including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2026, which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Worksport získal přímou investici za 1,20 USD na akcii, tedy přibližně dvojnásobek nedávné tržní ceny. Investor zároveň projevil zájem o další financování až do výše 10 milionů USD.
Major Investor Completes a Direct Investment Priced at $1.20 per Share - a Premium of More Than 100% to Recent Trading Levels
The Investor Has Also Expressed Interest in Evaluating Up to $10 Million in Potential Additional Financing as Worksport Advances Its 2026 Growth Plan
WEST SENECA, NY / ACCESS Newswire / June 18, 2026 / Worksport Ltd. (NASDAQ:WKSP) ("Worksport" or the "Company"), a U.S.-based innovator and manufacturer of hybrid and clean energy solutions primarily for the light truck, overlanding, and global consumer goods markets, today announced a premium-priced direct investment from a specialized private investment firm based in Jericho, New York.
The direct investment was priced at $1.20 per unit (each unit consisting of one share of common stock and one warrant), representing approximately a 100% premium to Worksport's recent trading price of $0.5983, underscoring the investor's confidence in the Company's outlook and long-term growth potential. The financing also includes warrants exercisable at $1.50 per share, further aligning the transaction with potential future upside in Worksport's common stock.
The investor has also expressed interest in evaluating additional financing transactions with Worksport of up to $10 million, subject to market conditions, available registration capacity, regulatory requirements, definitive documentation, and Company approval. There can be no assurance that any additional financing will be completed, and any such transaction would be subject to negotiation and execution of definitive agreements on terms acceptable to both parties.
Premium-Priced Capital Reflects Outside Confidence During a Key Execution Year
Worksport believes the structure of this investment is notable because it was priced at a substantial premium to the Company's recent market price. Management views the premium pricing, warrant structure, and additional financing interest as a constructive signal as Worksport continues executing against its 2026 commercial growth plan.
The investment was completed through a registered direct offering pursuant to the Company's effective shelf registration statement on Form S-3. The initial investment amount was $250,000. D. Boral Capital LLC acted as exclusive placement agent for the offering. Investors may review the terms and conditions of the offering and the warrants in the Company's Current Report on Form 8-K which will be filed with the SEC.
This announcement follows several recent Worksport milestones. The Company reported Q1 2026 net sales of $3.3 million, up 47.9% year over year, and gross profit of approximately $854,000, up 115.5% year over year, with gross margin improving to 26%. Worksport has also reiterated its target of reaching initial operational cash-flow positivity within 2026, driven by a quarterly revenue goal of $9M with 35% gross margins.
Worksport's recent growth plan is supported by several active business drivers, including expanded tonneau cover sales, the launch of the Company's new Nexus tonneau cover, early commercialization of SOLIS and COR, and broader B2B and B2C distribution growth. The Company also recently announced a distribution relationship with Tri-State Enterprises, projected by Worksport to become a seven-figure annual account.
In addition to its core tonneau and clean-energy product strategy, Worksport recently announced that its subsidiary, Terravis Energy, secured a newly issued U.S. patent for its ZeroFrost™ heat-pump technology. Management believes this patent strengthens the Company's long-term intellectual property position while preserving potential upside beyond Worksport's core 2026 revenue drivers.
CEO Commentary
"We believe this premium-priced investment sends an important message at a pivotal time for Worksport," said Steven Rossi, Founder and Chief Executive Officer of Worksport. "Our shares have been trading at levels that we believe do not reflect the commercial progress, product portfolio, manufacturing platform, and revenue trajectory we are building. A direct investment priced at $1.20 per share, paired with $1.50 warrants and interest in evaluating up to $10 million in total financing, represents a strong vote of confidence in our direction."
Mr. Rossi continued, "The dollar amount of this initial investment is not the headline. The headline is that Worksport secured capital at a substantial premium to the market while continuing to attract interest from investors who recognize the scale of the opportunity ahead. We are focused on converting our inventory, expanding distribution, increasing sales velocity, launching high-margin products, and executing toward operational cash flow positivity. Our objective remains clear: build a stronger company, create long-term shareholder value, and position Worksport for sustained growth."
Stay tuned for more information and join our mailing list to stay up to date with the latest: Join Worksport's Newsletter
Connect with Worksport Chief Executive Officer, Steven Rossi
Steven Rossi X (Twitter)
Steven Rossi LinkedIn
About Worksport
Worksport Ltd. (NASDAQ:WKSP), through its subsidiaries, designs, develops, manufactures, and owns the intellectual property on a variety of tonneau covers, solar integrations, portable power systems, and clean heating & cooling solutions. Worksport's hard-folding cover, designed and manufactured in-house, is compatible with all major truck models and is gaining traction with newer truck makers including the electric vehicle (EV) sector. Worksport seeks to capitalize on the growing shift of consumer mindsets towards clean energy integrations with its proprietary solar solutions, mobile energy storage systems (ESS), and Cold-Climate Heat Pump (CCHP) technology. Terravis Energy's website is terravisenergy.com.
Connect With Worksport
Please follow the Company's social media accounts on X (previously Twitter), Facebook, LinkedIn, YouTube, and Instagram, the links of which are links to external third-party websites, as well as sign up for the Company's newsletters at investors.worksport.com.
Social Media Disclaimer
The Company does not endorse, ensure the accuracy of, or accept any responsibility for any content on these third-party websites other than content published by the Company. Investors and others should note that the Company announces material financial information to our investors using our investor relations website, press releases, Securities and Exchange Commission ("SEC") filings, and public conference calls and webcasts. The Company also uses social media to announce Company news and other information. The Company encourages investors, the media, and others to review the information the Company publishes on social media. The Company does not selectively disclose material non-public information on social media. If there is any significant financial information, the Company will release it broadly to the public through a press release or SEC filing prior to publishing it on social media.
Forward-Looking Statements
The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "scheduled," "expect," "future," "intend," "plan," "project," "envisioned," "should," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. These statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial situation may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) supply chain delays; (ii) acceptance of our products by consumers; (iii) delays in or nonacceptance by third parties to sell our products; (iv) competition from other producers of similar products; and (v) with respect to any potential additional financing transactions, there can be no assurance that any such transactions will be consummated, and any such transactions would be subject to, among other things, market conditions, available shelf registration capacity, applicable regulatory requirements (including Nasdaq listing rules), negotiation and execution of definitive documentation on mutually acceptable terms, and approval by the Company's Board of Directors. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, including, without limitation, our latest Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at www.sec.gov. As a result of these matters, changes in facts, assumptions not being realized or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. The forward-looking statements made in this press release are made only as of the date of this press release, and the Company undertakes no obligation to update them to reflect subsequent events or circumstances.
Worksport oznámil rekordní hrubou marži kolem 35 % v květnu a nového distribučního partnera Meyer Distributing. Firma zároveň cílí na více než 36 mil. USD roční příležitosti v příjmech.
Company announces three major operating inflections: preliminary May record breaking gross margin of approximately 35% (up 660 Basis Points), a new Meyer Distributing relationship, and a $36M+ 12-month revenue opportunity supported by accelerating B2C and B2B growth.
The announcement follows last week's premium-priced direct investment and highlights the distribution scale, margin expansion, and revenue drivers that management believes lead the Company's path toward near-term operational cash-flow positivity.
WEST SENECA, NY / ACCESS Newswire / June 22, 2026 / Worksport Ltd. (NASDAQ:WKSP) ("Worksport" or the "Company"), a U.S.-based innovator and manufacturer of hybrid and clean energy solutions primarily for the light truck, overlanding, and global consumer goods markets, today announced three new commercial and operational developments that management believes mark a potential inflection point in Worksport's 2026 growth plan.
The Company announced that it has secured Meyer Distributing as a new national distribution partner, achieved 35% gross margin in May 2026 (up from 28.4% in Q1 2026), and is now targeting a $36 million+ 12-month revenue opportunity supported by increasing B2C activity, expanding B2B distribution, newly launched products, and improving operating leverage.
The announcement follows Worksport's recently completed premium-priced direct investment, which the Company believes reflected investor confidence in its strategic direction. With annualized revenue currently tracking above $20 million and momentum continuing to build during the second quarter, management believes the Company is entering the second half of 2026 with a significantly stronger commercial and operating foundation.
Preliminary May Gross Margin Reaches Approximately 35%
Worksport today announced that it achieved approximately 35% gross margin in May 2026, representing a new record margin metric for the company, based on preliminary unaudited internal results. This represents continued margin improvement from approximately 11% gross margin in December 2024 and approximately 30% gross margin in December 2025. Gross margin has increased despite U.S. aluminum prices rising approximately 50% in two years. Management believes any future decline in aluminum prices could provide additional gross margin expansion. .
Management believes the improvement reflects continued progress in production efficiency, cost discipline, pricing strength, and operating scale. The margin milestone is important because, at higher gross margins, each incremental dollar of revenue can contribute more meaningfully toward covering fixed operating costs.
Management estimates that, assuming an approximate 35% gross margin level, Worksport would need to generate roughly $9 million in quarterly revenue to achieve operational cash-flow positivity. Worksport continues to target initial operational cash-flow positivity within 2026, supported by increased sales velocity and gross margins, expanding B2B distribution, ongoing B2C demand, and execution across its product portfolio.
New Meyer Distributing Relationship Expands Worksport's B2B Reach
Worksport also announced that it has secured Meyer Distributing as its first multinational distribution partner and has received an initial purchase order for Worksport tonneau covers. Meyer Distributing is one of North America's leading automotive aftermarket wholesale distribution networks, serving dealers across the United States, Canada, and international markets with over 3.5 million sq. ft. of warehouse space. Meyer was also recognized by the Specialty Equipment Market Association (SEMA) as Warehouse Distributor of the Year in 2010, 2015, and 2017.
For Worksport, the Meyer relationship represents more than an initial order. It marks a significant B2B milestone that gives the Company access to a larger base of recurring orders from thousands of dealers, installers, and aftermarket resellers across USA and Canada, at a time when Worksport is expanding production, launching new products, and targeting meaningful revenue growth in 2026.
The Company believes the addition of Meyer-combined with recently announced Tri-State Enterprises traction and existing wholesale and dealer relationships including Patriot Auto, and Worksport's expanding dealer network-strengthens its commercial platform and supports a larger recurring revenue opportunity as Worksport products move through established aftermarket sales channels.
$36M+ Annualized Revenue Opportunity Supported by B2C and B2B Growth
Worksport's B2C activity is currently tracking near approximately $1 million per month, or approximately $12 million annualized. Separately, B2B sales were recently tracking near approximately $0.7 million per month, or approximately $8.4 million annualized.
With the addition of Meyer Distributing, recent Tri-State momentum, existing channel relationships, and continued dealer network expansion, management believes B2B annualized revenue potential can expand toward $24 million or more over the next 12 months following activation and ramp-up of these relationships.
When combined with current B2C activity, this supports a total annualized revenue opportunity of approximately $36 million or more. Management believes this opportunity aligns with Worksport's previously stated near-term cash-flow positivity goals and reflects a more scalable commercial base than the Company had entering the year.
CEO Commentary
"We believe Worksport is entering a very different phase of the business," said Steven Rossi, Founder and Chief Executive Officer of Worksport. "Last week's investment reflected external confidence in our direction. Today's update demonstrates an operating foundation: expanding distribution, improving gross margins, compelling B2C activity, and a clear revenue path toward near-term operational cash-flow positivity."
Mr. Rossi added, "The Meyer relationship is an important step for our B2B strategy. Meyer is a respected name in automotive aftermarket distribution, and we believe its reach can help Worksport products move through a much larger dealer and installer network over time. Combined with Tri-State, Patriot Auto, AllPro, our expanding dealer base, and our new Nexus cover, we believe the commercial architecture needed to scale is coming together."
Mr. Rossi concluded, "At approximately 35% gross margin, Worksport looks very different than it did a year ago. Each additional dollar of revenue has more potential impact. Our objective remains clear: increase sales velocity, expand margins, convert inventory, grow distribution, and pursue initial operational cash-flow positivity within 2026. We believe the inflection point we have been working toward is beginning to take shape."
Worksport intends to continue updating shareholders as B2B onboarding, distributor sell-through, NEXUS adoption, margin progression, and overall revenue conversion progress through 2026.
Stay tuned for more information and join our mailing list to stay up to date with the latest: Join Worksport's Newsletter
Connect with Worksport Chief Executive Officer, Steven Rossi
Steven Rossi X (Twitter)
Steven Rossi LinkedIn
About Worksport
Worksport Ltd. (Nasdaq: WKSP), through its subsidiaries, designs, develops, manufactures, and owns the intellectual property on a variety of tonneau covers, solar integrations, portable power systems, and clean heating & cooling solutions. Worksport's hard-folding cover, designed and manufactured in-house, is compatible with all major truck models and is gaining traction with newer truck makers including the electric vehicle (EV) sector. Worksport seeks to capitalize on the growing shift of consumer mindsets towards clean energy integrations with its proprietary solar solutions, mobile energy storage systems (ESS), and Cold-Climate Heat Pump (CCHP) technology. Terravis Energy's website is terravisenergy.com.
Connect with Worksport
Please follow the Company's social media accounts on X (previously Twitter), Facebook,
LinkedIn, YouTube, and Instagram, the links of which are links to external third-party websites, as well as sign up for the Company's newsletters at investors.worksport.com.
Social Media Disclaimer
The Company does not endorse, ensure the accuracy of, or accept any responsibility for any content on these third-party websites other than content published by the Company. Investors and others should note that the Company announces material financial information to our investors using our investor relations website, press releases, Securities and Exchange Commission ("SEC") filings, and public conference calls and webcasts. The Company also uses social media to announce Company news and other information. The Company encourages investors, the media, and others to review the information the Company publishes on social media. The Company does not selectively disclose material non-public information on social media. If there is any significant financial information, the Company will release it broadly to the public through a press release or SEC filing prior to publishing it on social media.
Forward-Looking Statements
The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "scheduled," "expect," "future," "intend," "plan," "project," "envisioned," "should," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. These statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial situation may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) supply chain delays; (ii) acceptance of our products by consumers; (iii) delays in or nonacceptance by third parties to sell our products; (iv) competition from other producers of similar products; and (v) with respect to any potential additional financing transactions, there can be no assurance that any such transactions will be consummated, and any such transactions would be subject to, among other things, market conditions, available shelf registration capacity, applicable regulatory requirements (including Nasdaq listing rules), negotiation and execution of definitive documentation on mutually acceptable terms, and approval by the Company's Board of Directors. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, including, without limitation, our latest Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at www.sec.gov. As a result of these matters, changes in facts, assumptions not being realized or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. The forward-looking statements made in this press release are made only as of the date of this press release, and the Company undertakes no obligation to update them to reflect subsequent events or circumstances.
Petrobras chce do září obnovit výstavbu továrny na hnojiva UFN-III v Tres Lagoas, která má po dokončení stát 1 miliardu dolarů. Spuštění provozu plánuje na rok 2029.
A drone view shows the building of the Brazil's state-run oil company Petrobras, amid a workers strike, in Rio de Janeiro, Brazil December 19, 2025. REUTERS/Pilar Olivares/File Photo Purchase Licensing Rights, opens new tab
CompaniesRIO DE JANEIRO, June 18 (Reuters) - Brazil's state-run oil firm Petrobras (PETR3.SA), opens new tab plans to resume construction of a fertilizer plant in Mato Grosso do Sul state by September, in another move to reduce the country's dependence on imports, executive William Franca said on Thursday.
Construction of the UFN-III fertilizer plant in Tres Lagoas, which will cost $1 billion to finish, has been on hold since 2015.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
The company aims to begin operations in 2029, Franca, Petrobras' director of industrial processes and products, told Reuters.
The nitrogen fertilizer plant will have production capacity of 3,600 metric tons per day of urea and 2,200 tons per day of ammonia.
The Tres Lagoas location is considered strategic due to its proximity to major agribusiness consumer hubs such as the states of Mato Grosso, Mato Grosso do Sul, Goias, Parana and Sao Paulo.
The resumption is part of a broader Petrobras strategy to reduce Brazil's dependence on imported fertilizers. The company has reactivated other nitrogen fertilizer units in Parana, Bahia and Sergipe.
"This plant alone should reduce urea imports by 12%. With the other plants combined, that reduction could reach 35%," Franca said.
PRESSURE MAY EASE ON REFINERIESFollowing a U.S.-Iran interim agreement to end the war between the countries, pressure is likely to decrease on Petrobras' refining operations, which have run at high levels to minimize fuel imports.
The refineries are operating at around 101% of capacity, and are expected to remain at that level through June, Franca said. Petrobras increased processing during the war to cut the need for imports.
Under a more stable scenario, the company intends to resume scheduled maintenance shutdowns that had been postponed, Franca said, without providing details.
"It's not possible to stay above 100% all the time. We postponed some shutdowns because of the war, but we will mainly carry out some planned outages, especially in 2027, also due to regulatory requirements," he said.
Reporting by Rodrigo Viga Gaier; Writing by Fernando Cardoso; Editing by Mark Porter, Rod Nickel
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Petrobras schválila projekt za 1,2 mld. USD na výrobu bioQAV a obnovitelné nafty v rafinerii Presidente Bernardes. Výstavba má začít letos, komerční provoz je cílen na rok 2030 s kapacitou 15 000 barelů denně.
Key Takeaways Petrobras approved a $1.2B bioQAV and renewable diesel project at the Presidente Bernardes Refinery.PBR plans construction this year, with commercial operations targeted for 2030 and 15,000 bpd capacity.Petrobras included the project in its 2026-2030 Strategic Plan and approved final contracting to proceed. Petrobras (PBR - Free Report) has taken a significant step toward advancing sustainable energy production by approving a $1.2 billion investment to develop a state-of-the-art facility dedicated to the production of renewable jet fuel (bioQAV) and renewable diesel, according to Reuters. The project represents one of the most important renewable fuel initiatives in Latin America and reinforces Petrobras' commitment to balancing traditional energy operations with emerging low-carbon solutions.
The newly approved investment aligns with Petrobras' long-term strategic vision and positions it at the forefront of the growing global demand for cleaner transportation fuels. As governments, airlines and industries seek to reduce carbon emissions, renewable aviation and diesel fuels are becoming increasingly critical components of the worldwide energy transition.
New BioQAV and Renewable Diesel Plant Planned for Sao Paulo StateThe renewable fuel facility will be constructed at Petrobras' Presidente Bernardes Refinery in the state of São Paulo, one of the company's most important refining complexes. The location offers strategic advantages, including existing infrastructure, logistical connectivity and access to major domestic and international fuel markets.
According to company plans, construction is expected to begin during the current year, while commercial operations are scheduled to commence in 2030. Once operational, the plant will have the capacity to produce up to 15,000 barrels per day of renewable fuels, making it a major contributor to Brazil's sustainable fuel production capacity.
The project was already incorporated into Petrobras' 2026-2030 Strategic Plan, demonstrating that renewable energy investments remain a central component of its growth strategy.
Growing Demand for Renewable Jet Fuel Drives InvestmentThe aviation industry is under increasing pressure to reduce greenhouse gas emissions. Renewable jet fuel, commonly referred to as Sustainable Aviation Fuel (“SAF”) or bioQAV in Brazil, has emerged as one of the most promising solutions for decarbonizing air transportation.
Unlike conventional jet fuel derived solely from fossil sources, renewable jet fuel can significantly lower lifecycle carbon emissions while remaining compatible with existing aircraft engines and airport infrastructure. This compatibility allows airlines to reduce environmental impact without requiring major fleet modifications.
By investing heavily in bioQAV production, Petrobras is positioning itself to capitalize on rising global demand. International aviation organizations, regulators and airlines are establishing ambitious targets for SAF adoption, creating substantial long-term market opportunities for producers capable of delivering large-scale supply.
Renewable Diesel Expands Petrobras' Sustainable Fuel PortfolioIn addition to renewable aviation fuel, the new facility will produce substantial volumes of renewable diesel, a fuel that offers significant environmental benefits compared with traditional petroleum-based diesel.
Renewable diesel is manufactured using renewable feedstocks and can be utilized within existing diesel engines and distribution systems. The fuel provides lower emissions while maintaining performance standards required by transportation, industrial and commercial sectors.
As global demand for cleaner transportation fuels continues to expand, renewable diesel is expected to play a critical role in helping countries meet climate commitments while ensuring reliable energy supplies. Petrobras' investment demonstrates confidence in the long-term growth prospects of this market segment.
Strategic Importance of the Presidente Bernardes Refinery ProjectThe selection of the Presidente Bernardes Refinery as the project site highlights Petrobras' strategy of leveraging existing assets to support energy transition goals. Integrating renewable fuel production within an established refining complex enables operational efficiencies, optimized logistics and enhanced cost competitiveness.
The refinery has long served as a cornerstone of Petrobras' downstream operations. The addition of renewable fuel capabilities transforms the site into a more diversified energy hub capable of supporting both traditional and emerging fuel markets.
This approach reflects a broader trend among global energy companies, many of which are adapting existing refining infrastructure to accommodate renewable fuel production rather than constructing entirely new facilities from scratch.
Petrobras' 2026-2030 Strategic Plan Emphasizes SustainabilityThe renewable fuel project forms part of Petrobras' broader strategy to navigate evolving energy markets while maintaining profitability and competitiveness. The company's 2026-2030 strategic roadmap outlines substantial investments aimed at improving operational efficiency, expanding lower-carbon businesses and strengthening long-term value creation.
As environmental regulations tighten worldwide and customer preferences increasingly favor sustainable products, investments in renewable fuels offer Petrobras an opportunity to diversify revenue streams while supporting national and international decarbonization efforts.
As per the news, the board's approval marks a critical milestone, allowing Petrobras to advance into the final contracting phase before construction activities begin.
Economic Benefits for Brazil and the Renewable Energy SectorBeyond environmental advantages, the project is expected to generate significant economic benefits. Large-scale infrastructure developments typically create employment opportunities throughout planning, construction and operational phases.
The investment may also stimulate growth across Brazil's renewable energy supply chain, including feedstock production, logistics, engineering services and technology development. Such initiatives can strengthen Brazil's position as a leading participant in the global renewable fuels market.
Furthermore, increased domestic production of renewable fuels could enhance energy security while reducing dependence on imported sustainable fuel supplies as demand accelerates in the coming decades.
Global Renewable Fuel Market Continues to ExpandThe worldwide renewable fuel market is experiencing rapid growth as industries seek practical pathways to reduce emissions. Aviation, freight transportation, shipping and industrial sectors are increasingly incorporating renewable fuel solutions into their sustainability strategies.
Analysts project continued expansion in both renewable diesel and sustainable aviation fuel markets due to supportive government policies, corporate climate commitments and technological advancements. Producers capable of achieving commercial-scale output are expected to benefit from strong demand fundamentals over the long term.
Petrobras' decision to invest $1.2 billion underscores confidence in these market dynamics and reflects its intention to remain a key player in the evolving global energy landscape.
A Landmark Step Toward a Lower-Carbon FutureThe approval of Petrobras' renewable fuel plant represents a landmark development for Brazil's energy sector. With planned production of up to 15,000 barrels per day of bioQAV and renewable diesel, the facility will become an important contributor to sustainable fuel availability in the region.
As construction moves forward and final contracts are executed, the project stands as a powerful example of how major energy companies are adapting to changing market demands. By combining industrial expertise, strategic infrastructure and substantial investment, Petrobras is laying the foundation for a more diversified and lower-carbon energy future while strengthening its competitive position in the global renewable fuels market.
PBR's Zacks Rank & Key PicksCurrently, PBR has a Zacks Rank #3 (Hold).
Investors interested in the energy sector might look at some better-ranked stocks like Delek US Holdings (DK - Free Report) , Phillips 66 (PSX - Free Report) and Murphy USA (MUSA - Free Report) , sporting a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Delek US is valued at $2.54 billion. It is a U.S.-based downstream energy company that focuses on refining crude oil and distributing petroleum products. Headquartered in Brentwood, TN, Delek US Holdings operates through two main segments: refining and logistics.
Phillips 66 is valued at $66.61 billion. It is a diversified energy company that refines crude oil, markets petroleum products, and operates midstream, chemicals, and renewable fuels businesses. Phillips 66 operates across the United States and internationally.
Murphy USA is valued at $10.18 billion. The company is one of the largest independent gasoline and convenience store retailers in the United States, operating a network of stores primarily located near Walmart locations. Murphy USA focuses on offering low-cost fuel and everyday convenience products, supported by a strong loyalty program and disciplined capital-allocation strategy.
Nebius má po 1. čtvrtletí 2026 v hotovosti 9,3 mld. USD a zvýšil capex pro rok 2026 na 20–25 mld. USD. Firma říká, že poptávka převyšuje nabídku a volná kapacita je vyprodaná.
Key Takeaways Nebius ended Q1 2026 with $9.3B in cash after debt, equity and upfront-payment inflows.Nebius lifted 2026 capex guidance to $20B-$25B as it accelerates capacity expansion.Nebius says demand exceeds supply, available capacity is selling out and 2027 commitments are in place. Nebius Group N.V. (NBIS - Free Report) has built a sturdy cash profile with $9.3 billion in cash and cash equivalents at the end of the first quarter of 2026. A strong cash position offers ample financial flexibility to pursue expansion, both organic and inorganic.
The cash build was driven by various financial initiatives, including a $4.3 billion convertible debt raise (gross proceeds) and a $2 billion equity investment from NVIDIA, alongside customer upfront payments that boosted operating cash flow to $2.3 billion for the quarter.
This fortified balance sheet comes at a time when Nebius is rapidly focused on capacity expansion, which has led to a sharp acceleration in capital expenditures. Capex for 2026 is now expected to be $20-$25 billion, up from its earlier guidance of $16-$20 billion.
Management noted that the capacity deployment is tied to visibility into future demand, particularly for 2027, for which it already has customer commitments in place. The company also noted that it is already selling out the available capacity, with demand consistently exceeding supply, implying that spending is less speculative and more about meeting anticipated workloads.
Importantly, Nebius is using various sources to fund capacity expansion. The company is raising capital through asset-backed financing buoyed by its contracts with Meta and Microsoft (MSFT - Free Report) . Other financing options include corporate-level debt and an at-the-market program.
With demand continuing to exceed supply and most capacity already sold out, Nebius appears well positioned to convert its cash strength into capacity expansion. While execution remains key, the company’s sizable cash and funding flexibility provide a strong foundation to scale its AI cloud platform. However, the opportunity is unfolding in a highly competitive space with tech giants and pure plays like CoreWeave (CRWV - Free Report) aggressively focused on capacity build to capture a rapidly developing market.
Taking a Look at Competitors’ Financial ResourcesCoreWeave is shoring up its financial resources to support AI infrastructure buildouts. At the first quarter-end, the company had more than $3.3 billion in cash, cash equivalents, restricted cash and marketable securities, while securing more than $20 billion in debt and equity capital financing year to date (as announced on the last earnings call), widening access to capital while lowering its cost of debt.
Like NBIS, the company also raised $2 billion in equity tied to its NVIDIA partnership. CRWV has dramatically accelerated investments to keep up with AI demand. 2026 capital expenditures are projected to be between $31 billion and $35 billion, reflecting the broad scale of its AI infrastructure ambitions.
Microsoft’s financial resources are stupendous. As of March 31, 2026, cash, cash equivalents and short-term investments stood at $78.3 billion. For the last reported quarter, the company generated $46.7 billion in operating cash flow, up 26% year over year, while free cash flow stood at $15.8 billion despite accelerated capital spending. MSFT is scaling investments, with fiscal third-quarter capital expenditures hovering at $31.9 billion. Fiscal fourth-quarter capex is expected to exceed more than $40 billion, reflecting the continued buildout of AI infrastructure.
For calendar 2026, Microsoft plans to invest approximately $190 billion in capex, including about $25 billion attributed to component pricing pressures, underscoring both scale and inflationary pressures in AI infrastructure. Increasing capital intensity remains a key concern for investors. MSFT's long-term debt (including the current portion) was $40.3 billion as of March 31, 2026.
NBIS Price Performance, Valuation and EstimatesShares of Nebius are up 40.6% in the past month compared with the Internet – Software and Services industry’s 11.3% growth.
Image Source: Zacks Investment Research
On a forward price-to-sales basis, NBIS’ shares are trading at 10.62X, above the Internet Software Services industry’s 4.53X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for NBIS’ earnings for 2026 has been revised upwards over the past 60 days.
Image Source: Zacks Investment Research
NBIS currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.